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HUMAN H ERPESVI RUSES 
MoRPHOlOGY AND ClASSIFICATION 
Virions of Herpesviridae family have a char-
acteristic morphology. An icosadeltahedral 
capsid surrounds an electron opaque core in 
which double stranded DNA is located. The 
capsid itself is surrounded by a tegument and 
"-
Figure 1: The morphology ofherpesviruses. 
a viral envelope. The viral envelope is the outer 
surface of the virion in which virus-encoded 
glycoproteins, exhibited as spikes, are embed-
ded (Fig.l). 
The overall size of the virions varies from 
120-300 nm. The double stranded DNA 
lb. 
a. schematic representation of the herpesvirion. Viral DNA is wrapped around a protein core that lies within a icosadelta-
hedal capsid . Together these form the nucleocapsid. The tegument, an amorphous protein structure, lies between the 
outer phospholipoprotein membrane and the nucleocapside. 
reprinted with permission from Pa11an-Langston, Dunkel E. Varicella Zoster IJirus diseases: Anterior segment of the eye. In: Pepose 
JS, Holland GN, Wi/he/mus I(R, editors. Ocular infection and immunity. StLouis: Mosby· Year Book;199G.p 934 
b. Electron Micrograph (EM) of the capsid ofHSV 
c. EM of the nucleus of a human corneal keratocyte with multiple herpes simplex virions. 
d. detail of EM c. matching the schematic representation of the virion in a. 
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Figure 2: Schematic representation of the arrangement of 
DNA sequences in the HSV genome' . 
The unique sequences (thin lines) are flanked by the 
inverted repeats boxes 
Letters below the line designate·. 
a
1 
terminal a sequence of the unique long component. 
an variable number of additional a sequences 
b the b sequence 
UL the unique sequence of the L component 
b' the repetitions of the b sequence 
am a variable number of a sequences 
c" the inverted c sequence 
U5 the unique sequence of the S component 
c the repetition of the c sequence 
as the terminal a sequence 
genome ranges from 120 to 230 kilo base pairs 
(kb)'. The genome of herpes simplex virus 
(HSV) or human herpesvirus type 1 (HHV-1), 
the prototype of the Alphaherpesvirinae (see 
below), has a unique organization (Fig. 2). It 
consists of long double stranded linear mole-
cules with several repeated and inverted 
sequences. The DNA has two stretches of 
unique sequences, one long (unique long 
sequence, U J and one that is much shorter 
(unique short sequence, Us)''. Each of these 
long sequences is bracketed by shorter identi-
cal DNA repeats. The viral DNA contains ter-
minal (TR) and internal reiterated (IR) 
sequences. Because of the variability in the 
number of these reiterations, the size of indi-
vidual genomes may vary by more than 10 kb 1 • 
The genome of herpesviruses encodes 
about 80 proteins. These proteins have regula-
tory functions, (e.g. DNA polymerase), or are 
structural proteins, (e.g. glycoproteins)'. The 
glycoproteins mediate attachment of the virus 
to cells, the capsid acts as a vector for the viral 
DNA', and several tegument proteins are 
involved in the initiation of viral replication3 • 
Both glycoproteins and structural proteins 
have been shown to play a role in the adaptive 
host immune responses'' (see below). 
The family Herpesviridae comprises a group 
of ancient large DNA viruses that are wide-
spread in the animal world, having mammals, 
fish, birds and reptiles as their host species. 
They are classified into three subfamilies a., ~ 
and y, initially primarily on basis of tissue tro-
pism and related pathogenesis, but to date 
largely on basis of DNA sequence homology.' 
Alphaherpesvirinae 
The cx-herpesviruses have a relatively vari-
able host range, a relative short replication 
cycle, rapid spread in culture, efficient destruc-
tion of infected cells and tendency to establish 
latent infections in neural tissue. They include 
HSV-1, HHV-1; HSV-2, HHV-2; and varicella 
zoster virus (VZV),HHV-3; Table 1. 
Betaherpesvirinae 
The ~-herpesviruses have a restricted host 
range. The reproductive cycle is long and the 
infection progresses slowly in culture. The 
infected cells frequently become enlarged 
(cytomegalia). Latency is established in lym-
phoreticular cells, kidneys and secretory 
glands. They include cytomegalovirus (CMV), 
HHV-5; HHV-6,and HHV-7; Table 1. 
Gammaherpesvirinae 
The y-herpesviruses have a very restricted 
host range. Viruses in this group infect specif-
ic T-or B-lymphocytes, causing either a lytic or 
latent infection. They include Epstein-Barr 
virus (EBV),HHV-4; and HHV-8; Table 1. 
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REPLICATION AND LATENCY OF 
HERPES SIMPLEX VIRUS (HSV). 
HSV-1 is the prototype of the a-her-
pesviruses. The lytic or productive cycle of 
Figure 3: Functional organization ofthe HSV-1 genome. 
The circles are described from inside out. 
Circle 1: map units and kb. 
Circle 2: sequence arrangement of HSV genome. 
infection starts with the attachment of virus 
particles to susceptible cells. This interaction 
requires sequential interaction betvveen viral 
membrane glycoproteins and cellular recep-
Circle 3: the transcriptional map of the HSV-1 genome. The map serves the purpose of identifying the direction of tran-
scription, the approximate initiation and termination sites. 
Circle 4: the known functions of the proteins. 
Reprinted with permission from: Roizman B. Sears A E. Herpes simplex lliruses and their replication. In: Fields BN et a/ 
editors. Fields 11irology, yd ed. Philadelphia: Lippincott Ra11en Publishers 1996:2231-95 
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Figure 4 and 5 both reprinted with permission from: Whitley 
RJ. Herpes simplex 11iruses. In: Fields BN eta/ editors. Fields 
IJirology. ]rd ed. Philadelphia: Lippincott RaiJen Publishers 
1996: 2297-2342. 
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tors. Entry of virus mediated by fusion of the 
envelope and plasma membranes rapidly fol-
lows the initial attachment\. Upon entry into 
the cell, the capsids are transported to the 
nuclear pores where DNA is released into the 
nucleus. Transcription of viral DNA takes 
place in the nucleus in an orderly program 
(Fig. 3). The earliest genes expressed are the 
five HSV immediate-early genes (a-phase, 2-4 
hours post-infection). They are important in 
priming the cell for further gene expression 
and mobilizing cellular transcription machin-
ery. This phase is followed by the early gene 
expression (~-phase, 5-7 hours post-infection): 
the expression of a number of genes either 
directly or indirectly involved in genome repli-
cation. Upon genome replication viral struc-
tural proteins are expressed in high abundance 
during the late phase (~Y/Y phase, timing 
depends on viral DNA synthesis). 
Viral capsids assemble in the nucleus, they 
bud through the host cell nuclear and cyto-
plasmic membranes, becoming enveloped in 
the process. Viral proteins are synthesized in 
the cytoplasm. Some of the host glycoproteins 
are captured during the process and end up on 
the outer surface of the virion. Enveloped 
infectious virions can either remain cell-asso-
ciated and spread to other cells via virus-medi-
ated fusion, or can be released from the cell for 
reinfection. "Cell-to-cell" spread has several 
important implications for the pathogenesis of 
the disease. Diseases induced by HSV are 
characterized by local spread and progression 
of lesions, thereby largely evading local 
immune surveillance and host mediated 
immune clearance). 
One of the most striking properties of all 
herpesviruses is their ability to persist in an 
apparently inactive state for varying durations 
of time, referred to as latency. The cellular site 
oflatency appears to be different from the pri-
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mary tissue in which the lytic infection occurs. 
HSV combines this property with a tendency 
for neurovirulence". During primary infection, 
neurons innervating the infected mucosa are 
invaded by the virus. After initial infection the 
HSV ascends by retrograde axonal transport in 
nerve axons to the innervating sensory gan-
glia''·7, in which the virus replicates for several 
days. Subsequently, one of two mutually exclu-
sive events can occur. Either viral replication 
with neuronal destruction, which can result in 
severe neurological devastation (myelitis or 
encephalitis), or establishment of a latent 
infection and neuronal survival (Fig. 4). Latent 
infection is defined as a type of persistent 
infection in which the viral genome is present 
but infectious virus is not produced except 
during intermittent episodes of reactivation. 
During latency little or no virus protein is syn-
thesized, although an untranslated virus tran-
script, the so-called latency associated tran-
script (LAT), is produced. Occasionally, latency 
is interrupted, and the virus reactivates as the 
result of provocative stimuli. These may 
include physical or emotional stress, fever, 
exposure to ultraviolet light, immune suppres-
sion, menstruation and tissue damage. As a 
consequence any local trauma can reactivate 
the virus and cause a manifest infection". 
Reactivated virus travels down the sensory 
nerve and spreads to and replicates in muco-
cutaneous epithelial cells, producing the 
characteristic symptoms (Fig. 5)'. Recurrent 
HSV infections predominantly occur at the 
site of primary infection. 
Latent infections persist for life in the sen-
sory ganglia''. Studies of HSV-induced skin 
diseases reveal that HSV-1 is isolated princi-
pally from oro-labial lesions innervated by the 
trigeminal ganglia, and that HSV-2 is fre-
quently isolated from lesions in the genital 
areas innervated by sacral ganglia. However, in 
addition to these two major sites, HSV can 
Chapter 1 Introduction 
cause latent infection in other sites of spinal 
ganglia'. In addition to ganglionic or neuronal 
latency, however, there is evidence for per-
sistence of HSV DNA in both the skin"' and 
the cornea11 · 1"·u. LAT, however, has not been 
detected in these peripheral sites. 
Recurrent H SV infections are thought to 
result mainly from reactivation of the HSV 
strain acquired during primary infection'"· 1'. 
However, genotypic analysis of HSV isolates 
showed that a target organ is not immune to 
reinfectionlb,l?.l.',l". Yet the frequency of reinfec-
tion, with an exogenous virus, referred to as 
superinfection, in large scale studies seems to 
be low21UI.n. 
OCULAR MANIFESTATIONS OF 
HUMAN HERPESVIRUS INFECTIONS 
(TABLE!) 
The pattern of clinical disease resulting 
from primary infection with human her-
pesviruses is largely determined by the virus 
involved, the portal of entry and the immune 
status of the host. Generally in the fully 
immunecompetent host both primary and 
recurrent infections cause mild or no symp-
toms'. When clinical symptoms do occur, they 
range from the common fever blisters on the 
lip to more rare and severe infections of the 
central nervous system. An overview of clinical 
manifestations of HHV infections is given in 
tables 1 and 2 and Figure 8. lmmunecompro-
mised persons, e.g. transplant recipients, 
neonates and AIDS patients, are at increased 
risk for severe herpesvirus infections. 
Of the eight human herpesviruses identi-
fied to date seven have been shown to have 
clinical implications for ocular infection. HSV-
1 and VZV are the viruses which causes eye 
disease most frequently''". Not only the eye 
proper, may be affected, also infections of the 
adnexae, like the eye lid skin and lacrimal 
gland, as well as infections of the cranial 
nerves"' are possible. 
11 
HSV-2 infections of the eye are relatively 
rare, with clinical manifestations identical to 
those ofHSV-1. 
Primary and recurrent HSV infections in 
immunecompetent patients predominantly 
present with vesicular or ulcerating lesions on 
skin or mucous membranes. The mouth and 
lips are the most common sites ofHSV-1 infec-
tion. Reactivation of herpesviruses is common 
in the imrnunecompromised host, usually 
resulting in asymptomatic viral shedding or in 
progressive mucocutaneous infection. HSV, 
can disseminate and cause diffuse visceral 
infection"('. The clinical presentations of ocular 
HSV infections are discussed below. 
Varicella, caused by primary infection with 
VZV, is a common childhood infection. Ocular 
involvement in varicella frequently occurs on 
the eyelids, whereas corneal involvement is 
uncon1mon. Recurrent VZV infection (herpes 
zoster) presents as a cluster of vesicular lesions 
which appear unilaterally in the dermatomal 
distribution of one or more adjacent sensory 
nerves"'. Herpes zoster ophthalmicus is a clini-
cal syndrome involving the ophthalmic branch 
of the trigeminal nerve. Ocular complications 
occur in 50-72% of patients with herpes zoster 
ophthalmicus''. In case of VZV infections of 
the eye the same clinical manifestations as in 
HSV-1 infections are possible. In addition to 
these manifestations, postherpetic neuralgia 
and cranial nerve palsies may occur"''. Ocular 
disease caused by the reactivation oflatent VZV 
is more likely to occur in the elderly and the 
immunecompromised30 '3 ',l 2-33 • 
EBV is the most common etiologic agent of 
infectious mononucleosis'·'. EBV is also associ-
ated with malignant disease, including differ-
ent types of lymphomas and nasopharyngeal 
carcinomaJ.uo. Ocular manifestations occur 
rarely in EBV infection. When present, they 
may encompass a wide range of clinical pic-
tures, including infections of the anterior seg-
ment of the eye"', neuro-ophthalmological syn-
dromes)~ and intra-ocular lymphoma'·1• 
Congenital infections with CMV primarily 
affect the reticuloendothelial system and the 
central nervous system (CNS), whereas 
acquired CMV infection in immunecompetent 
individuals is usually asymptomatic. Some 
patients, however, develop a syndrome resem-
bling infectious mononucleosis. Progression to 
invasive organ disease is mainly seen in 
immunecompromised patients "l. Ocular mani-
festations are rarely seen in congenital CMV 
infections. Ocular involvement in CMV infec-
tions in the adult population is confined to 
immunecompromised patients. In this group 
CMV is a common cause of retinitis40 • 
Of the more recently discovered human 
herpesviruses, HHV-6 and HHV-7 have been 
associated with febrile illnesses and the child-
hood disease, exanthema subitum·' 1 • In 
immunecompromised patients the spectrum of 
disease is extended to solid organ infections 
and bone marrow depression'". To date HHV-7 
has not been associated with ocular disease. 
Clinically manifest infections with HHV-8 are 
predominantly seen in immunecompromised 
patients. This virus seems to resemble EBV in 
its possible oncogenic properties·'-\. In isolated 
cases HHV-6 and HHV-8 are associated with 
intraocular lymphomas 1'·'·-•. 
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TABLE 1: CLINICAL PRESENTATIONS OF HUMAN HERPESVIRUS INFECTIONS 
human general ocular 
herpesvirus 
Class Immune competent Immune compromised Immune competent Immune compromised 
herpes simplex virus mucocutaneous infections Bell's palsy frequent recurrences 
type 1 predominantly facial and skin blepharitis prolonged infections 
HSV-1 pharyngitis+ mononucleosis conjunctivitis 
HHV-1 infectiosa epithelial keratitis 
encephalitis (rare) encephalitis immune stromal keratitis 
a neonatal infections (rare) necrotizing keratitis 
d·1sseminated disease (rare) dissem·mated disease (neurotrophic keratopathy} 
endotheliitis 
trabeculitis 
anterior uveitis 
acute retinal necrosis acute retinal necrosis 
herpes simplex virus mucocutaneous infections See HSV-1 
type 2 predominantly genital ocular manifestations 
HSV-2 rare 
HHV-2 neonatal infections 
encephalitis (rare) encephalitis 
a disseminated disease (rare) disseminated disease 
varicella zoster virus chickenpox (varicella) reinfection conjunctivitis disseminated disease 
blepharitis 
vzv 
HHV-3 shingles (zoster) recurrence of infection skin infection of ri nV increased incidence and 
HZO recurrent HZO 
a See HSV-1 retrobulbar neuritis 
extra-ocular muscle palsies acute retinal necrosis 
progressive outer retinal 
necrosis 
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TABLE 1: CLINICAL PRESENTATIONS OF HUMAN HERPESVIRUS INFECTIONS CONTINUED 
human general ocular 
herpesvirus 
Class Immune competent Immune compromised Immune competent Immune compromised 
Epstein-Barr virus infectious mononucleosis B-lymfoprol iferative Parinaud oculoglandular disease 
EBV Burkitt's lymphoma disease cranial nerve palsies 
HHV-4 Hodgkin disease oral leukoplakia dacryoaden it its 
T-celllymphoma immunoblastic con j u nctiv it is 
y nasopharyngeal lymphoma episcleritis 
carcmoma epithelial keratitis 
immune stromal keratitis 
anterior uveitis 
chorioretinitis 
papillitis 
primary ocular lymphoma 
cytomegalovirus congenital infections infectious CMV retinitis 
CMV "mfectious mononucleos·ls mononucleosis 
HHV-s hepatitis (rare) neuropathy, 
pneumonitis (rare) men in go-enceph a I it is 
~ hepatitis 
Carditis 
pneumonitis 
Gllesions 
human herpesvirus exanthem subitum febrile illness primary ocular lymphoma 
type 6 febrile illness pneumonitis 
HHV-6 ~ hepatitis 
encephalitis 
bone marrow 
depression 
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TABLE 1: CLINICAL PRESENTATIONS OF HUMAN HERPESVIRUS INFECTIONS CONTINUED 
human general ocular 
herpesvirus 
Class lmmun competent Immune compromised Immune competent Immune compromised 
human herpes- exanthem subitum post-transplant multi-
virus type 7 febrile illness organ infection 
HHV-7 
~ 
human herpes- associated with: l<aposi sarcoma of 
virus type 8 Kaposi -sarcoma adnexa and 
HHV-8 angiosarcoma intraocular lymphoma conjunctiva 
y primary effusion B-cell intraocular lymphoma 
lymphoma 
multricentric 
Castleman's disease 
multiple myeloma 
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EPIDEMIOLOGY OF HSV-1 
INFECTIONS 
TRANSMISSION OF HSV-1 
Herpesviruses do not persist well on en-
vironmental surfaces, and infection needs 
direct inoculation into areas where they can 
replicate. The first line of defense against the 
virus is the keratin layer of the superficial epi-
dermis, which prevents direct access of these 
viruses to cell-membranes. In the absence of 
keratin, for instance in mucous membranes, 
cells are more prone to be infected". HSV-1 
can be transmitted following close contact with 
the secretions, skin, or mucous membranes of 
a person shedding virus. Infection occurs via 
the mucosal surfaces. Infections with HSV-2 
are usually acquired through sexual contact. 
Humans are considered to be the only 
natural reservoir of HSV. HSV infects its host 
generally in the first decades of life'. Primary 
infections with H SV manifest clinically only in 
1-6% of the time'(· and most episodes of clini-
cal disease are manifestations of reactivation 
of HSV infection. Because only a third of the 
individuals who harbor HSV recognize disease 
symptoms during primary or recurrent infec-
tions, serologic studies are used to defining the 
prevalence of HSV infections in the popula-
tion. Seroprevalence rates of HSV vary with 
age, sex, sexual behavior, socio-economic sta-
tus and geographic location". In adult popula-
tions the prevalence of HSV-1 antibodies 
varies from 45%4" to 88%'"'-·49 ·'~. Corresponding 
with seroprevalence 70-80% of healthy individ-
uals have HSV- DNA in their trigeminal 
ganglion. 
There is a trend towards a decreasing inci-
dence of HSV-1 infections in the developed 
world" "". Antibodies to HSV-2 are rarely 
found before ages of onset of sexual activity. 
There is a trend towards an increasing inci-
dence of HSV-2 infections in both the de-
veloped and developing countries"7 ·"'1 · 5 ~. 
Although most genital H SV infections are 
caused by HSV-2 infection, a recognizable and 
growing portion is attributable to HSV-1 infec-
tions55. 
Among recipients of organ transplants, 
transmission of viruses through donor tissues 
is a well recognized clinical problem. CMV is 
the most prominent example. Manifest infec-
tion may occur, besides from reactivation, by 
graft-to-host transmission of donor-derived 
virus as a result of transplantation. Though 
rare, there are reports demonstrating probable 
HSVtransmission to seronegative organ trans-
plant recipients%·". 
Corneal transplantation is the most com-
mon type of tissue transplantation in The 
Netherlands. It is usually a safe procedure with 
little associated morbidity. In 5-10% of these 
patients herpetic keratitis is the reason for pen-
etrating keratoplasty (PKP)''. Herpetic keratitis 
recurs relatively frequently (10-20%) after PKP. 
After PKP for reasons unrelated to HSV infec-
tion patients may still develop herpetic kerati-
tis in their graft59.w.oJ.(,", referred to as: 'newly 
acquired HSV keratitis after PKP'. The origin 
of HSV infection in these cases is unknown. 
EPIDEMIOLOGY OF OCULAR HSV-1 
INFECTION 
Ocular H SV infections are mainly confined 
to the anterior segment of the eye, including 
the conjunctiva and the eyelids (table 2). HSV 
appears to be the most common infectious 
cause of blindness in developed countriesr''. In 
developing countries, where chlamydia con-
junctivitis is endemic, it is only second to tra-
choma as a cause of corneal blindness. In mal-
nutrition combined with measles infection, 
HSV keratitis is a common cause of bilateral 
corneal blindness in children in the developing 
world""'. 
Despite the common exposure to HSV, ocu-
lar manifestations are only observed in about 
1% of those exposed. This may be an underes-
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timation because presenting symptoms of ble-
pharitis and conjunctivitis are mild, and the 
condition remains largely unrecognized. 
Only 5% of ocular H SV disease represent 
primary infections(,,. Liesegang et al. reported 
an incidence of 8.4 first ocular HSV infections 
per 100,000 person-years1+. The overall preva-
lence of ocular HSV infection has been esti-
mated at 149 cases per 100,000 person-years''5 • 
Blepharitis, conjunctivitis and epithelial ker-
atitis are the most common symptoms of pri-
mary ocular HSV infections. The predominant 
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form of recurrent disease is epithelial and 
stromal keratitis (see below; Table 2, page 25). 
Disease is bilateral in 12-19%''7"'' of cases. 
A history of epithelial keratitis is not a signifi-
cant risk factor for recurrent epithelial kerati-
tis, whereas previous multiple episodes of 
stromal keratitis markedly increase the proba-
bility of subsequent stromal keratitis''''. The 
interval between attacks shortens with timec'7 • 
Herpetic stromal keratitis is a leading 
infectious cause of blindness worldwide<>. 
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HOST IMMUNE RESPONSE 
TO HERPESVIRUSES 
Following a viral infection, the immune 
system will recognize the virus as a foreign 
entity and try to eliminate it from the host. At 
first, non-specific immune cells, including 
macrophages, polymorphonuclear cells (PMN) 
and natural killer (NK) cells, which are part of 
the innate immune system, are attracted to the 
site of infection. Secondly, a virus-specific 
immune response, (i.e. adaptive immunity) 
develops in which both B and T lymphocytes 
are involved. This constellation of immune 
responses to the virus serves to protect the 
infected organism from disseminated viral dis-
ease and deathc('. 
INNATE IMMUNE RESPONSE 
The first line of defense against her-
pesviruses is formed by the innate immune 
system. This system consists of cellular and 
soluble components. Macrophages and PMN 
recognize viral antigens in a non-specific fash-
ion and eliminate the virus by phagocytosis 
and subsequent intracellular degradation. 
Both cell types show a marked increase of 
uptake of virus when virions are opsonisized 
by antibody or complemenf1• The anti-viral 
effect of NK cells involves the lysis of viral 
infected cells and production of IFN~y upon 
stimulation with other cytokines ( e.g. IL~12). 
The recognition of a virus~ infected cell by NK 
cells is mediated either by the opsonization of 
an infected cell by virus~specific antibody'', or 
by antigen recognition independently of the 
histocompatibility complex (MHC)'' Herpes~ 
virus infection results in down-regulation of 
MHC class I molecules at the surface of an 
infected cell, rendering the cell susceptible to 
NK cell killing". Low NK cell activity is linked 
with increased human sensitivity to dissemi-
nated herpesvirus infections, including those 
with HSV, EBV and CMV'" Cells of the 
innate immune system are located in large 
numbers at strategic sites in and behind the 
physical barrier of the organism, or circulate 
through the body fluids awaiting attraction to 
the site of infection by chemotaxis. 
The complement system and cyto~ 
kinesjchemokines secreted by virus infected 
cells and inflammatory cells, form the major 
soluble component of the innate immune 
response to herpesvirus infection. Viral infec-
tion directly stimulates the production of IFN 
ct. and ~ by infected cells. Both IFN ct. and 0 
inhibit viral replication", enhance the ability of 
NK cells to kill infected target cells'' and 
facilitate antigen processing and presentation 
by MHC" The secretion of vanous 
chemokines, like interleukin 8 (IL~8), is 
induced at sites of viral infection providing a 
chemotactic signal for immune cells to 
infiltrate the affected tissue. 
This first line of immune defense facili-
tates an immediate response to invading infec-
tious agents, irrespective of the site of entry. 
Moreover, it will limit dissemination of the 
virus, while at the same time the development 
of a specific immune response in the draining 
lymphoid tissues is initiated to combat the 
remaining virus and to build up immunologi-
cal memory. 
ADAPTIVE IMMUNE RESPONSE 
Specific immune responses are mediated 
by lymphocytes, recognizing the antigen by 
specific membrane-bound antigen receptors. 
The adaptive immune response can be divided 
into a humoral and a cellular immune 
response, mediated by B and T lymphocytes, 
respectively. 
Humoral immunity: 
Virus-specific antibodies are important in 
the defense early in the course of viral infec-
tion and in defense against viruses that are 
liberated from lysed cells. Within several days 
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after onset of a herpesvirus infection, anti-
bodies to some of the viral proteins appear in 
the circulation. The major immunogens of 
H SV are the viral proteins expressed at the cell 
surface of infected cells: the glycoproteins"·". 
Neutralizing virus-specific antibodies bind to 
envelope proteins and prevent viral attach-
ment and entry into host celL Opsonizing 
antibodies may enhance phagocytic clearance 
of viral particles. Secretory immunoglobulins 
of the IgA isotype, i.e. sigA, may be important 
for neutralizing viruses that enter via the 
mucous membranes and trigger complement-
mediated lysis of infected cells"' Infectious 
cell-free virus is mainly detected during pri-
mary infection. Herpesviruses like HSV have a 
cell-to-cell spread and survive latently in the 
sensory neurons, being inaccessible to anti-
bodies after entry in the celL In H SV infection, 
antibodies do play a role in limiting dissemi-
nation the virus from the primary site of infec-
tion to the innervating sensory ganglia and 
other parts of the nervous system 7'· '''. Severe 
cases of herpesvirus infections have been 
described in antibody deficiency syndromes, 
indicating that antibodies are an important 
component in the immune response to HSV 
infection.-, 
Cellular immunity: 
Severe HSV infections in patients with 
impaired T cell immunity, e.g. AIDS patients 
and transplant recipients, indicate that these 
cells play an important role in controlling viral 
infection"'. Both virus-specific CD4· and CDS' 
T cells are mandatory in controlling her-
pesvirus infection. They distinguish virus-
infected from non-infected cells by their T cell 
receptor, recognizing virus-derived peptides 
associated with MHC class II or I molecules 
expressed at the cell surface of infected cells, 
respectivelt". Following activation, T cells can 
kill infected cells or secrete cytokines. Based 
on their cytokine production profile, T cells 
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can be divided into two groups, T1 and T2 
cells. T1 cells mainly secrete IL-2, IFN-y and 
TNF-a, whereas secretion of IL-4, IL-5 and IL· 
1 o is restricted to T2 cells. The subgroup ofT 
cells referred to as To cells secrete both TJ and 
T2 cytokines. In general herpesvirus-specific T 
cells responses are both T1 and To-like. 
Immune evasion 
Herpesviruses have evolved numerous 
strategies that favor their own survival by evad-
ing host immunity. These strategies fall into 
tvvo categories: indirect immunomodulatory 
effect of viral proteins by their interaction with 
the protein machinery of the host cell and the 
direct inhibitory effect of viral encoded pro· 
teins. 
Upon herpesvirus infection, virus-specific 
CDs· T cell recognition is hampered by the 
low level of MHC class I expression on infec-
ted cells. Several herpesvirus proteins, like 
infected cell protein (ICP) 47 of HSV-1, have 
been shown to inhibit the assembly and cell 
surface expression of stable MHC class I mol-
ecules". Recently, ICP 22 of HSV-1 has been 
shown to inhibit CD4· T cell responses"-
Additionally, herpesviruses are able to prevent 
apoptosis of infected celh'l. Some herpesvirus-
es produce molecules that directly inhibit 
innate and adaptive immune responses. For 
example, human CMV encodes a protein 
(UL!8), that inhibits Tljo responses and is 
homologous to MHC class I proteins, which 
acts as a decoy for NK cells''' and an EBV pro-
tein, that shows homology to IL-10". 
Furthermore, three glycoproteins of HSV 
modulate the innate immune response by 
binding to complement factor 3 b (gC)" or the 
humoral response by binding to the Fe portion 
of IgG molecules (complex of gE and gl) "'. 
Immunopathology 
An immunopathogenic response is an 
immune response that causes tissue damage. 
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This can occur when cells are destroyed with a 
limited regenerative capacity, or when repair 
deposits impair the function·". Several mecha-
nisms of immunopathology have been 
described. A consequence of persistent infec-
tion with some viruses is the formation of cir-
culating immune complexes composed of viral 
antigens and specific antibodies. These com-
plexes may become trapped in tissues and trig-
ger inflammatory responses in which comple-
ment and PMNs play a major role". 
During a immunopathogenic response the 
immune reaction changes focus with time, 
beginning with an appropriate antiviral 
response and spreading to encompass host 
antigens. Some viruses are known to contain 
amino-acid sequences that are also present in 
some self antigens. It has been postulated that 
because of this "molecular mimicry" antiviral 
immunity can lead to immune responses 
against self antigens. The virus antigen should 
be different enough from host sequences to 
initiate an immune response, but similar 
enough that the response is cross-reactive. The 
resulting 'anti-host' response will then be 
maintained even after clearance of the virus·'·'. 
Alternatively, virus infection may induce 
autoimmunity in the absence of shared anti-
gens, a mechanism known as 'bystander acti-
vation'. 
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IMMUNE PRIVILEGED SITES 
Immune responses are absent in some tis-
sues or organs, which phenomenon is general-
ly known as immune privilege. This pheno-
menon is considered to be aimed at preserva-
tion of the individual (brain, eye) on the one 
hand and preservation of the species on the 
other hand (testis, ovary, pregnant uterus). 
The eye is a largely immune privileged site, 
which is important since minute manifesta-
tions of inflammation may interfere with 
vision. 
A wide range of factors contribute to the 
immune privilege of the eye. For example the 
intra-ocular fluids have immunosuppressive 
capacities, like transforming growth factor-~ 
(TGF-~)'", and the central cornea lacks the key 
player in the immune response, the antigen 
presenting cell (APC)'"'. The eye constitutively 
expresses Fas ligand, which may kill Pas-
expressing inflammatory cells that enter these 
tissues'''. The implication of the immune pri-
vileged state is, that transplanted tissue, that 
would be rejected in most other locations of 
the body, is accepted when grafted into the eye: 
corneal transplants. 
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HERPESVIRUS KERATITIS 
CORNEAL MORPHOLOGY AND 
INNERVATION 
The cornea is the transparent tissue in the 
front of the eye that is primarily responsible 
for focusing light on the retina. The central 
cornea is about 0.52 mm thick. The tissue 
comprises five layers: epithelium, Bowman's 
layer, stroma, Descemet's membrane, and 
endothelium (Fig. 6). In the normal state the 
cornea does not contain blood vessels"i 
The corneal epithelium is a stratified squa-
mous, non-keratinizing epithelium, approxi-
mately five cell-layers thick. Epithelial cells 
adjacent to Bowman's layer can divide and 
renew the epithelial layer in two to four days. 
Epithelial wounds heal quickly over an intact 
Bowman's layer. 
Bowman's layer is a very thin (8-1 o ,um) 
acellular zone beneath the epithelium. 
Bowman's layer is often said to be resistant to 
trauma, offering a barrier to corneal invasion 
by micro-organisms and tumor-cells, but it is 
not known to which extent this is true. 
Bowman's layer is considered to have no 
regenerative capacity. 
The stroma which constitutes about 90% of 
the cornea consists mainly of collagen fibrils, 
ground substance and keratocytes. The colla-
gen fibrils of the cornea are uniform and 
small, about 250-300A in diameter. The 
ground substance surrounding the collagen 
fibrils is rich in glycosaminoglycans. The 
ground substance plays a role in maintaining 
the regular array of collagen fibrils. With stro-
mal edema the individual collagen fibril does 
not change, the volume of the ground sub-
stance increases, and with this the space 
between collagen fibrils. 
The keratocyte is the predominant cell of 
the stroma, but accounts only for about s% of 
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Figure 6: 
Photomicrograph of a cross section of a normal human cornea: 
ep the epithelium, 
B Bowman's layer 
stroma, 
D Descemet's membrane 
en endothelium 
the dry weight of the cornea. In response to 
stromal injury the keratocytes migrate into the 
wound area and undergo transformation into 
fibroblasts. They contribute to the scar forma-
tion by proliferation and collagen production. 
Descemet's membrane is produced by the 
endothelium and approximately 10,um thick. 
The endothelium is a monolayer of regular-
ly shaped hexagonal cells, lying posterior on 
Descemet' s membrane. The main function of 
the corneal endothelium is control of stromal 
hydration. This is essential for corneal trans-
parency. Endothelial cells generally do not 
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Figure 7: 
show mitotic activity. Cell density below a 
critical number (400-600 cellsjmm') is devas-
tating for the transparency of the cornea"'. 
Sensory innervation of the cornea is sup-
plied by the ophthalmic branch of the trigemi-
nal nerve (ramus I, nervus V). The nerve fiber 
pattern of the cornea has been described as 
radially oriented nerve bundles entering the 
cornea from the sclera at the middle one third 
of its thickness'' 1 • The nerves lose their myelin 
sheath after traversing 0.5-2.0 mm into the 
cornea and then continue as transparent axon 
cylinders. After passing Bowman's layer, they 
-~--
Nerve fiber bundles in the subbasal plexus run first in the 9-3 hours direc-
tion. After the first bifurcation they run in the in the 12-6 hours direction 
and after the second bifurcation they run again in the g-3 hours direction. 
The beaded fibers run singly and obliquely after branching. 
Reprinted with permission from: MUller LJ, Vrensen GFJM, Pels L. Nunes 
Cardozo 8, Willekens B. Architecture of human corneal nerves. ln~est 
Ophtha/mol Vis Sci 199J:38:g8s-994· 
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ramify and end within the epithelium as free 
nerve endings"".,. The nerve bundles in the 
subbasal plexus of the human cornea form a 
regular dense meshwork with equal density 
over a large central and mid-peripheral area··._, 
(Fig. 7). 
THE CORNEA: 
AN IMMUNE PRIVILEGED SITE 
The cornea is considered to be an immune 
privileged tissue, in part because it cannot 
directly be accessed by the immune system'": 
the cornea lacks blood and lymphatic vessels, 
structures that provide the conduit for trans-
portation of immunologic components into 
and out of most tissues"'·. The absence of blood 
vessels leads to sequestration of corneal anti-
gens from the circulation. The normal cornea 
also lacks professional antigen presenting cells 
(APCs) such as dendritic cells and 
macrophages, which are resident in most 
other tissues'". Factors present in the normal 
cornea that contribute to immune privilege are 
I L-1 receptor antagonist and Fas ligand. Both 
are constitutively expressed and promote ocu-
lar immune privilege by different pathways"''''. 
The cornea is in close contact with the fluid of 
the anterior chamber of the eye. Several mech-
anisms play a role in the immune privilege of 
the anterior chamber: blood-ocular barrier, the 
absence of lymphatic drainage from the 
intraocular structures, deviant host immune 
response after introduction of antigens (aque-
ous chamber associated immune deviation: 
ACAID) and soluble factors in the aqueous 
humor having a immunosuppressive effect on 
APC and T cells !I" ' 0 ' 
Although the cornea is an immune privi-
leged site, the complete immune apparatus is 
present in the iris and at the limbus, a tissue 
that constitutes the zone between the cornea 
and surrounding conjunctiva. The conjunctiva 
has a rich lymphatic network arising approxi-
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mately 1 mm peripherally from the limbus. 
During the course of inflammation Langer-
hans cells (dendritic cells) migrate from the 
limbus into the central cornea and the blood· 
ocular barrier can break down. In chronic 
inflammation the cornea becomes vascula-
rized and thus the immune privileged state 
can be lost"''. Moreover, early in the inflamma-
tory process, leukocytes extravasate from 
blood vessels in the limbus and migrate 
towards the center of the cornea. 
VIRUSES CAUSING KERATITIS 
Herpesvirus and adenovirus infections are 
the most common viral infections of the ante-
rior segment of the eye. Clinical manifesta-
tions of herpesvirus infections are summa-
rized in Tables 1 and 2. Infections with her-
pesviruses present usually in isolated cases, 
and are generally unilateral. The herpesvirus-
es HSV·l and ·2, VZV and CMV may cause 
active disease in a wide variety of ocular struc-
tures. However, ocular disease is mainly 
caused by HSV·! and VZV. 
Some viruses show an increased frequency 
of presentation associated with immunodefi-
ciency syndromes, including molluscum con-
tagiosum virus, CMV,VZV and papilloma 
viruses. Other viruses, like adeno-, entero- and 
coxsackieviruses cause epidemic outbreaks of 
disease. 
Some viral infections are becoming exceed-
ingly rare, or have even been eradicated, 
because of vaccination programs (e.g. small-
pox, measles, rubella, mumps), but some still 
cause significant morbidity in numerous 
developing countries. Especially the combina· 
tion of malnutrition and measles, should be 
mentioned in this context. 
HSV KERATITIS 
HSV keratitis ranges from a superficial 
inflammation of the cornea to a complex ocu-
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lar disease. lt is usually initiated by the cyto· 
pathic effect of the virus and followed by 
inflammatory responses, which may affect all 
layers of the cornea. The ocular sequelae of 
HSV infections are determined by the fre· 
quency and duration of the recurrent disease 
episodes and the immunological response 
elicited. The four main categories of HSV ke· 
ratitislfc.Jo\ are infectious epithelial keratitis 
(IEK), neurotrophic keratopathy, herpetic stro· 
mal keratitis (H S K), and endotheliitis. Each of 
these is subdivided into more specific clinical 
presentations (Fig.8, page 25 and 73) 
Infectious epithelial keratitis 
The earliest epithelial lesions ofHSV infec· 
tion in the cornea are small vesicles in the 
epithelium"", which have also been described 
as punctate epithelial keratopathy'"5 • Vesicles 
coalesce and a branching, linear lesion with 
terminal bulbs (swollen epithelial borders) 
develops, leading to the most common pres-
entation of HSV keratitis: dendritic keratitis. 
In the borders of the lesion infectious virus 
may be present. As the disease process contin-
ues the center ulcerates and extends through 
the basement membrane""'. An enlarged den-
dritic ulcer, that is no longer linear, is referred 
to as a geographic ulcer. Another manifesta-
tion of IEK is the marginal ulcer. The proxi· 
miry of the limbus leads to a rapid infiltration 
of leukocytes and neovascularization. The 
ulcer may lack the typical dendritic shape'" 
Neurotrophic keratitis 
Multiple episodes of herpetic disease can 
result in structural injury to Bowman's layer 
and corneal stroma. Early findings include 
irregularity of corneal surface and lack of nor-
mal luster. Punctate epitheliopathy may 
progress to a persistent epithelial defect, oval 
shaped with smooth grayish borders"""". 
Untreated or mistreated lesions may progress 
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into ulceration, opacification, vascularization, 
and perforation of the cornea. 
Herpetic stromal keratitis 
The corneal stroma may be affected as 
result of a corneal HSV infection through a 
variety of mechanisms. Stromal keratitis is a 
more severe and prolonged manifestation of 
HSV disease and occurs when the virus initi-
ates a chronic corneal inflammation. It can be 
classified as immune stromal keratitis (1 S K) 
and necrotizing stromal keratitis (NSK)' 02 "103 • 
These two manifestations are not mutually 
exclusive and probably a continuum. 
IS K may present as superficial stromal 
scarring or the so called "ghost scars", deeper 
located infiltrative stromal keratitis. A rare 
form of ISK is a white ring shaped stromal 
lesion or the so-called immune ring. The 
inflammatory response results in cellular infil-
trate, edema, neovascularization and corneal 
scarring as a result of fibrosis and tissue 
destruction. 
The predominant feature of NSK is necro-
sis with tissue loss, often masked by edema in 
the active phase of the inflammation. The clin-
ical picture can evolve rather quickly and is 
sometimes refractory to treatment. The edema 
and neovascularization are more pronounced 
compared to ISK. Corneal scarring often leads 
to irregular astigmatism which may strongly 
interfere with vision. 
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Corneal endotheliitis 
Corneal endotheliitis is an inflammatory 
reaction at the level of the corneal endothe-
lium. In isolated endotheliitis stromal 
infiltrate and neovascularization are absent. 
Patients characteristically have keratic precipi-
tates (KP), stromal and epithelial edema, and 
mild iritis. HSV endotheliitis can be classified 
based on the distribution of the KP and the 
configuration of the overlying stromal and 
epithelial edema102• The most common form is 
disciform endotheliitis. Diffuse and linear 
forms of endotheliitis are also observed' 0·'-10'1• 
When inflammation persists or is left un-
treated, secondary neovascularization and 
scarring may occur. Chronic endotheliitis may 
lead to endothelial decompensation. 
Herpes keratitis after penetrating keratoplasty 
Herpesvirus infection in a corneal graft 
may present with the whole range of manifes-
tations as in non-operated eyes. Early after 
transplantation IEK may present as a large 
epithelial defect without the characteristic den-
dritic appearance"". In addition to this, her-
petic keratitis might present with the manifes-
tations of an allograft reaction: from a linear 
endotheliitis resembling a Khodadoust line''' 
to a diffuse endotheliitis, indiscernible from a 
full blown graft rejection"'. 
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TABLE 2: PREVALENCE OF CLINICAL MANIFESTATION IN INDIVIDUALS SUFFERING FROM OCULAR HSV INFECTION 
Clinical manifestation Jnitiaf clinical disease % 
B I e ph a riti ss7.6s_,,,,2 
Conjunctiv.ltis 67 '68·'' ·"' 
Epithelia I keratitis ( dend ritict'"' '"' 
Stromal keratitis (lSI<+ NSI<t'""' ' ,11) 
' (l<erato-) uveitis 67 _.,, 
Acute retinal necrosis" 4 
Others 
1: Periocular dermatitis 
4: Infectious epithelial kera-
titis (dendritic keratitis) 
6a: stromal keratitis 
Immune stromal keratitis 
38-54 
54-84 
15-63 
2-6 
4 
<0.00001 
<0.1 
2: Blepharitis 
s: Neurotrophic keratitis 
6b: stromal keratitis 
Recurrent disease % 
4-20 
4-20 
47-60 
20-48 
1 
<O.OOOOl 
<0.1 
3: Conjunctivitis 
(with ulceration) 
6c: stromal keratitis 
7: Endotheliitis 8: Uve'1tis g: (Ep-1-)scleritis 
Figure 8: Presentations of herpes simplex virus infections of the anterior eye segment 
Adapted from: R. Sundmacher: A clinico-IJirologic classification of herpetic anterior segment diseases with special reference to intra-
ocular herpes. In Herpetische Augen Erkmnkungen DOC 1980. Eds R. Sundmacher: MUnchen:JF Bergmann Verlag 1981:206 
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DIAGNOSTIC CRITERIA FOR 
HSV KERATITIS AND Dl FFERENTIAL 
DIAGNOSIS 
Traditionally the diagnosis of HSV keratitis 
is based on history and clinical presentation, 
occasionally complemented by viral culture. 
Viral isolation in cell culture remains the stan-
dard for the detection of infectious virus. This 
technique is not always available in general 
ophthalmology practice. Viral culture is an 
insensitive technique, particularly for the iso-
lation of HSV-1 from the deeper layers of the 
cornea. Cultures are only found positive in 
herpetic keratitis with an epithelial defect. The 
polymerase chain reaction (PCR) represents a 
sensitive research laboratory tool and has the 
advantage of detecting very small amounts of 
DNA or RNA. The detection of HSV DNA by 
PCR provides evidence for the presence of 
viral DNA, which not necessarily means the 
presence of infectious virus. 
Many lesions may present with a dendritic 
or dendriform lesion, including the epithe-
liopathy seen in healing corneas after a den-
dritic ulcer, a healing corneal abrasion, and the 
early stages of acanthamoeba keratitis. In ISK 
many other causative agents of infection are 
possible. However, 66% of unilateral ISK is 
caused by HSVm. Other viruses causing ISK 
are VZV, EBV, mumpsvirus, rubellavirus, 
measlesvirus and influenzavirus. Tuberculosis, 
lues acanthamoebiasis and onchocerciasis are 
other infections associated with ISK. The com~ 
plete differential diagnosis of stromal keratitis 
is extensive and beyond the scope of this thesis. 
In severe necrotizing disease, the clinical pic-
ture can be suggestive of bacterial keratitis, 
with ulceration, dense cellular infiltration and 
necrosis. Differential diagnosis of unilateral 
corneal edema with a normal endothelium in 
the opposite eye should bring up angle closure 
glaucoma and iridocorneal endothelial syn~ 
drome. When KPs are the only presenting sign 
other causes of anterior uveitis are possible. 
HSV has been implicated in other diseases 
of the anterior segment (Fig 8 and table 1). 
HSV DNA has been detected in the irido· 
corneal endothelial syndrome'"' "c, in the aque-
ous humor during a period of intra-ocular 
pressure elevation in Posner-Schlossman syn~ 
drome 11 '' and in idiopathic endotheliopa-
thy''''·1""'. 
PATHOGENESIS OF CORNEAL HSV 
INFECTION AND IMPLICATIONS FOR 
THERAPY 
IIIII Infectious Epithelial Keratitis 
IEK results from viral replication in corneal 
epithelium and destruction of corneal epithelial 
cells: cytopathic effect of the virus. The duration 
of viral replication in the cornea depends on 
viral factors, including viral load, virus strain 121 
and host factors like immune status. 
The immune response in IEK consists of 
HSV-specific IgG and IgA present in the tear 
film and corneal stroma, antibody-dependent 
cell-mediated cytotoxicity and HLA class I and 
class II restricted immune responses u" In 
addition to the specific immune reaction, IFN~ 
afB production by the infected epithelial cells 
limits the spread of the virus and allows reso-
lution of the lesion. 
These dendritic lesions heal without scar 
formation, when the epithelium is the sole tis-
sue affected. As the disease process continues, 
the infection can extend through the basement 
membrane""', into corneal fibroblast (kerato-
cytes) in the superficial corneal stroma under-
lying the site of the lesion resulting in 
HSK"' '"'. 
ln IEK topical application of antivirals 
accelerates the elimination of replicating virus 
from the cornea 125 . In this phase of the disease 
the immune response is directed at limiting 
the spread of the virus. Interference with this 
immune response, for instance by cortico-
steroids, may favor the spread of the virus into 
the stroma 1 "'·. 
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1111 Neurotrophic keratopathy 
HSV-induced neurotrophic lesions are nei-
ther infectious nor immunologic in origin. 
Neurotrophic keratopathy is a multifactorial dis-
ease. Impaired corneal innervation in combina-
tion with decreased tear secretion produces 
non-healing epithelial defects. Basement mem-
brane damage and stromal inflammation inter-
fere with normal epithelial wound healing. 
The resulting damage should determine 
the therapeutic approach. Artificial tears in dry 
eye syndromes, protection of a vulnerable 
basement membrane by bandage contact lens, 
or low strength steroids in chronic stromal 
inflammation. The keratopathy may be exacer-
bated by the chronic use of topical medica-
tions, especially antiviral treatment and toxic 
antibiotics. 
II Herpetic stromal keratitis 
The permanent loss of vision associated 
with HSV-1 corneal infection is due to an 
inflammatory response in the corneal stroma. 
When the herpesvirus reaches the corneal stro-
ma, viral antigens are presented on stromal 
cells and a cell mediated immune response is 
initiated. 
The experimental mouse model of H S K 
Current knowledge on the imrnunopatho-
genesis ofHSK is largely based on studies per-
formed in the experimental mouse model for 
HSIC 27 ·"'. The mouse develops a non-necroti-
zing form of HSK that resembles many char-
acteristics of ISK in humans. 
In the mouse model, HSK does not develop 
in the absence ofT cells'"''-' 1". The inflammato-
ry infiltrate in the cornea is dominated by 
PMN. These PMN produce proteolytic enzymes, 
resulting in surrounding cell lysis and are 
probably responsible for most of the tissue 
damage'-'-'. However, in most cases of HSV-1 
infection the chronic inflammation was found 
to be regulated by the CD4' cells'" " 
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Other cell types involved are Langerhans 
cells and macrophages. Langerhans cells are 
capable of presenting antigens to CD4- T cells. 
They rapidly migrate from the limbus into the 
central cornea after HSV infection~_,_, ll·'. 
CD4' T cells mediate their immunological 
functions through production of interrelated 
cytokines. 
The cytokines IL-2 and IFN-y are produced 
in HSV -1 infected mouse corneas'' 1 ,';". In the 
mouse model there is no IL-4 and IL-10 pro-
duction during active HSK. Based on the pat-
tern of cytokine production these CD4- T cells 
are referred to as Thl cells. IFN-y plays a pi-
votal role in the extravasation of PMN from 
blood vessels in the peripheral cornea. IL-2 
enhances IFN-y production subsequently 
inducing the chemotaxis of PMN s to the site of 
initial infection, and activates the PMN when 
arrived at the place of infection~.". PMN are 
known to secrete several other cytokines with 
possible antiviral function like IFN-a, and 
TN F-a and nitric oxide'". Production of Th2 
cytokines such as IL-10 and IL-4, detected in 
mouse corneas during the resolution phase, 
have been shown to inhibit HSK:YJ_ 
Human herpetic stromal keratitis 
Data on pathogenesis of human HSK, until 
recently, were limited to histopathologic stu-
dies of corneal specimens removed at corneal 
transplantation for HSK. The only human 
specimens of active inflammation are those 
from necrotizing stromal keratitis. In immune 
stromal disease transplantation is preferably 
performed after inflammation has subsided. 
Immune Stromal Keratitis 
The experimental mouse model shows 
clinically the most striking resemblance with 
human ISK. However, in contrast to the 
murine cornea, corneas of patients with non-
necrotizing keratitis do exhibit intra-corneal 
expression of viral antigens'·"'·'"·"·'. It seems 
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logical that the intra-corneal immune response 
in human ISK is -at least in part- directed to 
HSV antigens, definite proof however is still 
lacking. Studies on T cell involvement in the 
immunopathogenesis of stromal keratitis are 
limited to immunohistologic analysis and phe-
notypic characterization of corneal infiltrating 
T cellS 1421 -". Immune rings are thought to be a 
ring shaped antigen-antibody-complement 
precipitate similar to that of a Wessely ring'·u. 
This immune complex attracts a cellular infil-
trate, clinically visible with the resulting 
edema. 
Antiviral treatment in IS K is both directed 
at the presumed presence of the virus and at 
prevention of severe reactivation of infection 
during steroid therapy. Topical antivirals 
should be used in a therapeutic dose. It has not 
been established that oral antiviral therapy is 
effective in acute stromal disease. However, 
visual acuity improved over 6 months in sig-
nificantly more patients 1"" The main indica-
tion for oral acyclovir in ISK is prevention of 
recurrent disease by a long-term low dose of 
acyclovir:·". 
Steroid therapy in stromal keratitis reduces 
the risk of persistent or progressive stromal 
keratitis by 68%, and leads to a significant 
shorter time to resolution'·'··- Steroid dosage 
depends on the severity of disease. In corneal 
disease it is rarely necessary to use dosages 
exceeding dexamethasone 0.1% six times a 
day. When edema and hyperemia are resolving 
tapering can be started slowly. 
Necrotizing Stromal Keratitis 
In NSK cellular destruction is the result of 
both active viral replication in the corneal stro-
ma and a severe immune reaction'-10 • Viral pro-
files (inclusion bodies, particles, DNA) and 
viral antigens are detected frequently (up to 
91%) in corneal buttons of NSK patients'''. 
Cellular infiltrate consists predominantly of 
PMNs and mononuclear cells, in combination 
with a granulomatous reaction' 4'. 
Both the viral replication and the severe 
immune response should be treated vigorous-
ly. Control of HSV replication should precede 
attempts to modulate the immune response. 
Both topical and systemic antivirals should be 
used in high therapeutic doses, combined after 
two days with corticosteroid therapy"·". 
Ill Corneal endotheliitis. 
Endotheliitis probably results from lytic 
viral infection of the endothelium""· ].1.'·"'! with 
release of infectious virus into the aque-
ous'5'·'-'"·"'. In addition to lytic infection of 
endothelial cells, viral antigens may be 
expressed on the surface of infected cells. 
Immunecompetent cells may attack the 
endothelium, leading to enhanced damage. 
This process is probably analogous to the cel-
lular immune response in ISK. Histopa-
thologic studies in patients with acute 
endotheliitis are missing. The immune 
response is deleterious to the eye because the 
endothelium has no regenerative capacity. 
Endothelial dysfunction leads to stromal and 
epithelial edema. 
Treatment is similar to immune stromal 
keratitis. 
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SCOPE OF THE THESIS 
The aim of this thesis is to elucidate patho-
genic mechanisms of different forms of 
human HSV keratitis. HSV infection of the 
corneal epithelium causes a classical dendritic 
shaped lesion. Many studies could explain the 
development and growth in dendritic keratitis, 
but none of these found the anatomical sub-
strate for the linear branching pattern. The 
most obvious explanation would be, that the 
shape of dendritic ulcers corresponds with the 
anatomical pattern of innervating nerves of 
the cornea. In chapter 2 a relationship between 
the shape of dendritic ulcers in infectious 
epithelial keratitis and the subbasal nerve 
plexus of the corneal epithelium is postulated. 
Recurrence of HSV keratitis is a com-
mon complication after PKP for corneal opa-
cities resulting from HSV infection. After PKP, 
for reasons unrelated to HSV keratitis, epithe-
lial defects may still be caused by HSV. In 
chapter 3 the incidence of newly acquired HSV 
keratitis after PKP is determined and possible 
contributing factors are assessed. Several pos-
sibilities as to the origin of the infecting HSV 
exist. These include reactivation oflatent virus 
in the trigeminal ganglion, horizontal spread, 
or transmission through the donor cornea. To 
test the assumption of graft-to-host transmis-
sion of HSV by PKP, surplus corneal material 
was examined for the presence of HSV DNA. 
Chapter 1 Intmduction 
Because the amount of viral DNA available 
could be very limited, a new method inde-
pendent of viral culture, was developed to 
allow distinction between different virus 
strains. The newly developed technique was 
used to test our hypothesis that graft-to-host 
transmission of HSV is possible. This new 
method was used to determine the incidence 
of HSV-1 superinfection in patients with 
recurrent HSV keratitis. 
Although HSK has been studied 
extensively in the mouse model, it is not clear 
what triggers the immune response and to 
what extent the mouse data correlate with find-
ings in human keratitis. The most logical idea, 
that virus-derived proteins are the eliciting fac-
tor for the immune response, has been ruled 
out in the experimental HSK mouse model. 
Alternative sources of the keratogenic anti-
gens, like auto-antigens, have been suggested. 
Data on the pathogenesis of human HSK are 
limited. Therefore, in chapter 4 the antigen-
specificity of corneal T cells in HSK patients 
was investigated. Besides this, corneas of 
patients with HSK were examined for the 
presence of corneal antigen reactive T cells 
(auto-reactive T cells). 
Chapter 5 provides a concise summary 
of the data generated in the framework of this 
thesis, and concludes with an overall discus-
sion of the data and their possible impact on 
current ophthalmologic practice. 
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SUMMARY 
Purpose: 
Herpetic epithelial keratitis (HEK) is a common sequel of a corneal infection with herpes sim-
plex virus (HSV). Classical HEK lesions have a dendritic shape. 
The objective in this study was to test fbe hypothesis that the subbasal nerve plexus of the 
corneal epithelium is responsible for the shape of dendritic herpes simplex virus keratitis. 
Methods: 
A total of 114 patients with recurrent HEK (rHEK) were included. Eighty-five eyes developed 
rHEK without previous corneal surgery (group I) and 29 eyes developed rHEK after penetrating 
keratoplasty (PKP) performed for corneal opacities resulting from HSV keratitis. 
Branching patterns and orientation characteristics of the dendritic lesion in the corneal epithe-
lium were determined with the use of slitlamp photographs. For each dendrite, all branching 
angles were measured and the orientation on the cornea was determined. 
Results: 
In both groups a preference for branching angles near 90' and 135' is found. The orientation 
(main angle) of the dendritic lesion in group 1 has a preference for either a vertical or a horizon-
tal distribution on the cornea. Group 2 does not show a preference for any particular orientation 
on the cornea. 
Conclusions: 
The branching pattern and the orientation of the dendritic lesion in rHEK in not operated eyes 
correlated with the anatomy of the subbasal nerve plexus in the human corneal epithelium. After 
PKP the branching pattern of the dendritic lesions is the same as in eyes without previous corneal 
surgery, however the vertical or horizontal orientation on the donor cornea is lost. This might be 
explained by the random placement of the donor button during transplantation. 
INTRODUCTION 
The neurotropic herpes simplex virus 
(HSV) is a frequent cause of corneal disease 
that may lead to corneal opacification requir-
ing penetrating keratoplasty (PKP).' Herpes 
simplex epithelial keratitis (HEK) has a classi-
cal dendritic shape. The underlying pathogen-
esis of this characteristic lesion has to our 
knowledge never been elucidated. Knowledge 
of the underlying morphogenesis of the den-
drite will increase understanding of the mech-
anisms of dendritic lesion formation and viral 
spread in the cornea. 
The morphological features of epithelial 
HSV infection are - in part - due to contigu-
ous cell-to-cell spread of the virus in the 
corneal epithelium restricted only by local 
immune surveillance"--'. This "contiguous cell-
to-cell spread" does, however, not explain the 
branching pattern of •.he dendritic corneal 
lesion. One would expect a similar growth pat-
tern in HEK as in bacterial keratitis: an almost 
circular corneal lesion would develop. The 
affinity of herpes simplex virus for neural tis-
sues has led to the idea that the shape of the 
epithelial dendritic lesions might correspond 
with the anatomical pattern of the corneal 
nerves: in 1919, Vogt reported abnormally pro-
nounced corneal nerves in dendritic kerahtis· 1 • 
However, several studies have failed to demon-
strate a correlation between the anatomical 
pattern of fbe corneal nerves and the pattern of 
dendrites in HEK.' "'·. The nerve fiber pattern 
of the mammalian cornea has been described 
as radially oriented nerve fibers entering the 
Chapter 2 The dendritic pattem in epithelial herpes simplex virus kemtitis 41 
Figure 1a: Figure 1 b: 
Nerve fiber bundles in the subbasal plexus run f1rst in the 
9-3 hours direction. After the first bifurcation they run 1n 
the in the 12-6 hours direction and after the second bifur-
cation they run again in the 9-3 hours direction. The bead-
ed fibers run singly and obliquely after branching. 
Light micrograph of nerve fiber bundles and their side branches in the 
subbasal plexus of a semi thin 14m section. Bar"' o.osmm, the numbers 9 
and 3 represent the 9 and 3 o'clock position.,.,= Main nen;e fiber bundle run-
ning horizontally oriented (Fig. 1a and 1b both reprinted with permission from: 
MUller LJ, Vrensen GFJM. Pels L, Nunes Cardozo 8, Willekens B. Architecture 
of human corneal nerves. Invest Ophthalmol Vis Sci 1997;38:985-994) 
corneal stroma via the sclera. After passing 
Bowman's layer in the periphery of the cornea 
they ramify in the subbasal plexus as leashes'''. 
Nowadays it is known by the work of 
Muller et a!."' that the nerve fiber bundles of 
the human cornea form a regular meshwork in 
the subbasal plexus. running between the 
corneal epithelial basal cell layer and Bow-
man's layer. (Fig. la and b). Single fibers turn 
upwards into the upper layers of the corneal 
epithelium''··. 
The aim of the present study was to inves-
tigate the possible correlation between the ori-
entation and branching pattern of human 
HEK dendritic lesion and the anatomy of the 
subbasal nerve plexus of the human corneal 
epithelium. 
PATIENTS AND METHODS 
Patients 
To determine whether the branching pat-
tern and the orientation of the dendritic HSV 
lesions are congruent we examined dendritic 
and geographical lesions in the corneal epithe-
lium. One hundred fourteen patients with 
rHEK were included. After informed consent 
was obtained, photographs were taken with a 
Zeiss slitlampcamera (Oberkochen, Germany) 
and fluorescein staining with blue light and 
j or Rose Bengal staining with white light. 
Patients were divided into two groups: group 1 
consisted of patients who developed rHEK 
without previous corneal surgery and group 2 
consisted of patients with rHEK in their donor 
corneas after PKP. 
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Figure 2 Measurement of the branching angles and the mah'l angle in a dendr'ltic lesion. 
Examples of a dendritic lesion on a non-operated cornea (2a) and on a cornea after PKP (2b). 
2A + D: the original dendritic lesion. 
28-"- E: branching angles: points were drawn in the middle of all branches of the dendritic lesion. Lines were drawn 
through straight parts of the dendritic les1ons using these points The angles between two consecutive parts of the 
dendritic les'1on were measured as a branching angle (angle a and b). (Not all branching angles of this dendritic 
lesion are drawn in this figure for reasons of clarity) 
2C + F: main angle: points (shown only in the ion gest branch} are drawn in the middle of all branches of the dendrif1c 
lesion. The connecting !ine using most points was considered the best fitting or direction line. Angle cis meas-
ured with the use of the horizontal axis. 
Inclusion criteria: 
Only patients with epithelial herpetic ker-
atitis were included in this study. The diagno-
sis of HEK was based on ocular examination 
and clinical history, com.plemented with viral 
culture after photography (data not shown). 
Only one active HEK period per patient was 
allowed in this study. 
Exclusion criteria: 
Photographs with subepithelial fluorescein 
leakage, were not taken into consideration. 
Very small dendrites were excluded because 
the line of orientation and branching angles 
could not be determined accurately (group 1: 
n~9; group2: n~3). Dendritic lesions in the 
recipient cornea of group 2 were excluded 
(n~4). The present study was performed 
according the Declarations of Helsinki. 
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Horizontal axes: branching angles in degrees divided in groups of20°. 
Vertical axes: number of measured branching angles. 
3a: Group 1 (non-operated corneas). n=8s patients. 
3b: Group 2 (after PI<P). n=29 patients. 
Measurement of the main and branching 
angles of human HEK dendrites 
All color transparencies of HEK dendritic 
lesions were projected onto paper. The borders 
of the dendritic lesion, the corneal,limbal bor, 
ders, the donor-recipient interface and the 12 
o'clock position of the cornea were traced on the 
same paper. From these drawings the branch-
ing angles and the main angle were measured. 
Meas~trement of branching angles: 
To determine the branching angles, lines 
were drawn through at least two points placed 
in the middle of a straight part of distinctive 
and well,demarcated branches of the dendritic 
lesion (Fig. 2B +E, angles a and b). The angle 
(for instance a or b) between two consecutive 
direction lines was measured. All measurable 
branching angles of the dendritic lesion were 
determined. 
Measurement of main angles in human HEK 
The orientation of the dendritic lesion on 
the cornea was determined as illustrated in fig-
ure 2C+F. Points were placed in the middle of 
the location where a side,branch forks off. 
Connecting lines were drawn through these 
points. The straight line going through most 
points was accepted as best fitting line, the 
direction-line. The main angle is the angle 
between the direction line and the off! line of a 
superimposed orthogonal grid (Fig. 2C + F, 
angle c). To determine whether a horizontal or 
vertical preference in orientation is present the 
relative main angle, the smallest angle 
betvveen the 0-180ffi axis and the main line of 
orientation the dendritic lesion, was deter-
mined. In case of dendritic lesions with multi-
ple elongated branches, the direction,Jine 
through the longest branch was used to deter, 
mine the main angle. 
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Statistical Analyses: 
The Mann-Whitney test was used to test 
against a difference in the prevalence rate of 
branching angles between the two groups 
studied. Because in group 2 the donor corneal 
button is placed randomly rotated in the recip-
ient, it is hypothesized that all angles are 
equally likely (i.e. no preference for certain 
angles). The exact Pearson chi-square test is 
used to test the null hypothesis that the two 
angle distributions (without specifying these 
distributions) are the same in both groups. 
The chi-square goodness-of-fit test was used to 
test how well a hypothesized uniform distribu-
tion of the main angle fits to the observed data. 
RESULTS 
In total 114 patients with recurrent HEK 
were included of which 85 had not undergone 
surgery (group 1) and 29 had undergone a PKP 
procedure (group 2). 
Branching angles of human HEK dendritic 
lesions 
In both groups there was a preference for 
branching angles near 90' and 135' (Fig. 3a 
and b). 
In group 1 the 90' and 135' bars account 
for 88% (56% and 32% respectively) of all 
measured angles. In group 2 this is 94% (42% 
and 52% respectively). There is a significant 
difference in preference of group 1 for the 
angles near 90' and of group 2 for the angles 
near 135' (Mann-Whitney test: p~ 0.028 and 
p~ 0.003 respectively, Fig. 3A and B). 
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Main angles of human HEK dendritic 
lesions 
In group 1 the angles of orientation are not 
distributed uniformly. There is a preference 
for main angles around 90ffl and 180ffl (chi-
square goodness-of-fit test: p<0.0005. Fig. 4a) 
Group 2 does not show a preference for any 
particular main angle as can be deduced from 
the uniform distribution of the orientation of 
the main angles (chi-square goodness-of-fit 
test: p~0.989, Fig. 4b). A comparison of the 
angle distributions (without specifying these 
distributions) in both groups using the ordi-
nary exact Pearson chi-square test yields a p-
value of 0.285, Indicating the significant 
difference in orientation of the dendritic lesion 
between the two groups. 
For a direct comparison of the two groups 
in order to test the latter hypothesis, group 2 is 
too small to have sufficient power. 
DISCUSSION 
HSV-1 needs a neuronal substrate to travel 
from the trigeminal ganglion to the cornea and 
cause rHEIC'·'". To our knowledge, this is the 
first study to show a positive congruency 
between the anatomy of the subbasal nerve 
plexus of the corneal epithelium and the pat-
tern of the dendritic lesions in patients with 
HSV-1-induced rHEK. 
The current model for rHEK is: virus parti-
cles reach the cornea by the sensory nerve fibers 
and the dendritic lesions develops within the 
corneal epithelium by contiguous cell-to-cell 
spread"'. It is suggested that the initial virus tar-
gets are the deeper epithelial layers". 
Disruption of the epithelium through this 
mechanism alone, would lead to a situation 
similar to bacterial keratitis, leading to the same 
round or oval shaped lesions. The previous 
studies, however, do not explain the branching 
pattern of the dendritic lesion adequately. 
Mechanical factors as blinking or pooling of 
infectious virus in the tear meniscus could be 
responsible for vertical or horizontal lesions on 
the cornea. However in other infectious 
processes of the cornea linear branching lesions 
are not found, indicating a different underlying 
pathogenesis in epithelial HSV keratitis. 
Until recently the corneal epithelial inner-
vation have been described as radial oriented 
nerve bundles, ramifying as leashes in the sub-
basal epithelial nerve plexus-'". ln 1997 Muller 
et al. described the subbasal nerve plexus of 
the corneal epithelium as a regular meshwork 
with mainly perpendicular and oblique angles 
(45' or 135').'".The epithelial subbasal nerve 
plexus of the human cornea is unique in the 
animal world.'"·'·'. 
Our results show that the branching angles 
of dendritic lesions have a preference for 
angles near 90' and 135' in both groups (Fig 
3). Thus, the subbasal plexus of the corneal 
epithelium might indeed be the anatomic 
structure responsible for the characteristic 
form of the dendritic lesion in recurrent HEK. 
Our hypothesis of distribution of reactivat-
ed HSV to the epithelial cells is illustrated in 
figure 5: The reactivated HSV travels from the 
ganglion along the sensory nerves, through the 
epithelial subbasal nerve plexus, to the end 
fibers that reach up into the corneal epithelial 
wing cells. As a result of this, only wing cells 
above a nerve fiber will become infected. By 
contiguous cell-to-cell spread HSV will extend 
to the surface epithelium. When the spheres of 
infected cells around the tip of a nerve touch 
each other, they fuse and form a linear lesion, 
branching off dependent on the pattern of the 
underlying subbasal nerve plexus. 
Consequently, the spheres around the last 
nerve endings also explain the phenomenon of 
end bulbs in dendritic keratitis. Our hypothe-
sis of distribution is confirmed by the clinical 
description of the evolution of a dendritic 
lesion'''''. 
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The fractal properties attributed to HEK 
are, to our opinion, not caused by the growth 
pattern of the virus or the corneal epithelium, 
but by the underlying subbasal nerve 
plexus"'". The differences found in fractal 
properties betvveen early dendritic lesions and 
amoeboid shaped dendritic lesions can be 
explained by the cell-to-cell viral spread, 
leading to a more geographical or amoeboid 
shaped corneal lesion. When the size of the 
outlines of a dendritic lesion increases or in 
other words the longer the corneal epithelium 
is involved, the fractal properties of the 
dendritic lesion will diminish 1 '. 
The results of main angle measurements 
show a discrepancy between the transplanted 
and non-transplanted eyes (Fig 4). Group 2 
(post-PKP in donor cornea) does not have a 
preference for any main angle, indicating that 
the orientation of dendritic lesion can be 
found in every direction on a donor cornea 
after PKP. This can be explained by the fact 
that the original 12 o'clock position of the 
donor corneal button has been lost when it is 
placed randomly in the recipient during the 
PKP procedure. The finding, that dendritic 
lesions are similar in form after PKP, but 
merely rotated, suggests the same grid-like 
anatomy of the subbasal plexus in the donor 
cornea after PKP. This could have implications 
for concepts about reinnervation after PKP. 
After enucleation nerve fibers in the cornea 
degenerate within 10 hrs'd. Degenerated 
nerves or other (glia) tissue in the subbasal 
plexus may remain at their location and are 
perhaps able to facilitate the ingrowth of new 
nerves along the previous paths of the old sub-
basal plexus. Baum' has shown that a few days 
after PKP a dendritic lesion can be seen on a 
rabbit cornea. It is important to note that this 
study used a method of external inoculation of 
HSV- 1 after PKP and did not induce reactiva-
tion of herpetic keratitis. 
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Figures: Hypothesis on the spread of reactivated HSV into epithelial cells: 
Top: schematic three-dimensional drawing of corneal epithelium and sub-
basal plexus. The herpes simplex virus reaches the corneal epithelium 
through the subbasal plexus with its terminals at the location of the corneal 
epithelial wing cells. Spheres are drawn as a gradient to show the spread of 
herpes simplex virus into the corneal epithelium from cell to cell from the 
tip of the nerve fiber. 
e= epithelium, n= nerve fibers, b= Bowmans' layer 
Middle: frontal view: schematic drawing of the distribution of the herpes 
simplex virus in the corneal epithelium. Grey oblique line: nerve fiber of 
subbasal plexus underlying the corneal epithelial cells. The dots represent 
the nerve fiber endings in the wing cells of the epithelium. 
Middle and bottom: From left to right: 3 consecutive stages in the develop-
ment of a dendritic lesion. Left: no pathology. Middle: early dendritic lesion 
(dark cells). Right: complete dendritic lesion. 
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Confocal microscopy indicates that reinner-
vation of the central basal epithelium occurs 
within 2 years after PKP." We observed HSV 
dendrites in the central part of the donor but-
ton after a mean time of 31 months, but also 
within the first year after PKP (range: 1-192 
months, data not shown). At this moment, 
however, little is kno\Vll about the reinner-
vation of the corneal epithelium shortly after 
PKP\,,IY.2fl. 
The difference in branching angles 
between non-transplanted (preference 90") and 
transplanted eyes (preference 135") may be 
caused by specific preservation of parts of the 
subbasal plexus after transplantation. 
This study is the first to provide indirect 
evidence that the subbasal nerve plexus of the 
corneal epithelium is responsible for the den-
dritic pattern in HSV keratitis. The relation 
between the HEK and the subbasal nerve 
plexus explains the morphological features, 
the viral spread and the fractal properties, and 
is confirmed by the clinical description of the 
evolution of a dendritic lesion. 
In vivo confocal microscopy might substan-
tiate our hypothesis on the relation betw"een 
the herpetic dendritic tree and the subbasal 
nerve plexus. Yet, there might be problems 
visualizing the subbasal nerve plexus by confo-
cal microscopy in active HEK. Because it is 
known that sensitivity decreases during each 
episode ofherpetic keratitis, structural damage 
of the subbasal nerve plexus might occur dur-
ing or after infection. The original nerve 
plexus might be changed after an infection 
episode. 
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SUMMARY 
Background: 
After penetrating keratoplasty for reasons unrelated to herpes simplex virus (HSV) keratitis, 
any nonspecific epithelial defect may still be caused by HSV. The purpose of this study is to deter· 
mine the incidence of newly acquired herpetic keratitis and to assess contributing factors. 
Methods: 
The authors retrospectively studied the results of 2398 penetrating keratoplasties performed 
between 1980 and 1995. Three typical case histories are discussed. 
Results: 
Of 2112 patients in whom the primary diagnosis was not related to HSV keratitis, 18 present-
ed with epithelial herpetic keratitis in their corneal graft. The incidence of newly acquired herpet-
ic keratitis after penetrating keratoplasty was 1.2 per 1000 person-years. In most cases, the 
infection occurred in the first 2 years after the transplantation. Most often, well-known reactivat-
ing stimuli could have caused the HSV infection. 
Conclusions: 
Herpes simplex virus keratitis may develop after penetrating keratoplasty even without a clini-
cal history of HSV in the host. Thus, HSV should be considered in the differential diagnosis of a 
postpenetrating keratoplasty epithelial defect. The high incidence of this infection in the first 2 
years after such surgery suggests a causal relation between corneal transplantation and the HSV 
infection. 
INTRODUCTION 
Herpetic keratitis may recur after penetrating 
keratoplasty (PKP) performed for herpes simplex 
virus (HSV)-related corneal disease. After PKP 
for reasons unrelated to H SV, however, herpetic 
keratitis may not be readily suspected. 
The H SV keratitis after PKP performed for 
any reason may present as a classic dendritic 
keratitis (Fig 1) or as nonspecific large epithe-
lial defects (Fig 2).'' Either of these may occur 
together with an allograft reaction.) To our 
knowledge, only seven patients with newly 
acquired HSV keratitis after PKP have been 
described,' ' which may suggest that its inci-
dence rate is as low as in the normal popula-
tion. Nevertheless, as much as 95% of the 
population older than 60 years of age is 
seropositive for HSV type 1 (HSV-1)' and car-
ries the virus in a latent phase in the sensory 
ganglia. A wide variety of stimuli have been 
found to be able to stimulate recurrence, 
including febrile illnesses, stress, menstrua-
tion, sunlight, heat, and trauma. Any local 
trauma can reactivate the virus and cause a 
manifest infection, including penetrating ker-
atoplasty combined with postoperative topical 
steroid medication and suture removal(, 7 
Immune reactions also are considered as reac-
tivating stimuli. 1 We would therefore expect 
the incidence of newly acquired HSV keratitis 
after PKP to be higher than in the normal 
population. The incidence of new cases of 
HSV keratitis in the normal population is 8.4 
per loo,ooo person-years.' Because there are, to 
our knowledge, no data on the actual inci-
dence of newly acquired HSV keratitis after 
PKP, we currently have tried to assess it by 
reviewing the medical records of our patients 
who had transplantations between january 
1980 and January 1995. We also have tried to 
distinguish any possible reactivating stimuli. 
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PATIENTS AND METHODS 
We retrospectively examined the medical 
records of 2398 patients who had transplanta-
tions performed between January 1980 and 
January 1995. Of these, 2112 transplantations 
(88.1 %) had been performed for various 
corneal diseases unrelated to HSV. Of this 
group, 18 patients later presented with an HSV 
keratitis, all of which were epithelial. The clin-
ical data were scored and are presented in 
Table I. Only one patient (Table 1, patient 10) 
had a history of herpetic infections, which, in 
her case, were fever blisters. 
In the total group of 2112 transplants, 229 
whole globes stored in a moist chamber at 4'C 
were used for lamellar keratoplasty; for PKP, 
359 corneas had been in short-term storage in 
McCarey-Kaufman medium and another 1524 
corneas stored in organ culture at 34'C in min-
imal essential medium. Of the 18 newly 
acquired HSV after PKP, 3 corneas were stored 
in McCarey-Kaufman medium, 14 in mini-
mum essential medium, and l in a moist 
chamber. Possible causes of endogenous reac-
tivation in these cases have been listed in 
Table 2. Three cases are discussed to show how 
varied the signs of newly acquired HSV kerati-
tis after PKP may be. 
CASE REPORTS 
Case l. 
A 53-year-old woman (Table 1, patient 10) with 
bilateral keratoconus underwent PKP in her right 
eye in April1988. Her corneal epithelium was intact 
for the first 4 postoperative weeks. She then pre-
sented with a large epithelial defect and a small infil-
trate (Fig 3). Viral cultures from the cornea turned 
out to be positive for HSV-1. She was using topical 
dexamethasone 0.1% six times daily. As a result of 
frequently recurrent episodes of herpetic keratitis 
with stromal loss, 3 years later a conjunctival flap 
was deemed necessary to prevent perforation. 
Almost 2 years later, a repeat PKP was performed. 
Case 2. 
A 73-year-old man (Table 1, patient 13) 
underwent a PKP in June 1991 for corneal 
scarring secondary to a penetrating trauma in 
his right eye. Five months after surgery, while 
the patient was receiving topical dexametha-
sone 0.1% twice daily, an epithelial defect 
developed with marked stromal infiltration 
and localized endothelial precipitates (Fig 4). 
Topical treatment with tobramycin and 
atropine 1% was unsuccessful. We increased 
the dexamethasone 0.1% to six times daily to 
prevent an allograft reaction. Bacterial cultures 
were negative. Five months later he undenvent 
a repeat PKP. Histologic examination results 
of the removed corneal button showed an 
active inflammatory infiltrate, predominantly 
lymphocytic. No micro-organisms could be 
shown on light microscopy. Three months 
later he returned with localized stromal 
edema, an endothelial Khodadoust line, and a 
central dendriform herpetic keratitis. The top-
ical medication used at that time was topical 
dexamethasone 0.1% tvvice daily. 
Case 3· 
A 28-year-old man (Table 1, patient 16) with 
congenital glaucoma undenvent a third PKP in 
1992 in his right eye. Immediately after sur-
gery, the epithelium was absent and showed no 
recovery despite additional treatment with 
bandage contact lenses and frequent lubrica-
tion with autologous serum." He was using 
prednisolone 0.5% eye-drops eight times daily. 
Three months after surgery, viral cultures 
finally were positive for HSV-1. 
RESULTS 
Of the 2112 corneal transplants carried out 
for reasons unrelated to HSV keratitis, herpet-
ic keratitis all of which were epifhelial, devel-
oped in the graft of 18. Their clinical data are 
presented in Table I. The interval between the 
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transplantation and the onset of the keratitis 
varied from 1 day to 13 years. However, as 
many as 11 patients (61 %) 1 had their onset 
within 1 year and another 4 patients (22%) 
within the next year. Taken together, the inci-
dence of newly acquired HSV keratitis after 
PKP was 1.2 per 1000 person-years. 
In 13 patients, the infection was character-
ized by a dendritic keratitis, 8 of which had 
positive cultures for HSV-1. In another 5 
patients, the keratitis presented as a non-heal-
ing epithelial defect or as a non-specific ulcer. 
All these cases were HSV-1 culture proven. In 
three patients, the epithelial keratitis was asso-
ciated with a graft rejection: the eye was red, 
there was localized stromal edema, and there 
were endofbelial precipitates predominantly 
on the graft. We could not relate either the pri-
mary diagnosis calling for a PKP or the 
method the donor corneas had been stored to 
the occurrence of the newly acquired HSV ker-
atitis. The newly acquired HSV keratitis 
occurred in 14 cases during an episode of 
infection while the patient used dexametha-
sone 0.1% mice daily or less. In another seven 
cases, doses of four to six times daily of dex-
amethasone 0.1% were used. So in most cases, 
steroids could have been the reactivating stim-
ulus. 
In this patient group, the surgical trauma, 
suture removal, steroids, and immune reac-
tions could have been the reactivating stimuli 
(Table 2). In 16 of 18 patients, 1 of the men-
tioned stimuli could play a role in the occur-
rence of the HSV infection. Thus, in 16 of 18 
cases (88.9%), the presentation could be the 
result of endogenous reactivation. 
DISCUSSION 
In this retrospective study (1980 to 1995) of 
2112 corneal transplantations for reasons 
unrelated to HSV, we identified 18 cases of 
newly acquired epithelial herpetic keratitis 
after PKP. In the literature, only seven similar 
cases have been reported, which may suggest 
that its incidence rate is as low as that in the 
normal population. 
We found an incidence of 1.2 per looo per-
son-years, which is 14.2 times the incidence of 
herpetic keratitis in the normal population 
(95% confidence interval, 8.2 to 21.07).' We 
may have underestimated the actual incidence 
of newly acquired HSV keratitis after PKP, 
because we focused primarily on epithelial 
defects, whereas a herpes infection in a 
corneal graft may also present as a kerato-
uveitis, resembling an allograft reaction. 1·"· 10·". 
In addition, an herpetic endotheliitis resem-
bling the Khodadoust line in allograft reac-
tions has been recognized in normal corneas. 12 
Interestingly, the highest incidence of 
newly acquired HSV keratitis after PKP 
occurred in the first 2 years after the surgery, 
which suggests a relation between fbe corneal 
transplantation and the presentation of the 
infection. It remains unclear, however, what 
actually triggers the reactivation of the infec-
tion. Also, it remains unsettled where, the 
HSV originates. Insight into these two ques-
tions might lead to better prevention of the 
infection. Several possibilities as to the origin 
of the virus exist, such as reactivation of the 
latent virus in the trigeminal ganglia, viral 
transmission through tear-shedding, viral 
transmission through donor corneas, and viral 
growth in the storage medium. 
Endogenous reactivation of latent virus in 
the trigeminal ganglion is the most important 
cause of active herpetic keratitis. 13 . 15 Probably, 
reactivating stimuli related to the corneal 
transplantation played a role in our patients. 
In this patient group, the surgical trauma, 
suture removal, steroids, and immune reac-
tions could have been the reactivating stimuli 
(Table 2). Ocular surgery, per se, appears to be 
a fairly weak stimulus to reactivate HSV, 
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Figure 1 
Classic herpes simplex viral keratitis in donor cornea (Table 1, patient 2). 
Figure 2 
Nonspecific epithelial defects and superficial stromal scarring in a patient who had transplantation for keratoconus (Table 1, patient 15). 
Figure 3 
Large epithelial defects small stromal infiltrate with positive culture for HVS type 1, moth after PI<P for keratoconus (Table 1, patient 10). 
Figure 4 
Stromal infiltrate (Table 1, patient 13) with negative bacterial cultures. Three months after repeat PI<P, the patient showed a beginning allo-
graft rejection and a classic central dendriform herpetic keratitis. 
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Table 1 
HSV =herpes simplex virus; TBC =tuberculosis; assoc =associated; PI<P =penetrating keratoplasty; 
dex= dexamethasone phosphate 0.1%; fml = fluorometholone 0.1%; 
predn= prednisolone sodium phosphate 0.5%; pf =prednisolone acetate 1%; albicort 
pb= triamcinolone acetonide 40mg peribulbar; LI<P =lamellar keratoplasty; nd= not done 
,,, Storage method: Ml<= McCarey-l<aufman medium; MCh= moist chamber 4C; MEM= minimal essential medium 
·':·.', Presentation time until·. a, first PI<P; orb, second PI<P 
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TABLE 1. CLINICAL DATA OF PATIENTS WITH NEWLY ACQUIRED HERPES SIMPLEX VIRUS KERATITIS 
Case No. Time until 
Gender Year of Primary presentation of Graft Use of 
Age (yrs) Operation Storage''' Diagnosis HSV (mos)''"'- Rejection Steroids First Signs Culture 
1, F, 59 1980 MK Lattice dystrophy 156 - none Recurrent dendrf1c + 
ulcer on donor 
1980 Reis Bueckler fml3 
- Central dendrites nd 2, F, 74 MK 9 
dystrophy albicort pb on donor 
interstial 
keratitis 
---
Ps€udophakic - dex 6 
-~--
Central infiTtrate 3, M, 70 1984 Ml< 
'· 0 
-
bullous RePKP in donor 
keratopathy 
b,l8 - dex 1 Large ulcer on donor + 
--~ ---· MCh Lattice dystrophy ---· Recurrent dendrites 4, M, 39 1985 99 none 
on LI<P 
--· 
MEM Interstitial deX"l Recurrent d-eridrite ~·-na-5, F, 53 1985 '4 
keratitis assoc on interface 
TBC 
Dendri-te on dono-~-~ 6-;-M, 75 1986 --MEM Int-erstitial - - dex 1 
---·-
51 + 
keratif1s assoc 
measles 
... 
-· 
- PseudOphakic dex 4 Recurrerit dendrites 7, M, 73 1986 MEM 2 + 
bullous on donor and 
-· 
keratopathy _____ 
---··· 
recipient 
--
8, F. 48 1987 MEM Chem1cal burn 5 + - -aex-2-- Central epithelial d€fect + 
9, M, 74 1987 MEM Interstitial 11 dex 1 dendrite on -interface nd 
keratitis as soc 
TBC 
--
lg88 l<eratoconus ·- dex 6 Recurrent dend-rite 10, F, 53 MEM 1 + 
on interface 
----· 
1989 
---
-
chemican;urr;--
-----
d€x 2 Atypical geographic n,F,59 MEM 9 - + 
ulcer in donor 
12, F, 82 1989 MEM InterStitial dex 1. oral Dendrite on donor -·-21 -
keratitis assoc prednisone ulcer in recipient 
TBC 5mg(d 
-
13, M, 73 1991 MEM Penetrating 
'· 5 dex 2 1, nonspecific ulcer + 
trauma RePKP interface 
b, 3 + dex 2 2, dendtrites on + 
donor 
---·· 
·-
----
PseudoP"hakic 
-
Predn 6 
·-- Geogr-aphic ulcer-- -q, F, 82 1992 MEM 3 + 
bullous on donor 
keratopa_thy 
15, F, 21 1992 MEM Keratoconus 1 dex 4 Reclirrent dendrTt.es -
on interface 
16, M, 28 1992 MEM Buphthalmos o or 3 - predn 8 Non healing + 
third PKP epithelial defect 
after 3 mos 
·- ·-
17, F, 72 1992 MEM 'Fuchs 2) fml3 Multiple dendrites + 
endothelial on donor, pressure 
dystrophy rise 
18, F, 69 MEM Fuchs "dex 1 - Small dendriform nd 1992 a, 22 + 
endothelial lesions, pressure rise 
dystrophy b, 25 - pf 8 Multiple large + 
dendrites on donor 
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TABLE 2: POSITIVE CAUSES OF THE 
ENDOGENOUS TEACTIVATION lN 
THE 18 PATIENTS 
Unknown trauma 
Corneal trephination 
Suture removal 
High steroids 
Immune reaction 
In one patient, both factors could have played a role. 
2 
2 
because the incidence of HSV keratitis there-
after remains comparatively low compared to 
the high prevalence of latent virus in the gen-
eral population. Moreover, HSV keratitis after 
cataract surgery appears to be rather rare. 
Another possibility could be transmission of 
HSV by way of tear shedding. In 1967, 
Kaufman et aP(' found asymptomatic ocular 
shedding in !.8% of specimens taken from 
patients without a history of herpetic eye dis-
ease. This finding could not be confirmed, 
however, by studies from Kaye et al. 1 ' 
Yet another possibility might be the trans-
mission of virus through the donor cornea. 
Rabies, Creutzfeldt-Jakob disease, and hepati-
tis B virus are proved to be transmitted by 
corneal transplantation.1·'_1" Recently, extraneu-
ronal localization of HSV-DNA was reported 
in the corneas of patients with no history of 
herpetic eye disease.""-"' Transmission of this 
DNA by corneal transplantation could be pos-
sible when this DNA is viable. In the group of 
patients who had transplantation for diagnoses 
not related to HSV, 5% to lo% of them will be 
seronegative for HSV. These patients might be 
at risk of developing an HSV infection after 
transplantation with an HSV-positive donor 
cornea. This might lead to a primary infection 
presenting directly after surgery as a slow or 
nonhealing defect or lead to primary graft fail-
ure or to colonization of the trigeminal gan-
glion with subsequent reactivation leading to a 
manifest infection. Openshaw et aF< could not 
show seroconversion after transplantation of 
corneas containing viral sequences in HSV-1 
naive recipient rabbits in the s months there-
after. To prove transmission from donor 
cornea to recipient, the isolation of the HSV-
DNA from the donor and the comparison of 
this to the HSV -DNA from the virus isolated 
from the herpetic keratitis should be per-
formed involving several hypervariable seg-
ments of virus DNA." 
Complete identity of the viral genome of 
donor and recipient probably will be hard to 
prove. The viability of the HSV-DNA detected 
with the polymerase chain reaction remains a 
controversial issue. 
Cleator et aP" showed viral growth in organ 
culture storage, although its occurrence is 
rather rare. We could not find a relation 
between this clinical picture and the corneal 
storage technique. 
We believe that, in most cases, the presen-
tation of the infection will result from endoge-
nous reactivation of the trigeminal ganglion by 
transplantation-related reactivating stimuli. 
We want to emphasize the need to consider 
HSV keratitis in the differential diagnosis of a 
post-PKP epithelial defect in a patient without 
a history of HSV infection. 
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SUMMARY 
Herpes simplex virus type 1 (HSV-1 )-related disease ranges from a localized, self-limiting ill-
ness to fatal disease in imrnunocompromised individuals. The corneal disease herpetic keratitis 
may develop after reactivation of a latent virus or reinfection with an exogenous herpesvirus. 
Molecular analysis of the virus involved may allow distinction betvveen these tvvo options. The 
HSV-1 genome contains several hypervariable regions that vary in numbers of reiterating regions 
(reiterations I to VIII [Rei to ReVIll]) between individual strains. Twenty-four HSV-1 clones, 
derived by subcloning of HSV-1 (strain F) twice in limiting dilutions, were tested in a PCR-based 
assay to analyze the stabilities of Rei, Relii, Re!V, and ReV!!. Rei and Relll proved to vary in size 
upon subcloning, whereas Re!V and ReV!l were stable. Subsequently, 37 unrelated isolates and 10 
sequential isolates from five patients, all with HSV-1-induced keratitis, were genotyped for Re!V 
and ReV!!. Of the 3 7 unrelated samples, 34 (92%) could be discriminated, while the genotypes of 
the viruses in sequential samples were identical for each individual. Conclusively, the data show 
that the approach presented allows the rapid and accurate discrimination ofHSV-1 strains in stud-
ies that address the transmission and pathogenesis of HSV-1 infections. 
INTRODUCTION 
Herpes simplex virus (HSV) type 1 (HSV-1) 
infections are widespread in the human popula-
tion and may cause a variety of disease symp-
toms, including localized recurrent ocular 
lesions like uveitis and keratitis'''. Clinical man-
ifestations associated with herpetic corneal 
infections are herpetic epithelial keratitis and 
the development of the potentially corneablind· 
ing disease herpetic stromal keratitis. It may be 
of clinical importance to know whether recur-
rent corneal HSV-1 infections are caused by 
reactivation of a latent virus or reinfection with 
an exogenous virus. Genetically different HSV-1 
strains can induce different types of ocular 
lesions'' Intratypic differences between HSV 
strains have been demonstrated by plaque mor-
phology, serology, and DNA restriction analysis' 
., "". The method generally used to discriminate 
HSV-1 strains is restriction fragment length 
polymorphism (RFLP) analysis' " ,._,, ,,,_, 
Since this technique depends on virus culture to 
obtain sufficient quantities of viral DNA, it is 
unsuitable for rapid diagnosis or when no virus 
can be isolated. Vogel et aL'' reported on an 
alternative method for clinical HSV strain dif-
ferentiation that uses PCR amplification and 
subsequent RFLP analysis. We have chosen to 
develop a different strategy, based on the vari-
ability ofreiterated sequences within the HSV-1 
genome. The genome of HSV-1 consists of a 
unique long (UL) and a unique short (Us) 
sequence, each of which is flanked by inverted 
repeat sequences'·''' Several hypervariable 
regions, designated reiterations I to VIII (Rei to 
ReVIll), have been identified within the HSV-1 
genome (Fig. 1). These regions contain multiple 
repeating sequences, which vary in numbers 
betvveen unrelated HSV-1. strains'·" 1')" '·' '' :.< '' 
The stability of these regions varies. Rei, Reiii, 
Re!V, and Re VII have been demonstrated to be 
relatively stable during a short period of viral 
replication, and it has been suggested that sev-
eral of these hypervariable regions could be 
used as markers to discriminate HSV-1 strains': 
''. Rei and Relii are located within the "a" 
sequence of the repeat regions that flank the 
unique short sequence. RelY is present twice 
within the HSV-1 genome and is located within 
introns of both the genes US 1 and US 12, 
whereas ReVII is located within the protein-cod-
ing region ofUSlO and US11'" ''.This report 
describes the development of a PCR method 
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that is used to discriminate HSV-1 strains and 
that is based on the variability of reiterated 
sequences within the HSV-1 genome. This 
approach was successfully used to discriminate 
37 unrelated corneal HSV-1 isolates obtained 
from patients with herpetic corneal disease. 
Additionally, sequential HSV-1 isolates from 
five herpetic keratitis patients were compared. 
MATERIALS AND METHODS 
CUnical samples and viruses. 
Corneal swab specimens were obtained 
from 3 7 patients with herpetic keratitis at the 
Rotterdam Eye Hospital (Rotterdam, The 
Netherlands) for diagnostic purposes. 
Sequential samples (n ~ 2) were obtained 
(mean time interval, 19 months; range, 9 to 
38 months) from 5 patients: from the same eye 
for four patients and from different eyes for 
one patient. Virus was grown on human 
embryonic lung fibroblasts and was harvested 
when approximately 75% of the monolayer dis-
played a cytopathic effect. All culture samples 
were confirmed to be HSV-1 positive by PCR 
(data not shown). To determine the stability of 
the hypervariable regions, 24 subclones were 
generated from HSV-1 F (ATCC VR-733) by 
subcloning twice in limiting dilution as 
described before'". 
Nucleic acid extraction. 
DNA was extracted from 100 )11 of virus cul-
ture samples by a guanidinium thiocyanate-
Celite binding method, as described before'. 
Briefly, a sample was added to a tube contain-
ing 1 ml of lysis buffer and 40 )11 of Celite sus-
pension (Fischer Scientific, Den Bosch, The 
Netherlands), mixed, and incubated for 10 min 
at room temperature. The Celite-bound DNA 
was washed twice with wash buffer, twice with 
70% (voljvol) ethanol, and once with acetone 
and was subsequently dried. DNA was extract-
ed by resuspending the pellet in 150 )11 of 
water at 56"C for 10 min. A volume of 5 )11 of 
the resulting DNA suspension was used per 
PCR mixture. 
PCR amplification. 
Primers were designed to amplify distinct 
regions in the HSV-1 genome that contained 
Rei, Relll, Re!V, or ReVII. PCR amplification 
was performed with several combinations of 
primers (Table 1). The PCRs were performed 
in 50-,ul volumes. The reaction mixture con-
tained 1.25 U of cloned Pfu DNA polymerase 
(Stratagene Europe, Amsterdam, The 
Netherlands), corresponding buffer supple-
mented with S% (voljvol) dimethyl sulfoxide 
(DMSO), each of the primers at a concentra-
tion of 1 ,uM, and each deoxynucleoside 
triphosphate, including equimolar amounts of 
dGTP and 7-deaza-2'-dGTP (Boehringer 
Mannheim, Mannheim, Germany), at a con-
centration of 200 )1M. A S-)11 sample of the 
DNA suspension was added, and the reaction 
mixtures were overlaid with SO )11 of mineral 
oil. PCR amplification was carried out as fol-
lows: an initial denaturation step of9S"C for 5 
min, followed by 45 cycles of alternating denat-
uration (1 min, 95"C), primer annealing (1 
min at the appropriate temperature; Table 1), 
and primer extension (1 min, 72"C). A final 
extension step of 7 min at 72°C was included. 
For negative control samples, the DNA sus-
pension was replaced by water. All PCRs were 
performed in a Perkin-Elmer 480 thermocycler 
(PE Biosystems, Nieuwerkerk ajd I)ssel, The 
Netherlands). 
Detection of amplified products. 
Amplicons were size fractionated in 2% 
agarose gels and were visualized by ethidium 
bromide staining. The specificities of the 
amplicons were confirmed by Southern blot-
ting'". Briefly, the electrophoresed samples 
were transferred onto Hybond N+ membranes 
(Amersham, Pharmacia Biotech). 
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Us 
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USll --o-
USIO +e:::J-
m i t i m 
I II III IV VII IV !II !I l 
Reiteration Sequence (5'--+3') Length (bp) 
CCGCTCCTCCCC1 12 
CCGCTCCTCCC2 11 
CCGTCTGTGGGTGGGGCTCCTCCC2 24 
CCGCTCCTCCCC3 12 
CCGCTCCTCCCCGCTCCCGCGGCCCCGCCCCCAACGC3 37 
Ill CCGCCCCTCGCCCCCTC1 17 
IV CCCCCTCCTCCGCCCCCGCGTC1 22 
CCCCCTCCTCCACCCCCGCGTC1 22 
VII CCCCGGTCTCCCCGGGAG 1 18 
FIC.1. Map of herpes simplex virus type 1 (HSV-1) genome and location and sequences of reiterations. 
A HSV-1 DNA consists of2 covalently rmked components (LandS), each of which consists of unique sequences (ULand 
U5) flanked by inverted repeat sequences (IR and TR). The short "a" sequence is located at both termini of the genome 
and in the inverse orientation at the L-S junction'". The enlargement of the S component shows the s'-->3' orientations 
ofmRNA species as horizontal arrows with introns as V-shaped indents. Protein coding regions are shown as open 
boxes. Vertical arrows indicate locations of reiterations and Roman numerals as location numbers as defined by Rixon et 
al.". 
B Reiteration-specific sequences, as indicated by the superscript numbers, were derived from the following strains: 1, 
MP17; 2, USA-8; 3, F. 
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Hybridization was performed overnight at 
37'e with [y-32P]ATP-labeled Re-specific 
oligonucleotides (Table 1). Posthybridization 
washes were performed twice with 23 sse (13 
sse is 0.15 M Nael plus 0.015 M sodium cit-
rate)-0.1% sodium dodecy! sulfate at 37'e for 
10 min. The filters were exposed with intensi-
fying screens at -80'C. In case of small differ-
ences in length between amplicons from 
individual samples, the DNA fragments were 
electrophoresed on denaturing (8 M urea) 6% 
acrylamide gels''. The lengths of the amplicons 
were estimated by comparison to a 100-bp 
DNA ladder (Gibco BRL). To confirm differ-
A B 
I I 2 j .J ~ [, " .\ •! 1<1 ( 
FIG. 2. Amplification ofhypervariable regions within the HSV-1 genome. 
A PCR amplification of regions containing Rei, Rei II, RelY, and ReVII was 
performed with DNA from various HSV-1 (strain F) subclones. 
Amplicons were electrophoresed on a 2% agarose gel and were visual-
ized by ethidium bromide staining. Ten representative samples from 24 
subclones analyzed are shown. Lane F, parental strain HSV-1 F; lanes 1 
to 10, HSV-1 F subclones; lane C, water control: lanes M, 100-bp 
molecular size marker. Numbers on the left are in base pairs. 
B Autoradiogram of DNA in gel from panel A after Southern blot transfer 
and hybridization with a Re-specific probe. 
ences in amplicon length, all samples tested 
were finally electrophoresed in order of 
increasing length. 
RESULTS 
Amplification of hypervariable genomic 
HSV-1 regions containing Rei, Reii/, ReiV, 
and ReVI/. 
On the basis of documented variability and 
stability" '', hypervariable regions containing 
Rel, Reiii, RelV, and ReVll were selected as 
candidate templates for PeR-mediated dis-
crimination of unrelated HSV-1 strains. 
Amplification of these regions was not pos-
sible or was insufficient under standard PCR 
conditions (data not shown). 
Alternative conditions, selected to decrease 
the formation of secondary structures due to 
the high G+e contents of these sequences, 
improved amplification of the target 
sequences and allowed direct visualization of 
the amplicons with ethidium bromide. The 
specificities of the amplicons were confirmed 
by hybridization with a y-''P-labeled Re-specif-
ic probe following Southern blotting (Fig. 2). 
Consistent results were obtained in all cases in 
subsequent experiments. To test the stabilities 
of Rei, Reiii, Re!V, and ReVII, PeR amplifica-
tion of these regions was performed with 24 
separate subclones of HSV-1 F, and the 
sequences of these regions were compared 
with those of the amplicons of the parental 
strains (Fig. 2). For the regions containing 
ReiV and ReVII, amplicons from all 24 sub-
clones were identical in size to those of their 
parental strains, indicating the stability of 
Re!V andRe- VII during the two limiting dilu-
tion rounds. For the regions containing Rei 
and Relll, not all separate subclones showed 
the same amplicon length as their parental 
strains, differences being greatest for Reiii 
(Fig. 2). Consequently, ReiV and ReVII were 
further used to discriminate 3 7 unrelated 
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TABLE 1. PRIMERS USED f'OR AMPLIFICATION AND DETECTION OF HSV-1 REITERATIONS 
Genome 
region Primer' 
"a" sequence ReiF 
ReiR 
"a" sequence Rei IIF 
ReiiiR 
US1 ReiVUS1 F 
ReiVUS1R 
US12 ReiVUS12F 
ReiVUS12R 
US10-USn ReVIIUS1011 F 
ReVIIUS1011 R 
Rei Rei probe 
Rei II Rei II probe 
RelY ReiV probe 
ReVII ReVII probe 
1 F. forward; R, reverse. 
Optimal 
annealing 
temp ('C) Sequence (s' -> 9') 
72 GCCGCCACCGCTITAAAGGGCCGC 
GTGCTCTGTIGGTTICACCTGTGGCAGC 
72 TCTCTACCTCAGTGCCGCCAATCTCAGGTC 
CGAAGACGCAATAAACGGCAACAACCTG 
64 TCCGACGACAGAAACCCACC 
GTCCCGGAGGACCACAGTGG 
ss TITTIGCACGGGTAAGCAC 
TGGTGTCCAGGAAGGTGTCC 
s6 AGCGTATGCTCCATGTIGTG 
CGAGAACCTAGGGAACCCA 
37 CCGCTCCTCCCC 
37 CCGCCCCTCGCCCCCTC 
37 CCCCCTCCTCCACCCCCGCGTC 
37 CCCCGGTCTCCCCGGGAG 
2 Positions correspond to the genomic HSV-1 sequence HE1CG (accession no. X14112). 
Position in genomeo 
125976-125999 and 152234-152257 
126368-126395 and 151838-151865 
126742-126771 and 151462-151491 
127171-127198 and 151035-151062 
132333-132352 
132615-132634 
145853-145871 
145535-145554 
144697-144716 
144928-144946 
HSV-1 isolates obtained from keratitis 
patients. The results of the analyses performed 
with all 37 clinical corneal HSV-1 isolates are 
summarized in Table 2. As an example, differ-
ences in amplicon lengths betvveen unrelated 
clinical isolates from 10 patients are shown in 
Fig. 3A. The variability in the US!O- US11 
region (Re VI I) was low, showing only three 
different alleles. Regions US! and US12 
(ReiV) showed a wider variety of alleles, with 
14 and 15 different alleles detected among the 
3 7 samples analyzed, respectively (Table 2). 
Combination of the results for the three ampli-
fied regions showed that 34 of the 3 7 isolates 
(92%) displayed unique combinations of 
amplicons. For some clinical samples, no PCR 
product could be detected by ethidium bro-
mide staining or multiple fragments 
appeared. This was probably due to the poor 
quality of the template DNA. Hybridization 
with the labeled probe, however, readily 
enabled the detection of the Re-specific ampli-
con in these samples (data not shown). 
Analysis of sequential corneal HSV-1 isolates. 
Sequential corneal HSV-1 isolates obtained 
from five patients with recurrent herpetic 
corneal infections were analyzed (Fig. 3; Table 
2). The ReiV- and ReVII-specific amplicons 
showed interindividual variations in length. 
However, the amplicons from the sequential 
samples from each individual were identical. 
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TABLE 2. LENGTH OF REITERATION-SPECIFIC AMPLICONS 
OF CORNEAL HSV-1 ISOLATES 
Estimated amplicon length (bp) 
Isolate or sample Region Region Region 
and patient no.- USw-USn US; US12 
(ReYII) (RelY) (RelY) 
Unrelated 
HSV-1 isolates 
; 2'5 270 )70 
2 
"S 280 220 
3 "S 280 270 
4 "S 290 280 
5 "S 295 2)0 
6 2'5 305 JOO 
7 220 2W JW 
8 220 220 220 
9 220 220 220 
;o 220 260 260 
n 220 260 290 
" 
220 260 290 
'3 220 280 260 
'4 220 280 260 
; 5 220 290 260 
;6 220 290 280 
'7 220 305 2JO 
;8 220 JOS 3W 
'9 220 )70 370 
20 220 )80 JOO 
" 
220 380 390 
22 220 4W 220 
2) 220 4W 460 
24 220 420 300 
25 220 420 420 
26 225 260 270 
27 225 260 280 
28 225 290 260 
29 225 290 270 
30 225 2 95 220 
3' 225 2 95 290 
32 225 )20 220 
33 225 )20 )20 
34 225 )20 380 
35 225 340 220 
)6 225 340 340 
37 225 370 370 
Sequential samples 
" 
"5 280 270 
;b 
''5 280 270 
za "5 280 220 
2b 
"5 280 220 
J2 "5 295 230 
jb 
"5 295 230 
42 "5 305 JOO 
4b "5 305 JOO 
sa 225 220 220 
sb 225 220 220 
1 Three pairs of patients (patients 8 and 9, patients 11 
and 12, and patients 13 and 14) were infected with unre-
lated clinical isolates with identical DNA patterns. 
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DISCUSSION 
In the present paper, we present a PCR-
based approach that allows the rapid and accu-
rate discrimination of unrelated HSV-1 
strains. The method generally used to discrim-
inate HSV-1 strains is RFLP analysis 7· 1'· 1'- 1''· "" 
2
')·". This method requires virus culture, is 
time-consuming, and is highly labor-intensive. 
Furthermore, culture requires viable virus, 
which is not always obtainable from certain 
types of clinical samples (e.g., cerebrospinal 
and intraocular fluids). More recently, a system 
that uses PCR amplification and subsequent 
RFLP analysis has been developed to facilitate 
discrimination of HSV-1 strains, eliminating 
the necessity of virus culture. This method, 
however, is not significantly less time-consum-
ing or labor-intensive than conventional strain 
differentiation". Conventional RFLP analysis 
with restriction endonucleases that recognize 
6 bp (6-bp REs) is insufficient for differentia-
tion of HSV-1 strains of a predominant geno-
type. The use of 4-bp REs and RFLP analyses 
of reiterated sequences greatly improved the 
differentiation rate. As in our study, the RFLP 
analysis of reiterated sequences was based on 
various numbers of repeats. Use of both tech-
niques generated similar results, verifying the 
applicability of either method in molecular epi-
demiological studies" ". Similar hypervariable 
regions have been used successfully to dis-
criminate strains of other herpesviruses like 
Epstein-Barr virus and human cytomegalo-
viruS23. 1''. 
To be applicable in a PCR-based assay for 
discrimination of different HSV-1 strains, 
these regions should show a considerable 
degree of variability and should remain stable 
during a relatively short time of replication. 
We tested the suitability of several HSV-1 
hypervariable regions for discrimination of 
unrelated HSV-1 strains. 
Due to their G+C-rich sequences, standard 
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PCR protocols failed to reproducibly amplify 
the regions tested. The high G+C content 
increases the formation of secondary struc-
tures, preventing consistent amplification of 
the repeats. We tested a number of PCR con-
ditions in order to obtain consistent DNA 
amplification. Addition of DMSO as a cosol-
vent to the reaction mixture has previously 
been shown to facilitate DNA amplification of 
G+C-rich sequences". Introduction of the 
exonuclease activity of the Pfo DNA poly-
merase enzyme in the PCR mixture prevents 
"skipping'' of the repeats, which could result 
in the formation of products smaller than the 
actual size of the template repeat". Another 
modification was the introduction of 7-deaza-
2'-dGTP. This analogue of dGTP is equally 
well incorporated into DNA but exerts a lesser 
binding strength to dCTP than normal dGTP" ". 
The use of Pfu polymerase, SO% 7-deaza-2'-
dGTP as a replacement for 100% dGTP, and 
5% DMSO resulted in the most consistent 
ampli- fication of the large alleles. The speci-
ficities of the amplicons were confirmed by 
hybridization with Re-specific probes after 
Southern blotting. 
Analysis of subclones of HSV-1 F showed 
that the stability of the Rei and Relll 
sequences was too low to be useful for dis-
crimination of HSV-1 strains. In contrast, 
ReiV and ReV!! were shown to be stable dur-
ing this procedure. Thus. regions USl (ReiV), 
US12 (Re!V). and US10-US11 (ReV!!) were 
chosen for use in the discrimination of unre-
lated corneal HSV-1 isolates. 
In agreement with previous studies, the 
variability in the US 10-US 11 region was found 
to be relatively low" ''. We detected only three 
different alleles among 3 7 unrelated clinical 
HSV-1 isolates, which is not surprising since 
ReV!! is located within a protein-coding 
region, making it a target for selective pres-
sure. More drastic changes in the length of 
US10- USll could influence the translation or 
A B 
\'-111]1 
FIG. 3· Variability ofRe-containing regions US1, US12, and US1o-US11 
between unrelated and sequential corneal HSV-1 isolates. 
PCR amplification was performed with DNA from corneal HSV-1 isolates. 
Am pi icons were analyzed as described in the legend to Fig. z. 
A Results for 10 representative samples among the 37 samples analyzed. 
B Amplicons from sequential samples from five individuals. Lane C, 
water control; lanes M, 100-bp molecular size marker. Numbers on the 
left are in base pairs. 
function of the proteins encoded by genes 
USlO and USll. In contrast, the RelY-
containing sequences are located in the 
introns of genes US 1 and US 12. We found 14 
and 15 different alleles for regions US1 and 
US12, respectively, in the 37 corneal HSV-1 
isolates analyzed. Comparison of the alleles 
from the three regions for all37 corneal HSV-
1 isolates revealed 34 unique combinations. 
The isolates with identical combinations were 
obtained at different time points, indicating 
that this was most likely not due to contami-
nation during virus isolation or culture proce-
dures. 
Sequential corneal isolates from five indi-
viduals with recurrent herpetic corneal infec-
tions were analyzed. For each individual, 
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sequential samples showed identical DNA pat-
terns, while the patterns for samples from dif-
ferent patients were different. These results 
indicate that the recurrent infections were 
most likely caused by the same virus. A com-
parative sequence database search revealed 
several point mutations between different 
HSV-1 strains, in addition to various numbers 
of repeats. More detailed analysis, like 
sequencing of the amplicons, might provide 
more conclusive evidence for this assumption. 
This also demonstrates that these hypervari-
able regions remain stable during reactivation 
and replication of latent HSV-1 in the corneas 
of these individuals. 
Additionally, we have also analyzed clinical 
samples in which no viable virus can usually 
be detected'. Re sequence-specific PCR analy-
ses were performed with DNA isolated from 
affected corneal buttons and rims obtained 
from patients with herpetic stromal keratitis 
during therapeutic keratoplasty. The PCR 
approach proved to be sensitive enough for 
amplification of the low levels of viral DNA 
present in these samples (unpublished data). 
The major advantage of the approach present-
ed is that it provides the opportunity to dis-
criminate HSV-1 strains without virus culture 
or RFLP analysis, making it convenient for 
rapid diagnostic testing. Although not suitable 
for classification ofHSV-1 strains, it provides a 
powerful tool that can be used to address ques-
tions regarding reactivation and the modes of 
transmission of HSV-1. For example, it could 
be used to assess the risk of HSV-1 transmis-
sion through cornea transplantation and other 
manifestations of recurrent HSV-1 infections. 
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w 
1 
3 
2 
4,5 
6 
7 
8 
9 
1: Periocular dermatitis 
4: Infectious epithelial kera-
titis (dendritic keratitis) 
6a: stromal keratitis 
Immune stromal keratitis 
7: Endotheliitis 
2: Blepharitis 
5: Neurotrophic keratitis 
6b: stromal keratitis 
Necrotizing stromal keratitis 
8: Uveitis 
Figure 8, chapter 1: Presentations of herpes simplex virus infections of the anterior eye segment 
3: Conjunctivit is 
(with ulceration) 
6c: stromal keratitis 
Immune ring 
g: (Epi-) scleri tis 
Adapted from: R. Sundmacher: A clinico-virologic classification of herpetic anterior segment diseases with special reference to intra-ocular herpes. In Herpetische Augen 
Erkrankungen DOC 1980. Eds R. Sundmacher. Miinchen:JF Bergmann Verlag 1981: 206 
(B) 
(E) 
Figure 2, chapter 2: Measurement ofthe branching angles and the main angle in a dendritic lesion. 
Examples of a dend ritic lesion on a non-operated cornea (2a) and on a corn ea after PKP (2b). 
2A + D: the original dendritic lesion. 
180 
90 
270 (C) 
90 
270 (F) 
28 + E: branch ing angles: po ints were drawn in the midd le of all branches of the dendritic lesion. Lin es were drawn through straight parts of the 
dendritic lesions using these points The angles between two consecutive parts of the dendritic les ion were measu red as a branch ing angle 
(angle a and b) . (Not all branching angles of th is dend ritic lesion are drawn in th is figure for reasons of clarity) 
2C + F: main angle: points (shown only in the longest branch) are drawn in the midd le of all branches of the dend ritic lesion. The connectin g line 
using most points was considered the best fitting or direction line. Angle c is meas ured with the use of the horizontal axis . 
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Figures 1-4, chapter 3: 
Figure 1 
Class ic herpes simplex viral kerat itis in donor cornea (Table 1, patient 2). 
Figure 2 
Nonspecific epithelial defects and superficial stromal scarring in a patient who had transplantation for keratoconus (Table 1, patient 15). 
Figure 3 
Large epithelial defects small stromal infiltrate with positive cu lture for HVS type 1, moth after PKP for keratoconus (Table 1, patient 10). 
Figure 4 
Stromal infiltrate (Table 1, patient 13) with negative bacteria l cultures . Three months after repeat PKP, the patient showed a beginning allograft rejec· 
t ion and a classic central dendriform herpetic keratitis. 
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Figure 2, chapter 4: 
J 
.. 
• 
. .. 
• 
Macroscopic, histologic and immuno histologic examination of corneas from patients with herpetic stromal keratitis. (A) Central corneal 
ulcer with descemetocele and impending perforation of the cornea of patient #5. (Band C) Central view of keratectomy specimen of patient 
#1 showing s trom al infiltration of inflammatory cells and a florid granulomatous reaction with foca l rupture of Descemet's membrane (Dm) 
(B; periodic acid · Schiff. PAS, m agnificat ion x1oo). Inset: h igher maniflcat ion of th en m ultinucleated giant cell (arrow) protruding through 
this rupture (C; PAS, x400). (D). Pa racentral view of keratectomy specimen of patient #5 sh ows (ad jacent to the ulcer) a deep s tromal 
defect with edema and infi lt ration of polymorphonuclear cells (arrow) reachi ng up to Dm (HE stra ining, x2oo). (E) Immunohistochemical 
staini ng for HSV-1 antigens demonstrating HSV antigens in stroma l keratocytes (arrow) in the corres pondi ng section of the cornea of 
patient #5 (hematoxylin counterstai ned, x4oo) . (F) Central view of keratectomy specimen of patient #6 with reactive hyperplasia of the 
epithelium. The cornea is infiltrated with predominantly mononuclea r cells (HE, x2oo) . (G) Immunohistochemical staining fo r CD4· cells 
demonstrating predominantly s ubepithelia l local ization of CD4· cells (arrow) in the corresponding section of the cornea of patient #6 
(hematoxylin counterstained, x2oo). 
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SUMMARY 
Purpose. 
Herpetic keratitis is a common sequel of a corneal infection with herpes simplex virus (HSV)-1. 
Recrudescent herpetic keratitis (RHK) may result in irreversible damage to the cornea. 
Recurrences may be caused by reactivation of endogenous HSV-1 or reinfection with exogenous 
HSV-1. The objective of this study was to determine the incidence and risk factors involved of 
HSV-1 superinfection in patients with RHK. 
Methods. 
From 30 patients with RHK, sequential corneal HSV-1 isolates were genotyped by PCR ampli-
fication of the hypervariable regions located within the HSV-1 genes USr, US10j11, and US12. The 
clinical data from the patients obtained retrospectively were: ophthalmologic history, clinical pic-
ture during recurrences, number and time points of penetrating keratoplasty (PKP), and steroid or 
acyclovir treatment. 
Results. 
Whereas the sequential corneal HSV-1 isolates of 19 (63%) of 30 patients had the same geno-
type (designated as group 1), the sequential isolates of 11 patients (3 7%) were genetically different 
(designated as group 2). Among the clinical data analyzed, only the time point of PKP was signif-
icantly different between the patient groups. Although no patients in group 1 had undergone trans-
plantation between samplings, 4 of 11 patients in group 2 underwent PKP during the 
interrecurrence period in the same eye from which the corneal HSV-1 isolates were obtained. 
Condusions. 
The data demonstrate that RHK is frequently associated with corneal reinfection with a differ-
ent HSV-1 strain and suggest that PKP is a risk factor for corneal HSV-1 superinfection. 
INTRODUCTION 
Herpes simplex virus (HSV) infections 
may elicit a variety of serious diseases in 
humans, including chronic herpetic kerati-
tis.'' A hallmark of HSV and other neurotrop-
ic herpes viruses is their ability to establish 
latency in sensory nerve ganglia of the host.' 
Despite the induction of an acquired state of 
immunity after primary HSV infection, 
recrudescent herpetic lesions are often 
observed. Patients who have had corneal 
HSV-1 infection risk recurrent corneal disease 
throughout life. Particularly prolonged or 
recurrent episodes of herpetic keratitis can 
result in decreased vision or blindness due to 
the development of herpetic stromal keratitis 
(HSK).'' 
Recrudescent HSV infections are thought 
to result from reactivation of the HSV strain 
acquired during primary infection __ ,_,, However, 
reinfection with a new HSV strain (i.e., super-
infection) at the site of primary infection has 
also been documented.''.c The route or mode of 
HSV superinfection and its clinical conse-
quences remain enigmatic. Genetically differ-
ent HSV strains have been shown to induce 
different types of ocular lesions.' Further-
more, newly acquired herpetic keratitis may 
develop after penetrating keratoplasty (PKP) in 
patients who undergo transplantation for rea-
sons unrelated to HSV infection, suggesting 
the possibility ofHSV-1 transmission through 
cornea transplantation.'' These issues under-
line the clinical importance of knowing 
whether recurrent corneal HSV-1 infections 
are caused by reactivation of latent virus or 
superinfection with a different virus strain. 
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Molecular analyses of corneal HSV-1 isolates 
may allow distinction between both options. 
The genome ofHSV-1 consists of a unique 
long (UL) and a unique short (Us) component, 
each of which is flanked by a pair of opposite-
ly oriented repeat elements. Several hypervari-
able regions have been identified in the HSV-1 
genome. These regions encompass unique 
tandemly repeated sequences, reiterations (Re) 
that vary in copy number and nucleotide 
sequences (Fig. 1).'"'" Generally, two types of 
restriction fragment length polymorphism 
(RFLP) analyses are used to differentiate 
HSV-1 isolates. One type is the variation due 
mostly to a gain or loss of a restriction enzyme 
cleavage site. The other appears as variation in 
length of cleaved fragments derived from Re-
containing genomic HSV~l regions. 11 Among 
the eight Re regions described for HSV-1. 
Re!V and -VIII (both located within the introns 
of genes US1 and USr2) and ReVII (located 
within the protein coding region of genes 
US10 and US11) have been shown to remain 
stable during in vitro culture and have been 
used as sensitive and reliable markers to dif-
ferentiate HSV-1 strains.'"--" 
We have recently developed a PCR method, 
based on the stability and strain-to-strain dif. 
ferences of Re!V, -VII, and -VIII that has facil-
itated the differentiation of up to 92% of 
unrelated HSV-1 strains."" The purpose of the 
present study was to determine the incidence 
and risk factors involved in corneal HSV-1 
superinfection in patients with recrudescent 
herpetic keratitis (RHK). 
MATERIAlS AND METHODS 
Patients and Clinica[ Samples 
Corneal swab specimens were obtained for 
diagnostic reasons from suspected herpetic 
corneal lesions and were used to inoculate 
human embryonic lung fibroblasts. Virus was 
harvested when approximately 75% of the 
monolayer showed cytopathic effect and was 
subsequently typed for HSV-1 or -2 by 
immunocytology and PCR." Serial samples 
from 30 immunocompetent patients with 
recurrent corneal HSV infections were found 
in a databank of 408 frozen corneal HSV-1 cul-
tures collected since 1980 at the Rotterdam Eye 
Hospital (Rotterdam, The Netherlands). The 
clinical items scored retrospectively were 
anatomic location (i.e., left or right eye), previ-
ous history of ocular disease, clinical picture at 
presentation of each recurrence, therapy regi-
men preceding the culture dates, total number 
ofPKPs, and PKPs between virus culture dates. 
The classification of herpetic keratitis was 
defined on clinical criteria.' The present study 
was performed according to the Declaration of 
Helsinki, and informed consent was obtained. 
Genotypic Analyses of Corneal HSV-1 Isolates 
Genotypic analyses of the viral strains were 
performed by amplification of the hypervariable 
regions within the HSV-1 genes US1, USrojrr, 
and US12. This method is based on strain-to-
strain differences in the number of Re and point 
mutations within these hypervariable genomic 
regions. 10 12 ' 13 ' 1' DNA was extracted from the pri-
mary corneal HSV-1 cultures, lysed in a guani-
dine isothiocyanate buffer using a silica solution 
(Celite; Jansen Chemika, Beers, Belgium), as 
described previously." The PCR primers and 
conditions for amplifying and detecting by 
Southern blot analysis of the hypervariable 
regions of the HSV-1 genes USr, USrojrr, and 
US12 have been described.15 In case of small dif-
ferences in length between amplicons (i.e., PCR 
products) from individual samples, the PCR 
products were run on denaturating {8 M urea) 
6% acrylamide gels. The lengths of the ampli-
cons were estimated by comparison to a 100- and 
25-bp DNA ladder (Gibco BRL, Grand Island, 
NY). To confirm similarities or differences in 
amplicon length, all samples were finally elec-
trophoresed in order of increasing length. 
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A The prototypic HSV-1 genome encompasses the covalently linked components L and S. Each component consists of 
unique sequences {ULand Us) bracketed by inverted repeat sequences (TR~, IRL, IRs, and TRs). A short sequence, a, is 
repeated directly at the termini of the genome and located at the L-5 junction. The enlargement of the S component 
shows the s'->3' orientations of mRNA species as horizontal arrows with introns shown as V-shaped indents. Protein-
coding regions are shown as open boxes. Vertical arrows indicate locations of Re regions, and Roman numerals indicate 
their locations as defined previously.''' 
B Re-specific sequences have been described previously.·"' ReiV exists as two forms that differ from each other ·m a single 
residue.'cN 
Statistical Analyses 
The statistical evaluation of the results 
was performed using the Fisher exact test. 
Results were considered statistically signifi-
cant at P < o.os. 
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RESULTS 
Patients' Characteristics and Genotypic 
Analyses of Sequential Corneal HSV-1 Isolates 
The group of30 patients with RHK includ-
ed in this study consisted of 13 women and 17 
men (mean age, 58.1 years; range, 17-78). 
From each patient, two (n ~ 25) or three (n ~ 4) 
sequential corneal HSV-1 isolates were 
obtained (mean time interval, 29.8 months; 
range, 0-170). Patient 22 had bilateral herpetic 
keratitis (Table 1). 
To differentiate whether RH K is due to 
reactivation of latent HSV-1 or superinfection 
with another HSV-1 strain, the sequential 
corneal HSV-1 isolates of the patients with 
RHK were genotyped using a recently devel-
oped PCR-based DNA fingerprint assay." The 
results of the PCR analyses, on the hypervari-
able regions of the genes USr, USroju, and 
US12, performed on the corneal HSV-1 isolates 
are summarized in Table 1. As an example, the 
size fractionation and Southern blot analyses 
of the USr- and USr2-specific amplicons 
obtained from the sequential samples of 
patients 1 through 5 and 20 through 24 are 
shown in Figure 2. The sequential corneal 
HSV-1 isolates of 19 (63%) of the 30 patients 
and 11 (3 7%) of the 30 patients showed either 
identical (patients 1-19; designated patient 
group 1) or different genotypes (patients 
20-30; designated patient group 2), respective-
ly (Table 1). The data suggest that more than 
one third of the corneas of the patients with 
RHK were superinfected with a different 
HSV-1 strain. In the case of patient 30, the 
newly acquired HSV-1 strain was cultured 
pending two post-PKP recurrences. This sug-
gests that the newly acquired HSV-1 strain had 
colonized the recipient. Combining the results 
of the three amplified genomic regions 
showed that the majority of the distinguishable 
HSV-1 isolates displayed unique combinations 
of amplicons (Table 1). 
In the case of patient 22, the data indicated 
that the bilateral herpetic keratitis was due to 
infections with different HSV-1 strains in 
either cornea. Patient 30 had two different 
HSV-1 strains identified. In the third episode 
sampled, the strain identified during the sec-
ond recurrence was isolated (Table 1). 
Comparison of Clinical Characteristics of 
Patients with RHK in Patient Groups 1 and 2 
Compared with previous reports on 
patients with RHK,''' our cohort consisted 
mainly of patients with severe entities of HSV-
induced keratitis, such as herpetic stromal and 
necrotizing keratitis. This is also reflected in 
the high number of PKPs in the patient cohort 
(Table 2; mean PKPs, 1.4 per patient; range, 
0-6). 
The clinical characteristics of the patients 
in groups J. and 2 were compared, to identify 
the factors predisposing for corneal HSV-1 
superinfection. Overall, the immune status 
and ophthalmic condition did not differ signif-
icantly between both groups (data not shown). 
Additionally, gender, inter-recurrence period, 
anatomic location of the lesions (left or right 
eye), ocular history, and clinical picture at time 
of recurrences were not statistically different 
between both groups (Tables 1, 2). 
Comparison of Therapeutic Regimen for RHK 
in Patient Groups 1 and 2 
The clinical outcome of corticosteroid treat-
ment before or during the convalescence peri-
od was not statistically different between both 
groups. The potential effects of long-term 
(val)acyclovir treatment were not numerous 
enough to be interpreted (data not shown). 
Although the mean number of PKP per 
patient did not significantly differ between 
both groups, indicating that both groups were 
comparable in disease severity, a correlation 
between corneal HSV-J. superinfection and 
time point of PKP was observed. Whereas no 
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Group 1 
Group 2 
TABLE 1. 
PATIENTS' CHARACTERISTICS AND GENETIC CHARACTERIZATION OF SEQUENTIAL CORNEAL HSV-1 IsoLATES FROM PATIENTS WITH RHK 
Estimated Amplicon Length (bp)' I Months I 
between HSV-1 
US10j11 Region US1 Region US12 Region lsolates 11 Eye 
Patient Sex Age (y) a b c a b c a b c a-b b-e Difference 111 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
3 0 
F 17 215 215 - 295 295 - 240 240 - 11 - + 
F 34 220 220 - 320 320 - 305 305 - 15 - + 
M 64 215 215 - 280 280 - 220 220 - 8 - -
M 54 225 225 - z8o 28o - 260 260 - 27 - + 
M 44 225 225 225 420 420 420 270 270 270 56 3 + 
F 59 215 215 215 270 270 270 370 370 370 8 11 -
M 39 215 215 - 280 280 - 270 270 - 170 - -
F 72 220 220 - 410 410 - 220 220 - 78 - -
M 74 225 225 - 320 320 - 310 310 - 22 - -
M 6g 225 225 - 220 220 - 200 200 - 12 - -
F 73 - 220 - 230 230 - 240 240 - 28 - + 
M 29 215 215 - 305 305 - 300 300 - 22 - -
M 6o 220 220 - z8o 280 - 260 z6o - 21 - -
M 67 225 225 - 220 220 - 220 220 - 11 - -
F 6g 225 225 - 295 295 - 290 290 - 36 - -
F 74 225 225 - 360 360 - 310 310 - 6 - -
M 52 230 230 - 260 260 - 260 26o - 77 - -
F 55 210 210 - 520 520 - 240 240 - 40 - -
F 78 230 230 230 300 300 300 260 260 260 3 4 -
M 63 225 225 - 260 310 - 2)0 300 - 7 - -
M 46 225 220 - 470 425 - 210 370 - 22 - -
M 6g 220 220 - 290 360 - 270 290 - 0 - + 
F 32 225 225 - 270 300 - 270 270 - 2 - -
F 75 225 225 - 35° 430 - 37° ]20 - 3 - -
F 38 215 215 - 320 410 - ]80 ]20 - 85 - -
M 72 225 225 - 370 JOO - 370 290 - 38 - -
M 65 220 220 - ]80 420 - 300 390 - 2 - -
M 78 225 225 - 340 490 - 220 220 - 2 - -
F 77 225 225 - 35° 490 - 210 210 - 28 - -
M 4 6 22 5 22 5 22 5 2 0 9 2 0 9 2 0 9 260 28o 280 12 5 43 -
a, band c represent the time points at wh'1ch corneal HSV-1 isolates were obtained. Data showing differences in amplicon length 
between sequential samples of individual patients are in italics. Based on the genotypic analyses, patients 1 through 19 were designated 
as group 1 (genotype sequential isolates identical} and patients 20 through 30 as group 2 (genotype sequential isolates different). 
II Patient 22 had bilateral herpetic keratitis. In patients. the first and second isolates were obtained from the left eye, and the third 
isolate was obtained from the right eye. 
IIII -and+ indicate that corneal HSV-1 isolates obtained were from the same or contralateral cornea, respectively. 
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Figure 2. 
patient in group 1 received a corneal transplant 
betv.reen the sampled recurrences, 4 of the 11 
patients in group 2 underwent a PKP during 
the inter-recurrence period in the same eye 
from which the sequential corneal HSV-1 iso-
lates were obtained (Table 2; P ~ 0.012). Patient 
30 received a corneal allograft between the first 
and second sampled recurrence. 
DISCUSSION 
HSVs have the ability to reside in latent 
form within neurons of the sensory ganglia 
that innervate the initial site of infection. It is 
therefore assumed that recurrent herpetic 
lesions are due to reactivation of the HSV 
strain acquired during the primary infec-
tion.'·'·-(· In contrast, HSV superinfection in 
patients with recrudescent herpetic lesions has 
been documented.('" Patients with recurrent 
':-• -
-
' ~· -----
.. ..._ 
--·-· 
Am pi icons of the hypervariable regions USr and US12 amplified from 
sequential corneal HSV-1 isolates from patients with RHK. Left: Amplicons 
were electrophoresed on 2.5% agarose gels and were visualized by ethi-
dium bromide staining. Representative sequential samples (a, b, and c) of 
10 patients are shown: patients 1 through s: {A) group 1, and patients 20 
through 24; (B) group 2. A 25-bp molecular size marker was run in parallel. 
Numbers on the left are in base pairs. Right: autoradiograph of DNA in gel 
after Southern blot hybridization with appropriate reiteration-specific probe. 
herpetic keratitis risk the development ofHSK, 
a leading cause of corneal blindness world-
wide'' The objective of the present study was 
to examine the two types of origins and risk fac-
tors involved in corneal HSV-1 superinfection 
in 30 patients with HSV-1-induced RHK. 
Genotypic analyses of sequential corneal 
HSV-1 isolates from 30 patients with RHK 
demonstrated that 63% of the patients 
(patients 1-19; designated as group 1) had evi-
dence of reactivation of the same H SV -1 strain. 
From five patients in group 1, the isolates were 
obtained from separate eyes. HSV-1 infection 
of the contralateral cornea most likely occurred 
through the external route (cross-infection). It 
was interesting that sequential isolates of 3 7% 
of the patients (patients 20-30; designated as 
group 2) had a different genotype, suggesting 
corneal HSV-1 superinfection in the inter-
recurrence period. 
Alternatively, the instability of the analyzed 
hypervariable regions may account for these 
differences. HSVs, similar to other DNA virus-
es, have less genomic variability than RNA 
viruses and are genetically more stable after in 
vitro passages. 11 ' 15 In addition to standard 
RFLP, several hypervariable regions within the 
HSV-1 genome have been used to differentiate 
H SV -1 isolates genetically. 11 Intra typic variation 
of the regions results from differences in the 
number of Re and point mutationS. 10·'"· 13 The 
stability of the eight HSV-1-specific Re regions 
described varies extensively. 11 Genotypic analy-
ses of HSV-1 single-plaque clones compared 
with their parental strain have shown that the 
hypervariable regions located within the HSV-1 
genes USr, USr2, and USrofrr remain stable 
during in vitro culture. n.ls Moreover, the mean 
inter-recurrence period of patient group 1 (30.4 
months) and the proofreading activity of Pfo 
DNA polymerase, implies that the intraindivid-
ual HSV-1 genotype differences are most likely 
not due to a genetic alteration of the initial 
strain or errors in amplifying these highly GC-
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Group 1 
Group 2 
TABLE 2. 
CuN I CAL CHARACTERISTICS AND CORNEA TRANS PLANTATIONS PERFORM ED ON PAT! ENTS WITH RHK 
PI<Ps 
History of HSV Diagnosis at Time Point of Sampling111 between 
Patient1 Mediated Eye Disease11 Time Point a Time Point b Time Point c PI<Ps (n) Samples1v 
1 None Blepharitis Blepharitis 0 No 
2 None IE I< IE I< 0 No 
3 ReelS I< IEK lEI< 0 No 
4 ReelS I< I El< lEI< 0 No 
5 BiiiSI< I El< lEI< IE I< 0 No 
6 reelS I< and uveitis I El< NSK NSI< 3 No 
7 reciSK IEK and lSI< I EK and lSI< 0 No 
8 NSK in PI<P I EK and lSI< lEI< and lSI< 3 No 
9 reelS I< lEI< and lSI< lEI< 0 No 
10 BiljreciSI< lEI< in PI<P lEI< in PKP 1 No 
11 BiljreciSI< and uveitis lEI< in PKP lEI< in PKP 2 No 
12 NewHSV in PKP lEI< in PKP lEI< in PKP 1 No 
13 NSK in PKP lEI< in PKP NSK in PKP 2 No 
14 reelS I< NSK in PKP lEI< in PKP 1 No 
15 newHSV in PKP NewHSV in PKP lEI< in PKP 2 No 
16 NSK lEI< and uveitis lEI< 0 No 
17 reelS I< in PKP IEK in PKP lEI< in PI<Pwith GR 2 No 
18 None lEI< in lSI< lEI< and HKU 0 No 
19 NSK lEI< in PKP IEK in PKP lEI< in PKP 1 No 
20 ISK and uveitis blepharitis lEI< 0 No 
21 Endothelitis lEI< lEI< 0 No 
22 reciEK and lSI< in PKP lEI< lEI< 2 No 
23 newHSV in PKP lEI< IEK 1 No 
24 lEI< IEK NSK 0 No 
25 NSK in PKP lEI< in PKP lEI< in PKP 2 Yes 
26 NSK lEI< in PKP lEI< in PKP 1 No 
27 NSK in PKP lEI< and lSI< I EK and lSI< 3 Yes 
28 NSK in PKP and uveitis I El< and uveitis I EK and uveitis 1 No 
29 NSK in PKP lSI< in PKP lEI< in PKP 3 Yes 
3 0 newHSV in PKP NSK in PKP lSI< in PKP NSK in PKP 6 Yes 
The sequential corneal HSV-1 isolates of patients 1 through 19 (designated as group 1) and 20 through 30 (designated as group 2) 
hadidentical or different genotypes, respectively. 
II HSV-mediated corneal diseases diagnosed were: immune stromal keratitis (ISK), necrotizing stromal keratitis (NSK), infectious epithe-
lial keratitis (IEK) and herpetic keratouveitis (HI<U). PKP, penetrating keratoplasty; LI<P, laminar keratoplasty, and GR, graft rejection; 
rec, recurrent; bil, bilateral; new, newly acquired. 
III Total number of preceding PI<Ps performed on each patient. 
IV PKP between sample dates in the patient cohort with identical versus different HSV-1 genotypes of the sequential corneal HSV-1 
isolates were statistically significant (Fisher exact test; P = 0.012). In patient 30 PKP was performed between time points a and b. 
Chapter 3 Pathogenetic mechanisms of herpetic keratitis occurring after penetrating keratoplasty 85 
rich DNA sequences, respectively. 
Analogous to our study, reinfection with 
new HSV-2 strains has been described in two 
of three patients with recurrent HSV-2 genital 
herpes.' The latter study and our data indicate 
that HSV superinfection is not as rare as pre-
viously suggested.''· To differentiate HSV 
strains, most investigators have used RFLP 
analyses with 6-bp recognizing restriction 
enzymes (REs)."-'· The lower efficacy of 6-bp 
RE, compared with the 4-bp RE, to differenti-
ate HSV-1 strains may account for the differ-
ent frequencies of HSV superinfection 
described. 11 
Generally, corneal HSV-1 infection results 
in the development of herpetic epithelial ker-
atitis in approximately two thirds of patients.' 
In the present study, however, the patient 
cohort consisted predominantly of patients 
with severe entities of herpetic keratitis 
(Table 2). Selection of individuals with a high-
er susceptibility for corneal HSV-1 infection 
may have occurred. Alternatively, the patients 
in group 2 may have been superinfected with 
a more virulent HSV-1 strain. 
Among the clinical data analyzed, only the 
time point of PKP was significantly different 
between the patient groups. Although no 
patients in group 1 had undergone transplan-
tation between sampling, 4 of 11 patients in 
group 2 underwent PKP during the inter-
recurrence period in the same eye from which 
the corneal HSV-1 isolates were obtained. The 
data suggest that PKP is a risk factor for 
corneal HSV-1 superinfection. Primary graft 
failure and endothelial abnormalities of cul-
tured eye bank corneas have been associated 
with the presence of HSV-1 DNA in affected 
corneal allografts."' The high prevalence of 
HSV-1 DNA in eye bank corneas (- 10%)"' has 
led to the hypothesis of HSV-1 latency in 
corneas. Although expression of HSV-1 laten-
cy-associated transcript, a marker of latency, 
has been detected in latently infected rabbit 
corneas and human HSK corneas, corneal 
H SV-1 latency remains controversial. l{·,l 7 
Recently, Zheng et al." have demonstrated 
HSV-1 transmission through PKP in an exper-
imental rabbit model. HSV-1 DNA was detect-
ed in recipient corneal rims and the 
innervating trigeminal ganglion (TG) of naive 
rabbits that received corneal allografts from 
latently infected rabbits. Moreover, infectious 
HSV-1 was recovered from the tear film of the 
rabbits that had undergone transplantation.'' 
Besides true ocular viral latency, putative 
HSV-1 transmission through PKP may be due 
to coincidental shedding of small amounts of 
infectious virus from the allograft or a low 
level of viral replication in corneal resident 
cells in the allograft at time of PKP.'' '' 
Alternatively, the TG may harbor a mixture 
of HSV-1 strains with which the patients were 
previously latently infected, before PKP. In 
animal model studies, corneal trauma (similar 
to PKP) has been shown to induce reactivation 
ofHSV-1 causing corneal HSV-1 infection."1'"' 
Assuming that the human TG can be latently 
infected with multiple HSV-1 strains, PKP 
may serve as a powerful reactivation stimulus 
to certain portions of the TG, allowing multi-
ple strains to reactivate.,., 
In conclusion, this study is the first to 
demonstrate a high frequency of corneal 
HSV-1 superinfection in patients with RHK. 
Although we could not determine the source 
or mode of corneal HSV-1 superinfection in 
patient group 2, the data suggest that PKP may 
be a risk factor for transmission ofHSV-1 with 
subsequent reactivation of the donor-derived 
HSV-1 strain in the corneal allograft. Recently, 
we have genetically characterized HSV-1 DNA 
isolated from a donor cornea before and after 
PKP in a patient with newly acquired herpetic 
keratitis. The DNA sequences were identical 
in both strains, providing conclusive evidence 
for graft-to-host transmission of HSV-1 
through corneal allograft." 
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Genetic characterization of herpes simplex virus type 1 (HSV-1) DNA isolated from a donor 
cornea before and after corneal transplantation demonstrated the transmission ofHSV-1 through 
transplantation. This study is the first to provide conclusive evidence for the transmission of 
HSV-1 by penetrating keratoplasty with subsequent reactivation of donor-derived HSV-1 in the 
transplanted cornea. 
Herpetic keratitis is a leading cause of 
blindness worldwide'. The current therapy of 
choice is penetrating keratoplasty (PKP), 
which is performed to restore sight in eyes 
blinded by corneal opacity arising from infec-
tion, trauma, inherited or acquired disease. 
Infectious agents that have been reported to be 
transmitted by PKP are the Creutzfeldt-fakob 
agent, hepatitis B and C virus, rabies virus, 
and cytomegalovirus2 • Corneal graft donors 
are routinely screened for these pathogens, 
but not for the presence of HSV in their 
corneas. HSV DNA has, however, been detect-
ed in corneas with no signs of infection and 
eye bank donor corneas-;. In patients without a 
clinical history of HSV keratitis, the emer-
gence of herpetic keratitis has been docu-
mented after PKP, suggesting graft-to-host 
transmission ofHSV through pj(p<c. 
A 28-year-old man with congenital glauco-
ma underwent a third PKP in his only func-
tional eye. He had undergone the first PKP to 
treat corneal opacity from congenital glauco-
ma. The second and third PKP were done 
because the previous graft was rejected. Post-
operative treatment consisted of 0.5% pred-
nisolone eye drops eight times daily. 
Immediately after surgery, an epithelial defect 
developed for which recovery was slow despite 
additional treatment with bandage lenses and 
frequent lu-brication with autologous serum. 
Three months post PKP, a large epithelial 
defect recurred from which HSV-1 was isolat-
ed (data not shown). After 3 months, the com-
bination of uncontrollable herpetic keratitis 
and choroidal effusion resulted in loss of 
vision. 
l!SHl/l!Sll 
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l'S I 
D R 
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Amplification ofhypervariable regions of the HSV-1 genes US10jUS11, US1 
and US12 obtained from the donor-derived corneoscleral rim (D) and 
post-PKP corneal HSV-1 isolate of the recipient (R). Sequences on 
Genebank; accession numbers AF324427 and AF324428 for the US1 
and US12 sequences. M=lOO bp molecular marker. 
H SV -1 DNA was amplified by PCR from 
the transplanted corneoscleral rim and the 
patient's serum was tested retrospectively for 
HSV antibodies. No HSV-specific IgM or IgG 
were present in the patient's serum before sur-
gery (data not shown). We hypothesized that 
HSV-1 was transmitted from the graft to the 
recipient with subsequent reactivation of 
donor-derived HSV-1 in the transplanted 
cornea. To test this assumption, the donor (D) 
and recipient (R) derived HSV-1 strains were 
genotyped using a PCR-based DNA finger-
print assay. This method is based on strain-to-
strain differences in the number of DNA 
repeats and point mutations within the hyper-
variable regions of the HSV-1 genes 
US!OjUSll, US! and US12'. The PCR prod-
ucts of the D and R derived HSV-1 strains were 
of the same size (Fig.). The US1 and US12 
PCR products were then sequenced. These 
DNA sequences were identical for both 
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strains, with multiple unique mutations as 
compared to the corresponding sequences of 
the HSV-1 F laboratory strain (data not 
shown). 
Donor-to-host transmission of infectious 
agents via corneal transplantation poses a real 
risk. Corneal donors are currently screened for 
several viruses, and bacterial and fungal cul-
tures are done before transplantation in most 
eye banks. Although the prevalence of HSV-1 
DNA in eye bank corneas is high (-10%),' only 
a minority of patients receiving such contami-
nated corneas have been shown to develop 
HSV-related eye disease'' This may result 
from the antiviral immunity of the recipient 
following a preceding HSV-1 infection. 
Alternatively, it may be due to low viral loads or 
poor reactivation of putatively latent virus in 
the allograft. The latency of extraneuronal 
HSV-1 in the cornea is not well-characterised, 
but it is generally assumed that post-PKP HSV 
keratitis arises from reactivation of the recipi-
ent's HSV-1'' However, HSV-1 related graft 
morbidity in patients without a previous histo-
ry of HSV infection has also been described, 
implicating the possibility of HSV-1 transmis-
sion by PKP''. 
92 
This HSV-naive patient lost his vision in 
his only functional eye due to graft-to-host 
transmission ofHSV-1, which resulted in graft 
failure in combination with choroidal effusion 
after glaucoma surgery. To our knowledge, this 
is the first report to provide conclusive evi-
dence for graft-to-host transmission of HSV-1 
through a corneal allograft. Although appar-
ently rare, this mode of transmission of HSV-1 
should be taken seriously. Transmission of 
HSV-1 to a seronegative recipient may be par-
ticularly dangerous, as the virus may cause 
potentially blinding eye infections in patients 
undergoing immunosuppressive treatment. To 
prevent HSV-1 transmission to HSV-1 naive 
recipients, serological matching of donor and 
recipient is an option. If an HSV-seronegative 
patient urgently requires PKP, and no 
seronegative donor is available, prophylactic 
acyclovir should be considered, particularly 
during immunosuppressive therapy. Our 
observations stress the need for further studies 
on the localization and latency ofHSV-1 in cor-
neoscleral tissue. 
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Penetrating keratoplasty (PKP) is currently 
the most common form of allografting. Five to 
10% of PKPs are performed for corneal opaci-
ties resulting from herpes simplex virus type-! 
(HSV-1) infection. About 0.9% of PKP reci-
pients who have not suffered from herpetic 
keratitis before, develop superficial epithelial 
defects due to HSV-1 infection'. An unknown 
number of additional cases of stromal and 
endothelial keratitis resembling allograft rejec-
tion, are caused by HSV-1 infection. A recent 
study in 25 patients with corneal HSV-1 infec-
tion after PKP, showed that the majority 
(n~14) developed severe ocular complications 
resulting in unilateral social blindness within 
three years (L.R. eta! unpublished). 
Corneal HSV-1 infection after PKP may be 
due to reactivation oflatent virus or horizontal 
viral transmission. Most corneal HSV-1 infec-
tions after PKP are believed to result from 
virus reactivation. However, similar forms of 
penetrating corneal surgery do not result in a 
comparable incidence of herpetic keratitis. 
Given an annual HSV-1 infection rate among 
adults of 5-10% per year, with ocular involve-
ment in about 1% the risk of ocular HSV-1 
infection through horizontal spread should be 
less than 0.1%. Consequently, HSV-1 trans-
mission through PKP, which we recently 
demonstrated to occur2 , is a real risk The 
demonstration of HSV-1 DNA in 10-20% of 
normal eye-bank corneas', further highlights 
this risk. In HSV-1 seronegative recipients the 
consequences may be more serious: no pre-
existing immunity against the virus is present 
and the local immunosuppression by the use 
of topical steroids aggravates this situation. In 
a worst case scenario, with 10 to 20% of the 
donor corneas indeed harbouring infectious 
HSV-1, and taking into account the age distri-
bution of donors and recipients, the overall 
risk of HSV-1 transmission by PKP would 
amount to 1.8% for Western Europe, 3.0% for 
the USA black and 3.5% for the USA white 
population (Fig.). 
To prevent HSV-1 transmission to seroneg-
ative patients by PKP, systemic acyclovir treat-
ment for a period that exceeds the 
immunosuppressive treatment is an option. 
This implies testing of all recipients for HSV-1 
antibodies. Matching of seronegative recipi-
ents with seronegative donors, whenever logis-
tically possible, would be an even more 
attractive option, obviating the need for pro-
phylactic antiviral treatment. The devastating 
consequences for especially seronegative PKP 
recipients, and the problems associated with 
prolonged systemic antiviral treatment, indi-
cate that routine serological screening and 
whenever possible matching of recipients and 
donors for HSV-1 status should be imple-
mented in corneal transplantation. 
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Figure: Overall risk for HSV-1 infection through PKP as a function of seroprevalence in the donor- and recipient population, 
with a postulated 100% transmission rate from DNA positive corneas. 
White arrows indicate the calculated overall infection risk. Overall seroprevalence is corrected for age composition of donor 
and recipient population in the different areas1·' 
Age distribution of corneal donors and recipients was taken in to account, using data from the Dutch Register for Corneal 
Transplantation. 
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SUMMARY 
Herpetic stromal keratitis (HSK) is a corneal disease initiated by a herpes simplex virus (HSV) 
infection with a postulated T cell-mediated immunopathology. To study the antigen specificity of 
cornea-infiltrating T cells in HSK patients, T cells were isolated and expanded by mitogenic stimu-
lation from corneas of 2 patients with HSV-1- mediated HSK. A substantial number of the T cell 
clones (TCCs) obtained from these T cell lines were HSV-specific. All HSV-specific TCCs were of the 
CD3-CD4'CDs- phenotype. These TCCs responded to autologous HSV-infected corneal keratocytes, 
which expressed HLA class II molecules following incubation with interferon-y. Upon HSV-specific 
stimulation, all TCCs secreted interleukin-4, interleukin-5, and interferon-y. The data presented sug-
gest that HSV-specific CD4- T cells play a role in the immunopathogenesis ofHSK in humans and 
that corneal keratocytes may act as antigen-presenting cells in this local T cell response. 
INTRODUCTION 
Recurrent herpes simplex virus (HSV) 
infections of the cornea can lead to tissue-
destructive inflammation of the corneal stro-
ma. This disease, known as herpetic stromal 
keratitis (HSK), is a leading infectious cause of 
corneal blindness world-wide. The stromal 
pathology seen in HSK patients is most proba-
bly not due to the direct cytopathic effect of the 
virus but more likely the result of a local cellu-
lar immune response (reviewed inl Studies in 
the mouse model of HSK have shown that 
CD4- T cells, possibly HSV-speciflc, that 
secrete type 1 cytokines (i.e., Th1 cells) play a 
pivotal role in the immunopathology of this 
disease'--1 • 
Studies on T cell involvement in the 
immunopathogenesis of HSK in humans is 
limited to immunohistologic analyses and phe-
notypic characterization of isolated intra-
corneal T cells'''. In the present study, a 
protocol was developed that enabled the expan-
sion and functional characterization of intra-
corneal T cells obtained from 2 HSK patients. 
MATERIALS AND METHODS 
Clinical material and reagents. 
Corneal buttons and peripheral blood 
mononuclear cells (PBMC) were obtained 
from 2 patients, 50- (patient 1) and 59-year-old 
(patient 2) men, following therapeutic pene-
trating keratoplasty. Although no HSV could 
be isolated, HSV-1- but not HSV-2- or varicella-
zoster virus (VZV)-specific DNA was detected 
by polymerase chain reaction (PCR) in the 
corneal tissue of both patients (data not 
shown). On the basis of these observations, 
ocular examinations, and the clinical history of 
both patients, the lesions were diagnosed as 
HSV-1- mediated ulcerative necrotizing HSK. 
The patients were HLA-typed. 
Isolation ofPBMC and the generation ofB 
lymphocyte cell lines (BLCLs) by transforma-
tion with Epstein-Barr virus (EBV) were per-
formed as described'. Virus stocks of the 
Macintyre strain ofHSV-1 (ATCC VR-539) and 
the MS strain of HSV-2 (ATCC VR-540) were 
generated on Vera cells. 
Generation ofT cell lines (TCLs) and T cell 
clones (TCCs). 
Intracorneal T cells were isolated from 
corneal buttons by treatment of disrupted 
corneal specimens with collagenase essentially 
as described previously". The cells were resus-
pended in RPM! 1640 supplemented with 
antibiotics and 10% heat-inactivated pooled 
human serum, referred to as complete medi-
um, which contained 50 U jmL human recom-
binant interleukin-2 (r!L-2; Eurocetus, 
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Amsterdam). The cell suspension was incubat-
ed in a 25-cm·' flask for 1 week. The nonadher-
ent cells were harvested, resuspended in 
complete medium containing riL-2 and 1 
!lgfmL phytohemagglutinin-L (PHA-L; 
Boehringer Mannheim, Almere, The Nether-
lands), and divided over 20 wells of a 96-well 
round-bottomed microliter plate. As feeder cell 
mixture, each well received 10' gamma-irradi-
ated (3000 rad) allogeneic PBMC from healthy 
donors and 5 x 10' gamma-irradiated cells of 
both the BLCLs APD (International 
Histocompatibility Workshop, IHW 9291) and 
BSM (IHW 9032). In parallel, PBMC-derived 
TCLs were generated by the same protocol 
using different starting concentrations of 
PBMC (i.e., 5 x 10' or I x 10'). All wells of the 
stimulated PBMC- and cornea-derived T cells 
showed T cell growth and were pooled. These 
cornea-derived TCLs were cloned by limiting 
dilution. The TCCs were restimulated every 
10-14 days with PHA-L and the allogeneic 
feeder cell mixture. 
Corneal keratocyte cultures. 
The adherent corneal cell cultures were 
maintained in 25-cm" flasks in keratocyte 
medium, consisting of SHEM (Dulbecco's 
MEMJF12' ', Gibco Laboratories, Breda, The 
Netherlands) supplemented with 10% heat-
inactivated fetal bovine serum and antibiotics. 
Growing primary keratocytes, with a fibrob-
last-like morphology, were passaged several 
times and cryo-preserved. By immunofluores-
cence staining, all cells stained positive for 
vimentin, whereas almost no reactivity was 
found for both the acidic and basic subfamilies 
of cytokeratin (data not shown). This indicates 
that the keratocyte cultures were not contami-
nated with corneal epithelial or endothelial 
cells. All experiments were performed with 
keratocytes betvveen passages 3 and 6. 
HLA class II expression on keratocytes was 
induced by incubation with 500 U Jml recom-
binant human interferon-y (r!FN-y; Preprotech, 
Breda, The Netherlands) for 4 days. 
T ceil proliferation assays. 
BLCL and r!FN-y-pretreated keratocytes 
were infected with either HSV-1 or HSV-2 at an 
MOl of 1-3 for 20 h; >90% of these cells were 
shown to be infected (data not shown). The 
virus- and mock-infected BLCL were UV- irra-
diated (2.5 x 10·• mWJmm'). The keratocytes 
were fixed with 0.5% paraformaldehyde as 
described previously'. About 3 x 10 T cells, at 
10-12 days after restimulation with PHA-L, 
were cultured in triplicate with 2 x 10-' virus- or 
mock-infected cells in 96-well tissue culture 
plates in complete medium for 72 h. Over the 
last 18 h of culture, the cells were pulsed with 
0.5 ,uCi of ['H] thymidine. The incorporated 
radioactivity was determined as described7 • 
"Cr release cytotoxicity assay. 
Cytotoxicity assays were performed in trip-
licate in 96 V-bottom plates, as described pre-
viously'. Briefly, target cells were prepared as 
described above. Effector cells were added to 5 
x 10' target cells at an effector-to-target ratio of 
30:1. Plates were incubated for 4 h at 37"C. 
Supernatants were harvested, and the "Cr con-
tent was measured in a gamma counter. The 
percentage of specific :; 1 Cr release was calculat-
ed as described previously'. 
T cell receptor (TCR) variable (V) gene a and 
~ usage of the T cells. 
The T cell repertoire and clonality of the 
cornea-derived TCLs or TCCs, respectively, 
were determined by analyzing the TCR V gene 
a. and~ usage as described previously''. Briefly, 
total RNA was isolated from -5 x10'' T cells. 
eDNA was synthesized using oligo-dT and 
reverse transcriptase (RT) (Boehringer 
Mannheim) and subsequently subjected to 
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TABLE 1. ANTIGEN SPECIFICITY, T CELL RECEPTOR (TCR) VARIABLE (V) GENE USAGE, AND CYTOKINE SECRETION LEVELS OFT CELLS OBTAINED 
FROM HERPETIC STROMAL KERATITIS (HSK} PATIENTS 
TCR usage [:H]-thymidine incorporation (cpm) cytokine secretion levels {pgjml) 
Patno. T cell Va v~ mock HSV-1 HSV-2 ll-2 ll-4 I L-5 IFN-y 
1 TCL (PB) NO NO 1057 ± 123 1401 ~ 151 NO 52 63 145 892 
TCL (cornea) dhrerse 1260 ± 338 8749 ± 1040 NO NO NO NO NO 
TCC 8 2 12-3 136 ± 15 12264 ± 713 115 ± 27 <10 47 68 373 
TCC 43 2 12.3 77± 3 15047 ± 813 g6 ± 33 24 72 280 456 
TCC 69 2 12.3 64 ± 7 8979 ± 261 70 ± 11 68 84 196 1268 
TCC 94 2 12.3 57 0 11 10016 ± 395 67 ± 14 22 108 770 475 
TCC 101 2 12.3 so ± 10 18760 ± 1031 82 ± 13 100 31 107 1656 
TCC111 NO NO 64 ± 5 16159 ± 484 64 ± 6 34 39 48 576 
TCC 114 14 3 62 ± 4 8747 ± 353 261 ± 43 NO NO NO NO 
TCC n8 2 12-3 62 ± 11 7101 :': 127 74 ± 19 <10 37 52 374 
TCC 138 2 12-3 52± 6 20907 I 887 54± 6 87 33 44 1265 
TCC 171 2 12.3 6s ± 3 20671 ± 1983 102 ± 4 <10 85 112 364 
TCC18o 7 2 36 ± 12 1512 ± 32 ]61 ± 44 NO NO NO NO 
TCC 200 12 4 64 ± 9 15884 ± 749 83 ± 19 142 ]10 277 3199 
2 TCL (PB) NO NO 1236 ± 463 1791 ± 325 NO 32 91 156 1088 
TCL (cornea) diverse 206 ± 36 32723 ± 702 NO NO ND ND ND 
TCC 4 1 5-1 48 ± 9 12517 ± 232 15033 ± 577 20 39 124 1415 
TCC12 1 5 1 63 ± 7 7470 ± 347 q861 ± 289 <10 788 419 978 
TCC 24 1 5-1 66 ± 17 9175 ± 121 12784 ± 316 <10 76) 11 og 720 
TCC 28 ND ND 61 0 2 1803 ± 112 2915 ± 25 14 61 27 444 
TCC 32 1 5-1 308 ± 1] 12966 ± 315 19041 ± 240 48 116 215 1618 
TCC 33 1 5-1 255 ± 8 15201 ± 547 13383 ± 397 NO ND ND ND 
TCC 68 1 5-1 48 ± 12 10252 = 523 13246 I 344 18 90 194 609 
TCC 69 1 5 1 6o ± 16 19864 ::: 852 21305 ± 465 110 47 239 1446 
TCC 79 14 10 88 ± 9 2236 ± 104 701 ± 70 <10 19 52 392 
TCC 10 1 .1 54 ± 16 10200 ± 11 101 8 7 ± 2 94 26 2 1 0 812 
NOTE: 
T cells tested were peripheral blood (PB)- or cornea-derived T cell lines (TCLs) and T cell clone (TCC). TCR Va and VB gene usage was 
determined by reverse transcriptase-polymerase chain reaction. Diverse, heterogeneous TCR Va and VB gene usage; NO, not done; IL, inter-
leukin; IFN, Interferon; T cells were incubated with mock- or HSV-1- or HSV-2-infected autologous B cells. Data are expressed as mean cpm 
± SO of triplicate cultures. Cytokine secretion levels were determined in culture supernatants ofT cells incubated for 40 h with autologous 
HSV+infected B cells. Cytokines were undetectable following incubation with mock-infected BLCL (data not shown) 
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keratocytes 
111111 TCC 69 (pat. 1) 
,--------p_a_t_ie_n_t __ 1 ____ ~~T~cc 4 ,-(p_at_._2 J ____ P_a_t_ie_n_t __ 2 ________ _, 
- I FN-y: mock 
- IFN-·1; HSV-1 
+ I FN-y : mock 
+ IFN-·r: HSV-1 --------1 +---------~ 
0 4 8 12 0 20 40 60 
counts per minute (cpm x 10"3) 
Figure 1. 
Proliferative response of HLA-DR- restricted HSV-specifk intracorneal CD4- T cell clones (TCCs} of patient 1 and 2 to HSV-1-infected OR-
autologous corneal keratocytes. Adherent keratocytes of patient 1 and 2 were either left untreated (-1 FN-y) or were induced to express H LA 
class II (+IFN-y) with IFN-y. Subsequently, these cell were either mock- or HSV-1- infected, fixed with paraformaldehyde, and incubated with 
TCCs from patient 1 (TCC 69) or 2 (TCC 4)- After incubation with [JH]thymidine was added, and ['H]thymidine incorporation by T cells was 
measured. Results are expressed as mean count per min (cpm) ± SD of triplicate cultures. 
PCR amplification using, separately, 30 Va or 
23 v~ gene (sub)family-specific 5' primers in 
combination with a 3' constant gene region a-
or ~- specific primer, respectively. The PCR 
products were characterized by Southern blot 
analysis. Alternatively, TCR V~ gene usage was 
determined by flow cytometry using a panel of 
V~ specific monoclonal antibodies that cover 
60%- 70% of CD3' peripheral blood T cells"'. 
Cytokine secretion by TCCs. 
To determine the levels of cytokines secreted 
by the TCCs, TCCs and autologous HSV-1- or 
mock-infected BLCL were incubated as 
described for T cell proliferation assays. Upon 
incubation for 40 h, cell-free culture super-
natants were assayed in parallel for IL-2, IL-4, IL-
5, and IFN-yusing compact ELISA kits according 
to procedures recommended by the manufactur-
er (CLB, Amsterdam, The Netherlands). 
RESULTS 
To analyze the antigen specificity ofT cells 
located in inflamed corneas of H S K patients, 
an experimental procedure was developed to 
generate TCLs from corneas. Following one 
round of stimulation of the nonadherent 
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corneal cell fraction with PHA-L and irradiated 
feeder cells, TCLs were obtained from 2 HSK 
patients. Similarly, TCLs were generated from 
the PBMC of these patients. Simultaneously, 
autologous adherent corneal keratocyte cell 
lines were obtained. All TCLs consisted pre-
dominantly of CDY cells. The cornea-derived 
TCLs of patients 1 and 2 contained 68% and 
84% CD4' and 23% and 11% CDS' T cells, res-
pectively. The corresponding PBMC- derived 
TCLs consisted of36% and 16% CD4- and 47% 
and 77% CDS' T cells, respectively. 
In contrast to the PBMC-derived TCLs, the 
cornea-derived TCLs of both H S K patients 
demonstrated an HSV-specific proliferative 
response (table 1). TCCs were obtained from 
the cornea-derived TCLs by limiting dilution. 
Twelve of 115 and 10 of 58 TCCs obtained 
from patients 1 and 2, respectively, were HSV-
specific. Whereas almost all TCCs from 
patient 1 were solely HSV-1-specific, the TCCs 
from patient 2 appeared to be HSV-1 and 
HSV-2-cross-reactive (table 1). All HSV-specif-
ic TCCs were CD3-CD4'CD8 and HLA-DR-
restricted. Upon stimulation with 
HSV-1-infected BLCL, all TCCs tested secreted 
significant amounts of IL-4, IL-5, and IFN-y. 
Not all TCCs secreted IL-2 (table 1). 
The T cell repertoire of the cornea-derived 
TCLs and the clonality of the TCCs were deter-
mined by analyzing their TCR Va and ~ gene 
usage by RT -PCR and V~-specific monoclonal 
antibodies. A heterogeneous TCR V a;l.l gene 
repertoire was observed in the TCLs of both 
patients (data not shown). The panel of TCCs 
of patients 1 and 2 consisted of 4 and 2 geneti-
cally different TCCs, respectively. The predom-
inance of one TCC expressing TCR Va2 and 
V~J2.3 or Val and V~S.l was observed among 
the TCCs of patients 1 and 2, respectively 
(table 1). Sequence analysis of the TCRa and~ 
hypervariable regions (i.e., CDR3) revealed that 
these TCCs were identical (data not shown). 
In addition to professional APC-like 
Langerhans' cells and macrophages, HSV-
infected HLA class 11-expressing keratocytes 
may present antigenic peptides to cornea-infil-
trating CD4' HSV-specific T cells. Although 
keratocytes, both in vivo and in vitro, do not 
normally express HLA class II molecules on 
the cell surface, their expression can be 
induced by IFN-y". The TCCs of both patients 
recognized only autologous HLA-DR- HSV-1-
infected keratocytes and not HLA-DR- mis-
matched keratocytes (i.e., keratocytes from the 
other patient). Results of a typical experiment 
are shown in figure 1. 
DISCUSSION 
HSK is an HSV-incited sight-threatening 
chronic inflammation of the corneal stroma. 
Viral antigens, as well as the cellular immune 
response of the host, are thought to contribute 
to the pathogenesis ofHSK'. Thus far, the anti-
gen specificity of cornea-infiltrating T cells in 
HSK patients remained elusive. A procedure 
was developed that facilitated the outgrowth 
and subsequent characterization of in vivo-
activated intracorneal T cells of 2 HSK 
patients. The high numbers of HSV-specific 
TCCs obtained from these cornea-derived 
TCLs indicate, as was also shown in the HSK 
mouse model, the infiltration of HSV-specific 
T cells into the cornea of HSK patients''. 
Although it is generally accepted that nonin-
flamed corneas are virtually devoid ofT cells, 
experiments using corneas from non-HSK 
patients would have provided additional evi-
dence for the observed compartmentalization 
of HSV-specific T cells in corneas of HSK 
patients (however, as for HSK corneal buttons, 
these tissue specimens are hard to obtain). The 
predominance of one HSV-specific TCC in 
both patients is not surprising given the low 
numbers ofT cells isolated from the corneal 
buttons. The number of HSV-specific T cells 
in the PBMC- derived TCLs of the HSK 
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patients was most likely too low to be detected 
in the proliferative assays. 
Although the cornea-derived TCLs consist-
ed of both CD4 • and CDS' T cells. only CD4' 
HSV-specific TCCs could be identified. 
Similar results have been reported for the HSK 
mouse model 1 • -'. In repeated experiments, we 
did not observe cytolytic activity of the cornea-
derived TCLs and TCCs towards autologous 
HSV-1-infected BLCL (data not shown). This 
observation is in contrast to those from the 
mouse model'. Using similar protocols, we 
have isolated cytolytic HSV- specific CD4· T 
cells from intraocular fluid samples of patients 
with HSV-incited acute retinal necrosis 
(unpublished data). This suggests the involve-
ment of a functionally different subset of CD4· 
HSV-specific T cells in the pathology of HSK 
compared with acute retinal necrosis. 
Heterogeneity in cytolytic properties ofhuman 
HSV-1-specific CD4' TCCs has been described 
for PBMC-derived TCCs". 
In the HSK mouse model, type-! cytokines 
such as IFN-y predominated during the active 
phase of disease. Type-2 cytokines, such as IL· 
10 and IL-4, tend to be associated with the 
recovery phase ofHSK". This is consistent with 
the observation that IFN-y contributes to 
corneal inflammation". As described for 
human PBMC-derived HSV·l·specific CD4' T 
cells", all cornea-derived HSV·specific TCCs 
secreted IL-4, IL·S, and IFN-y upon antigenic 
stimulation, indicating their Tho phenotype. 
In contrast to findings in the HSK mouse 
model, HSV antigens and HLA class II· 
expressing keratocytes can be detected during 
the active phase of the disease in corneas of 
HSK patients''". In particular, in patients with 
ulcerative necrotizing HSK, HSV antigens 
have been detected in stromal keratocytes and 
the extracellular stroma". Of interest, both 
HSK patients in the present study suffered 
from ulcerative necrotizing HSK. As described 
for human skin-derived keratinocytes", IFN-y-
pretreated corneal keratocytes were able to 
present HSV-1 antigen via HLA class II to 
HSV-specific CD4 'T cells. 
Although viral replication is required for 
the induction of HSK, viral antigens and 
mRNA are undetectable in corneas of mice at 
the time of clinical manifestation". The local T 
cell-mediated inflammatory response in HSK 
may therefore be directed against nonviral anti-
gens (e.g., corneal autoantigen)"'. A prelimi-
nary screening of the cornea-derived TCLs of 
both HSK patients did not reveal T cell reactiv-
ity against human corneal autoantigens (data 
not shown). Although this observation does not 
support the role of corneal autoantigen- specif-
ic T cells in the immunopathogenesis of 
human HSK, we cannot exclude this option. 
In conclusion, this study is the first to 
demonstrate the presence of a T cell response 
specific for the inciting agent in corneas of 
HSK patients. In addition to T cells, neu· 
trophils extensively infiltrate HSK corneas. 
The extravasation of neutrophils, which con-
tribute to viral clearance and the subsequent 
destruction of corneal tissue, has been sug-
gested to be regulated by IFN-y'". We hypothe-
size that the immunopathogenic role of 
intracorneal HSV-specific CD4• T cells in HSK 
is mediated by their secretion of IFN-y upon 
activation by infected macrophages, Langer-
barrs' cells, or possibly keratocytes. This may 
trigger neutrophil extravasation and subse-
quent neutrophil-mediated tissue destruction. 
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SUMMARY 
Purpose: 
Herpetic stromal keratitis (HSK) is a T-cell-mediated inflammatory disease initiated by a her-
pes simplex virus (HSV) infection of the cornea. Recently, studies in the HSK mouse model have 
shown that the immunopathogenic T-cells are directed against the HSV protein UL6 cross-react-
ing with an unknown corneal autoantigen. We have analyzed whether this type of autoimmunity 
may play a role in human HSK. 
Methods: 
T-celllines (TCL) were generated from corneal buttons of 12 patients with different clinical 
stages ofHSV-induced necrotizing stromal keratitis (n~ 9) or immune stromal keratitis (n~ 3). The 
initiating virus was identified by PCR and immunohistology performed on the corneal buttons. 
Peripheral blood mononuclear cells (PBMC) were isolated and B cell lines (BLCL) were generated 
by transformation with Epstein Barr virus. Proliferative responses of these intra-corneal TCL were 
determined by culturing T-cells with autologous BLCL infected with HSV-1-, HSV-2-, wild type 
vaccinia virus (VV-WT) or VV expressing HSV-1 UL6 (rVV-UL6). Alternatively, T-cells were incu-
bated with PBMC pulsed with human cornea protein extract. 
Results: 
Irrespective of clinical diagnosis or treatment, T -cells were recovered from the corneal buttons 
of all the 12 HSK patients. The intra-corneal TCL of 9 out of the 12 HSK patients showed HSV-
specific T-ee!! reactivity. In none of the TCL, T-ee!! reactivity against HSV-1 UL6 or human corneal 
antigens was detected. 
Conclusions: 
The data suggest that the potentially immunopathogenic intra-corneal T-ee!! response in HSK 
patients is directed to the initiating virus and not to a human corneal autoantigen or HSV-1 UL6. 
INTRODUCTION 
Herpes simplex virus (HSV) infections of 
the cornea can elicit the development of her-
petic stromal keratitis (HSK). HSK is a sight-
threatening disease in which tissue 
destruction, edema and corneal scarring are 
the result of an inflammatory response in the 
corneal stroma. Current knowledge on the 
immunopathogenesis of H S K is largely based 
on studies performed in the experimental 
mouse model for HSK that closely mimics 
necrotizing stromal keratitis in man. In the 
HSK mouse model, CD4• Th1 cells have been 
demonstrated to play a pivotal role in this local 
immunopathogenic response''. The other cell 
types involved are Langerhans cells (LC)\ 
macrophages and notably polymorphonuclear 
neutrophils (PMN)''. The nature of the anti-
gens recognized by these immunopathogenic 
cornea infiltrating T-cells is a matter of debate. 
A long-standing assumption has been that the 
intra-corneal T-cell response in HSK is direct-
ed to HSV-encoded antigens'·. Recently, howev· 
er, studies in the HSK mouse model have 
provided evidence that HSK is an HSV-
induced autoimmune disease''. HSK could be 
induced by CD4' T-cells directed to an epitope 
derived from the HSV-1 capsid protein UL6, 
that cross-reacts with an epitope of an antigen 
uniquely expressed in the murine cornea'. 
Recently, we have demonstrated the pres-
ence of HSV-specific CD4- Tho-like cells in 
corneas of two patients with necrotizing ulcer-
ative HSK. In this study no reactivity to human 
corneal antigens could be detected". 
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TABLE 1. 
CHARACTERISTICS OF HERPETIC STROMAL KERATITIS PATIENTS INCLUDED IN THE PRESENT STUDY 
Patient Sex·' I Age' Diagnosis 
1 M 51 Necrotizing stromal keratitis 
2 M 6o Necrof1z.1ng stromal keratitis 
3 M 71 Necrotizing stromal keratitis 
4 M 57 Necrotizing stromal keratitis 
5 M 68 Necrotizing stromal keratitis 
6 F 90 Necrotizing stromal keratitis 
7 M 73 Necrotizing stromal keratitis 
8 F 31 Necrotizing stromal keratitis 
9 F 74 Necrotizing stromal keratitis 
10 F 81 Immune stromal keratitis 
11 M 61 Immune stromal keratitis 
12 F 6 4 Immune stromal keratitis 
a M, male and F, female. 
b Age in years. 
HSV-1 
Disease PCR on 
status cornea' 
Active + 
Active + 
Active + 
Active + 
Active + 
Active + 
Quiescent + 
Active 
Quiescent ND 
Quiescent + 
Active 
Q uiescent 
c +or-, positive or negative HSV-1-specific PCR product detected. NO, not done. 
T1me s'1nce Time Topkal pre-operative 
keratitis first since last 
diagnosed' recurrence' Steroids Acyclovir 
352 1.5 No Yes 
480 0 Yes Yes 
4 0 Yes Yes 
104 0 Yes Yes 
240 0 No No 
235 0 No No 
8o 11 Yes Yes 
66 1.5 Yes No 
243 17 ) ? 
309 13 Yes No 
so 1 No No 
1 43 37 No No 
d Time in months. Times since last recurrence means time lapse since presentation of active disease in months, whereas active disease is 
defined as visible stromal infiltration with edema. In the patients with a time lapse of1-1.5 months, patients #1, 8 and 11, the cornea was 
still showing evident cellular infiltration. Impending perforation made penetrating keratoplasty neccessary. 
Nevertheless, autoreactive T-cells may still be 
involved in clinically distinct HSK entities. In 
the present paper we have determined the anti-
gen-specificity of cornea infiltrating T-cells, 
obtained from 12 patients with different clini-
cal forms of HSK. T cell reactivity was tested 
towards the HSV serotypes 1 and 2, recombi-
nant HSV-1 UL6 and a soluble human corneal 
protein extract. 
MATERIALS AND METHODS 
Clinical materials and reagents 
Corneal buttons and peripheral blood 
mononuclear cells (PBMC) were obtained 
from 12 patients, with HSV-induced necrotiz-
ing stromal keratitis (patients #1-9) or 
immune stromal keratitis (patients #10·12), 
following therapeutic penetrating keratoplasty. 
HSK classification, and quiescent disease for 
at least 6 months or active disease, was defined 
on the basis of clinical criteria'". The character-
istics, diagnosis and pre-operative treatment of 
the patients studied are listed in Table 1. 
Patient #12 was transplanted because of a 
corneal graft rejection due to a necrotizing 
ulcerative HSK, and patients #1 and #2 have 
been described previously>. Isolation of PBMC 
and the generation of B cell lines (BLCL), by 
transformation with Epstein Barr virus, were 
performed as described''. Virus stocks of the 
Macintyre strain of HSV-1 (American Type 
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Culture Collection; ATCC VR-539) and the MS 
strain of HSV-2 (ATCC VR-540) were generat-
ed and titrated in Vera cells. Recombinant vac-
cinia virus (VV) rVV- UL6 expressing the 
HSV-1 UL6 gene (strain 17) has been described 
and kindly provided by A.H. Patel (MRC 
Virology Unit, Institute of Virology, Glasgow, 
UK)". Virus stocks of the rVV-UL6 and the 
wildtype strain WR (ATCC VR-1354) were gen-
erated and titered on RK13 cells (ATCC CCL-
3 7). Protein was extracted from whole human 
corneas (n= 12), donated for transplantation 
but found unacceptable because of senile 
changes of the endothelium, by sanification of 
a Tris-buffered cornea tissue lysate as 
described previously for the generation of a 
soluble murine cornea protein extracf·". The 
present study was performed according the 
Declaration of Helsinki and informed consent 
was obtained from all patients. 
Immunohistochemistry 
Corneal buttons, obtained within 1 hr after 
surgery, were divided in two equal parts for 
immunohistologic analysis and T-cell recovery. 
One quarter of the cornea was snap frozen in 
optimal cutting tissue and one quarter was 
fixed with formalin and embedded in paraffin. 
Routine histopathology (hematoxylin( eosin 
and periodic acid-Schiff staining) and 
immunoperoxidase staining was performed 
on cryostat and paraffin sections as described 
previouslt 3 • Mouse anti-human monoclonal 
antibodies (Mabs) were used as primary anti-
bodies. The following Mabs were used as rec-
ommended by the supplier: anti-CD3 (Dako, 
Glostrup, Denmark), anti-CD4 and -CD8 
(Becton Dickinson, USA) and anti-HSV-1 
(Dako). Peroxidase-labeled polyclonal rabbit 
anti-mouse IgG antibody (Dako) was used as 
secondary antibody and visualized using 
diaminobenzidine or 3-amino-9-ethyl car-
bazole (Sigma St. Louis, MO)". 
DNA extraction and PC R analyses 
The surplus half of the corneal specimens 
were minced and treated with collagenase 
essentially as described previously". DNA was 
isolated from one-fourth part of the corneal 
cell suspension lysed in a guanidine isothio-
cyanate buffer using Celite solution If ansen 
Chemika, Beers, Belgium) according to Boom 
et a[ 1 -'. The PCR primers and conditions for 
detection of HSV type 1 and 2 and varicella 
zoster virus specific DNA following Southern 
blotting have been described previously' 1 . 
Cornea-derived T-celllines 
Corneal-derived T celi lines (TCL) were 
generated from the remaining corneal cell sus-
pension as described previously". After one 
round of mitogenic stimulation, using phyto-
hemagglutinin-L (PHA-L; Boehringer Mann-
heim, Mannheim, FRG) and allogeneic feeder 
cells, the intra-corneal TCLs were frozen in 
aliquots at -135°C. Control experiments, with 
corneas histologically devoid of infiltrating T-
cells did not result in the generation of TCLs, 
indicating that the method applied facilitates 
the recovery and outgrowth ofT cells compart-
mentalized to the cornea (data not shown). The 
TCL were characterized for cell surface expres-
sion of CD3, CD4, and CDS by triple color 
flowcytometry using fluorescein isothio-
cyanate (FITC)-, RPE- and RPE-Cy5-conjugat-
ed Mabs, respectively (Dako). 
T-cell proliferation assays 
Autologous BLCLs were infected with 
HSV-r, HSV-2 at a multiplicity of infection 
(MOl) of about 5 at 370C for 20 h. The virus-
and mock-infected cells were washed and UV-
irradiated (2.5 x ro-z mW(mm2). Alternatively, 
BLCLs were infected with the rVVs at an MOl 
of approximately 5 for 20 h and fixed with r% 
paraformaldehyde as described previouslyr6. 
The level of infection of the BLCLs with the 
respective viruses was determined by flowcy-
Chapter 4 Intmunopathoge11csis ofhwm(ln/irrpdic stromnl h:ratitis 111 
~~-------------------------------------, 
0 
" 
FIGURE 1. 
,, 
',' ' 
':, 
' 
Flowcytometric analysis of 8 cells infected with wildtype (dashed line) and 
recombinant vaccinia virus expressing HSV-1 UL6 (solid line) for the 
expression of HSV-1 Ul6. The x-axis and they-axis indicate the fluores-
cence intensity and relative cell number, respectively. For both cell popula-
tions, staining with 1% normal rabbit serum resulted in a similar histogram 
as for wildtype vaccinia virus infected B cells (data not shown). 
tometry. The expression ofHSV-r UL6 in rVV-
UL6-infected BLCLs was demonstrated using 
a rabbit anti-UL6 serum (2C2)n and subse-
quently FITC-conjugated swine-anti-rabbit 
serum (Dako). As for all viruses, about 70-
90% of the BLCL were shown to be infected 
(Fig. r). T-cells (3 x I04Jwell), removed from 
culture at day I0-12 after one mitogenic stimu-
lation, were cultured in triplicate together with 
virus- or mock-infected BLCLs (2 x ro4Jwell) 
in 96-well round-bottomed plates in rso ml 
complete medium at 370C in a COz-incubator. 
Complete medium consisted of RPMI-r64o 
(GIBCO-BRL, Breda, The Netherlands) supple-
mented with 10% heat-inactivated pooled 
human serum and antibiotics. Due to the lim-
ited ability of BLCLs to process and present 
exogenous antigens to T-cells, T-ee!! reactivity 
to human soluble cornea protein extract 
(HuSoCo; at final protein concentrations of so 
and roo mgjml) was performed using ros 
autologous PBMC (UV-irradiated) as antigen 
presenting cells (APC). The cells were cultured 
for 72 hand pulsed with 0.5 mCi [3H]-thymi-
dine over the last r8 h of culture. The cells 
were harvested and the incorporated radioac-
tivity was determined in a beta-scintillation 
counter. Proliferation was considered positive 
when stimulation indices, counts per minute 
(cpm) incorporated in response to antigen J 
cpm incorporated in response to control), were 
>4- T-cell reactivity to all antigens tested for 
were assayed simultaneously and PHA-L (r 
mgjml) was included as positive control forT-
cell proliferation. The assays were performed 
at least 2-times and the standard deviation was 
always < 30% of the mean cpm. 
RESULTS 
Immunohistochemistry on corneas of HSK 
patients 
Diagnostic analyses were performed on 
corneal buttons, obtained following therapeu-
tic penetrating keratoplasty, from 12 patients 
with necrotizing stromal keratitis (patients #1 
- #9) or immune stromal keratitis (patients #10 
· 12) '". All patients had a history of recurrent 
episodes of HSV-1-induced stromal keratitis 
(Table 1). The corneal histopathology observed 
in the HSK patients (Fig 2A) included granu-
lomatous reactions at the level of Descemet' s 
membrane (Fig. 2B and C), suppurative kerati· 
tis with edema (Fig. 2D and E), reactive hyper-
plasia of the epithelium and breakdown of 
Bowman's layer (Fig. 2F and G). A mononu-
clear cell infiltrate was observed in the corneas 
of all patients and consisted predominantly of 
CD4' T cells (fig. 2G). 
PCR analyses revealed the presence of 
HSV-1 DNA in 8 out of 11 corneas analyzed, 
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implicating that HSV-1 initiated the disease. 
HSV-1 DNA positive corneas were mainly 
obtained from patients with fulminant necro-
tizing stromal keratitis (Table 1). Evidence for 
an ongoing intra-corneal HSV-1 infection was 
only found in patient #s, demonstrated by the 
presence of HSV-1-infected keratocytes 
(Fig. 2E). 
Antigen specificity of cornea-derived T cell lines 
from HSK patients 
We have recently developed a protocol that 
enables the recovery and expansion of in vivo 
activated corneal infiltrating T -cells from 
corneal buttons ofHSK patients'. This method 
facilitated the generation of intra corneal TCLs 
from all 12 HSK patients studied. All TCLs 
consisted predominantly of CD3- T-cells and 
the ratio of CD4' and CDS' T-cells varied 
interindividually. Interestingly, the TCLs of 
tvvo patients with quiescent necrotizing stro-
mal keratitis consisted almost exclusively of 
CD4' T-cells (patients #7 and #9; Table 1). The 
reactivity of the cornea-derived TCLs towards 
the triggering virus was analyzed in T-cell pro-
liferation assays using mock-, HSV-1- and 
HSV-2-infected autologous BLCL as APC. The 
intra-corneal TCLs of 9 out of 12 patients 
showed HSV-specific T-cell reactivity (Table 2). 
Illustrative for the high sequence homology 
between the HSV serotypes, the majority of 
these TCLs recognized both HSV-1- and HSV-
2-infected BLCLs. In case of patient #8, how-
ever, the H SV-specific intra-corneal T-cell 
response was restricted to HSV-2. 
To test the hypothesis that an HSV-induced 
autoreactive intra-corneal T-cell response is 
involved in the immunopathogenesis of H S K 
in humans, the reactivity of the TCLs to recom-
binant HSV-1 ULG and a HuSoCo protein 
extract was determined. In repeated experi-
ments, none of the TCL showed significant 
responses to HSV-1 UL6 or human corneal 
antigens (Table 2). 
DISCUSSION 
HSV infection of the cornea can result in 
the development of stromal keratitis, a leading 
infectious cause of blindness worldwide. The 
adult cornea is an ocular tissue without consti-
tutive lymphoid components. Therefore, any 
intra-corneal T-cell found in HSK patients 
must have migrated into the cornea upon 
infection and subsequent inflammation. 
Experimental HSK animal models have been 
developed to investigate the immunopatho-
genesis of HSK. Based on these studies, HSK 
is considered to represent an immunopatho-
logical reaction in the corneal stroma coordi-
nated by CD4- Th1 cells''. 
Although the processes orchestrated by 
cornea infiltrating CD4' T-cells have been 
studied extensively, the target antigens recog-
nized remain unclear. Given the involvement 
of HSV in the etiology of HSK, HSV antigens 
are the most likely candidates. To address this 
notion we analyzed the antigen-specificity of 
cornea infiltrating T-cells in 12 patients with 
HSV-induced stromal keratitis. After one 
round of mitogenic stimulation, cornea-
derived TCLs were successfully generated 
from corneas of the 12 patients studied. Intra-
corneal HSV-specific T-cell reactivity, mainly 
HSV type-common, was observed in 9 out of 
12 corneas tested. These data indicate that T-
cells specific for the triggering virus infiltrate 
corneas of HSK patients. In patient #8, howev-
er, the HSV-specific response was solely direct-
ed to HSV-2. Possibly the determinants 
recognized by these T-cells are HSV type-com-
mon and are not efficiently processed and pre-
sented 1n HSV-1- as compared to 
HSV-2-infected BLCLs. Surprisingly, HSV 
reactive T-cells could also be detected in TCL of 
patients in a quiescent phase, treated with 
steroids and even from HSV DNA-negative 
corneas. These data suggest that HSV-specific 
T-cells can reside for longer periods of time, 
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Figure 2. 
Macroscopic, histologic and immunohistologic examination of corneas from patients with herpetic stromal keratitis. (A) Central corneal 
ulcer with descemetocele and impending perforation of the cornea of patient #5. (B and C) Central view of keratectomy specimen of patient 
#l showing stromal infiltration of inflammatory cells and a florid granulomatous reaction with focal rupture of Descemet's membrane (Om) 
(B; periodic acid- Schiff. PAS, magnification x10o). Inset·. higher manification of then multinucleated giant cell (arrow) protruding through 
this rupture (C; PAS, x4oo). (0). Paracentral view of keratectomy specimen of patient #5 shows (adjacent to the ulcer) a deep stromal 
defect with edema and infiltration of polymorphonuclear cells (arrow) reaching up to Om {HE straining, x2oo). (E) Immunohistochemical 
staining for HSV-1 antigens demonstrating HSV antigens in stromal keratocytes (arrow) in the corresponding section of the cornea of 
patient #5 (hematoxylin counterstained. X400). (F) Central view of keratectomy specimen of patient #6 with reactive hyperplasia of the 
epithelium. The cornea is "mfiltrated w'1th predom·mantly mononuclear cells (HE, x2oo). (G) Immunohistochem-Ical staining for CD4' cells 
demonstrating predominantly subepithelial localization of C04' cells (arrow) in the corresponding section of the cornea of patient #6 
(hematoxylin counterstained, x2oo). 
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TABLE2. 
PHENOTYPE AND ANTIGEN·SPECIFIC PROLIFERATIVE RESPONSES OF CORNEA·DERIVED T-CELL LINES FROM HSK PATIENTS 
%of cells with [!H)-thymidine incorporation (cpm)''' 
phenotype 
Patient BLCLJ BLCL/ BLCLJ BLCLJ BLCLJ PBMCJ PBMC/ 
No. CDJ' CD4' CD8 mock HSV-1 HSV-2 VV-WT rVV-UL6 Medium HuSoCo PHA-L 
1 92 68 2) 1,260 ± 122 8.749 ± 6s9 ND ND ND 131 :;:: 34 112 ± 52 21,026 ± 4809 
2 98 84 11 19 ± 9 9,158 :::: 584 ?.777 ± 109 29 ± 6 24 ± 7 370 ± 54 442 ± 77 14,233 ± 374 
3 97 67 '9 616 ± 133 1,173 ± 116 1,576 ± g8 119 ± 15 144 ± 83 83 ± 26 155 ± 51 27,059 ± 5168 
4 99 76 24 161 ± 61 1,253 ± 121 1,701 
"' 
97 ND ND 292 ± 37 243 ± 13 32.448 ± 4433 
5 g6 29 69 67 ± 26 455 ± 69 191 ± 19 27 ± 3 48 ± 5 so ± 7 49 ± 11 37,037 ± 559 
6 96 46 49 2,085 ± 308 29,125 ± 3088 9235 ± 780 ND ND 824 ± 55 913 ± 86 27,309 ± 1237 
7 99 97 3 123 ± 33 103 ± 2 128 ± 21 131 ± 21 163 ± 32 173 ± 33 123 ± 19 15,399 ± 6g6 
8 g8 34 6] 160 ± 78 332 ± 23 825 ± 39 ND NO 131 ± 41 112 ± 42 35.183 ± 809 
9 99 98 <1 109 ± 15 1,426 ± 159 4,014 ± 371 NO NO 8o ± s8 130 ± 22 J4,843 ± 1762 
10 g8 54 )2 387 ± 72 14,298 ± 1122 1,518 ± 294 104 ± 16 113 ± 28 374 ± 103 140 ;:: 32 31,829 ± g68 
11 96 53 43 go± 16 147 ± 29 170 ± 21 55 ± 15 63 ± 16 631 ± 57 290 ± 67 26,632 ± 643 
12 NO ND ND 6g 9 ± 172 6,718 ± 434 7,264 ± 6o 857 ± 93 778 ± 73 666 ± 10 2,424 ± 232 2-449 ± 1023 
T-cells were incubated with autologous B cell lines (BLCL) infected with herpes simplex virus (HSV) type 1 or 2, vaccinia virus wild-type 
(VV-WT) or recombinant VV expressing HSV-1 protein UL6. Alternatively, T-cells were cultured with autologous peripheral blood mononu-
clear cells (PBMC) in the presence of human soluble corneal protein extract (HuSoCo), medium or PHA-L (1 pgjml) as negative and pos-
tive control. Results using 50 ~tgjml HuSoCo are presented. The data are expressed as mean cpm :r: SD of triplicate cultures. ND, not 
done. 
and even under steroid treatment, in corneas of 
patients with HSV-induced stromal keratitis. 
In contrast to corneas of patients with 
necrotizing stromal keratitis" (Fig 2E), murine 
HSK corneas are devoid of HSV antigens'' 
Nonetheless, HSV-specific T cells have been 
demonstrated in whole-eye cell suspensions of 
mice with fulminate HSK'. Similarly, in 8 of 
the 9 HSK patients, from which intra corneal 
HSV-specific T-cells were recovered, the 
corneas were devoid ofHSV antigens. On infil-
tration of the cornea, these HSV-specific T-
cells may have been activated by viral peptides 
retained by corneal cells like LCs or the 
amount of HSV antigens in the corneas is too 
low to be detected by immunohistochemistry. 
Alternatively, potential keratogenic CD4- T-
cells infiltrating HSV-infected corneas may be 
activated nonspeciflcally, (e.g. by cytokine-
mediated bystander activation) 1 ', or activated 
upon recognition of sequestered corneal 
autoantigens unmasked or altered following 
HSV replication in the cornea'. Recently, stud-
ies performed in the murine HSK model have 
provided evidence for the latter assumption'·'. 
HSK could be induced in nude mice after 
adoptive transfer ofHSV-1 UL6 peptide-specif-
IC CD4< T-cells' cross-reacting with an 
unknown corneal protein'. We have analyzed 
whether this type of autoimmunity may play a 
role in human HSK. In none of the TCLs gen-
erated from corneas of any of the HS K patients 
studied here, reactivity to HSV-1 UL6 or a 
HuSoCo protein extract could be demonstrat-
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ed. Stimulation of the intra corneal TCLs with 
PHA-L resulted in high proliferative respons-
es, indicating that this is not due to a low via-
bility of the TCL tested (Table 2). The lack of 
reactivity towards HSV-1 UL6, harboring the 
cross-reactive epitope, is not surprising given 
the constraints of MHC allele-specific peptide 
binding'''. In case of the HuSoCo protein 
extract, the negative results could be due to a 
true lack of autoreactive T cells or inappropri-
ate corneal antigen preparation used. The 
putative corneal autoantigen could be located 
in the buffer-insoluble part of the human 
cornea extract, it may be genetically polymorph 
or the intra-corneal autoreactive T cell 
responses is mediated by CDs· T-cells. Given 
the nature of the HuCoSo protein extract and 
the type of assay used, i.e. exogenous antigen 
preparation in a T cell proliferation assay, the 
potential role of CDs+ cornea autoantigen spe-
cific T cells in HSK could not be addressed. In 
the HSK mouse model, the keratogenic T-ee!! 
clone recognized an unknown Tris-buffer solu-
ble cornea-specific antigen' and was able to 
induce the disease in HSK resistant mice argu-
ing against genetic polymorphism of the 
autoantigen. The HuSoCo protein extract used 
here, obtained from 12 human cornea buttons 
and similarly generated as described in the 
murine HSK study'·12, was a heterogeneous 
protein preparation in which the major soluble 
cornea protein BCP54'" was predominantly 
present (sodium dodelyl sulfate - polyacry-
lamide gel electrophoresis analysis; data not 
shown). Positive peripheral blood T-cell 
responses, using similar concentrations of an 
equivalent HuSoCo protein extract or purified 
BCP54, have been obtained in patients with 
inflammatory corneal diseases 20 '2 '. These data 
suggest that the HuSoCo protein extract used 
in the present study may be considered 
immunogenic. Although not formally exclud-
ed, the lack of intra-corneal T-cell reactivity to 
HSV-1 UL6 and human corneal antigens does 
not support the hypothesis that human HSK is 
an HSV-induced autoimmune disease. The 
cloning and identification of the putative H S K 
related murine cornea autoantigen and its 
human homologue will be needed to further 
address the validity of the molecular mimicry 
hypothesis at the single antigen level. 
In conclusion, the present study 
demonstrates T cells specific for the triggering 
virus in the corneas of the majority of the 12 
HSK patients studied. On antigenic stimula-
tion, the cornea-derived HSV-specific T cells 
from HSK patients secrete both interferon 
gamma (IFN-y) and interleukin 2 (IL-2)' (data 
not shown). In the mouse H S K model, both 
cytokines have been shown to shown to be 
pathologic in the cornea of HSV-1-infected 
mice''''. IFN-y has been shown to facilitate 
migration of PMN s from the blood into the 
cornea, and upon activation by IL-2 and per-
haps IFN-y secrete proteolytic enzymes that 
contribute to destruction of the cornea'·2.n. 
We hypothesize that HSV-specific T-cells play 
an important role in the local immunopatho-
genesis of HSK in humans. Upon entry into 
the cornea they are activated by HSV-infected 
corneal cells or by viral peptides retained by 
corneal cells like LC corneal cells and subse-
quently initiate an cytokine-mediated immu-
nopathogenic response in the cornea. 
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CHAPTER 5 
Summarizing Discussion/ 
Nederlandse samenvatting en discussie 
SUMMARIZING DISCUSSION 
Infections with several members of the 
human herpesviruses are the cause of signifi-
cant ocular morbidity. Of the human her-
pesviruses, HSV-1 is the most frequent cause 
of primary and recurrent eye disease. Despite 
the availability of effective antiviral treatment, 
recurrent HSV-1 infection continues to be the 
leading cause of corneal blindness in industri-
alized nations. This thesis describes new 
insights in the role of the virus and the intra-
corneal T cell response involved in the patho-
genesis of human HSV-1-induced keratitis. 
CLINICAL PRESENTATION OF 
INFECTIOUS EPITHELIAL 
KERATITIS: "ROCKING AROUND 
THE CLOCK" 
HSV infection of the corneal epithelium caus-
es a classical dendritic shaped infection, where-
as HSV infection of the skin causes round 
vesicles. Linear branching lesions like the den-
drites on the corneal surface are not found on 
the skin. It seems logical to postulate that HSV, 
with its affinity for neural tissue, causes lesions 
congruent with the anatomical pattern of 
innervating nerves of the target-organ. 
Until recently, the anatomical substrate for 
the linear branching pattern of IEK was 
unknown. This was probably in part due to the 
absence of knowledge of the subbasal nerve 
plexus in the corneal epithelium. In 1997, 
Muller et a!.' described the subbasal nerve 
plexus in the human cornea as a dense regular 
meshwork with bifurcations of the main nerve 
fiber bundles at almost right angles. The ori-
entation of the nerve fibers in the subbasal 
nerve plexus showed a 9-3 hours and 12-6 
hours direction'. In Chapter 2 the striking con-
gruency between the subbasal nerve plexus of 
the corneal epithelium and the pattern of the 
dendritic lesion in recurrent IEK is demon-
strated. Interestingly, the branching pattern of 
the dendrite is the same, regardless whether 
the dendrite occurs in an eye with or without 
previous PKP. However, after PKP the orienta-
tion of dendrites looses its preference for the 
9-hours and 12-6 hours direction. The fin-
ding that dendritic ulcers are merely rotated, 
suggests the same grid-like anatomy of the 
subbasal nerve plexus in the corneal epitheli-
um after PKP. This can be explained by postu-
lating that the original two dimensional 
orientation of the corneal button is lost during 
corneal transplantation. Reinnervation of the 
cornea may follow preserved parts of the sub-
basal plexus after transplantation. The ulti-
mate proof, whether the subbasal nerve plexus 
is the structure responsible for the dendritic 
pattern of IEK, should be given by in vivo con-
focal microscopy. 
HSV-1 INFECTIONS AFTER 
PENETRATING KERATOPLASTY 
PKP AND HSV KERATITIS. 
In the general population, ocular manifes-
tations ofHSV-1 infection can lead to unilater-
al blindness which may be an indication for 
PKP. Five to 10 % of PKPs are performed for 
corneal opacities resulting from HSV-1 infec-
tion'. PKP for HSV keratitis has a high rate of 
post-operative complications. Epithelial recur-
rences are a major problem after PKP. Graft 
rejections contribute to graft failure to a larger 
extent in PKP for HSV than in PKP for reasons 
unrelated to HSV-1 infection). Recurrences of 
HSV keratitis after PKP and the rate of 
immunological graft rejection in these grafts 
can be reduced by antiviral prophylaxis when 
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steroids are employed to prevent or treat graft 
rejection'. However, the use of prophylactic 
antiviral therapy is largely based on experience 
in patients with recurrent HSV related eye dis-
ease who have not undergone PKP'. 
NEWLY ACQUIRED CORNEAL HSV-1 
INFECTIONS AFTER PKP 
The finding, that HSV-1 keratitis occurs 
after PKP in patients without a previous history 
of HSV keratitis, raises questions about the fre-
quency and impact of this manifestation, about 
the mode of transmission in these patients, and 
about the numbers of transplant recipients at 
risk to develop this inflammatory disease. 
In this thesis, a retrospective analysis of the 
outcome of 2398 PKPs is presented'. Among 
2112 patients transplanted for reasons unrelat-
ed to HSV infection. 18 presented with HSV-1 
epithelial keratitis in their graft. The HSV-1 
infection was caused either by endogenous or 
exogenous virus. The incidence of newly 
acquired HSV keratitis after PKP was calculat-
ed to be 1.2 per 1000 person years, i.e.14-fold 
higher than that observed in the general popu-
lation7. A recent study conducted in 25 patients 
with this clinical manifestation, indicated that 
the majority of them (n~14) developed severe 
ocular complications resulting in social blind-
ness of the infected eye within three years 
(unpublished observation). In most cases, the 
newly acquired HSV-1 infection occurs within 
the first tvvo years after PKP, again suggesting 
a causal relationship between corneal trans-
plantation and HSV-1 infection. In our retro-
spective study it remained unsettled from 
where the virus originated. Several possibili-
ties exist, including reactivation of latent virus 
in the trigeminal ganglion and transmission 
through the donor cornea. Infectious agents 
that have been demonstrated to be transmitted 
following corneal transplantation including 
bacteria, fungi, Creutzfeldt-Jakob agent, hepa-
titis B- and C viruses and rabies virus'. 
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To substantiate the hypothesis that trans-
mission of HSV-1 through corneal transplan-
tation may occur, new diagnostic tools had to 
be developed. A new PCR method, based on 
the stability and strain-to-strain differences of 
reiterated sequences within the HSV-1 
genome, was developed''. The method facilitat-
ed differentiation of up to 92% of unrelated 
HSV-1 strains. The major advantage of the 
approach presented is, that it provides the 
opportunity to discriminate HSV-1 strains 
without virus culture. The method proved to 
be sensitive enough for amplification of the 
low levels of viral DNA present in corneal but-
tons and rims obtained from patients under-
going PKP. 
1t is assumed that recurrent herpetic 
lesions are due to reactivation of the strain 
acquired during primary infection. However, 
HSV-1 superinfection has been documented, 
but considered to be a relative rare event 111 • In 
the last part of chapter 3, we demonstrated a 
high frequency of corneal HSV-1 superinfec-
tion. Genotypic analysis, with the recently 
developed PCR method, demonstrated that 
63% of patients with recrudescent herpetic 
keratitis had evidence of reactivation of the 
same strain (group I). Consequently 37% of 
the patients had a different genotype (group 
!!), suggesting corneal HSV-1 superinfection 
in the inter-recurrence period. Selection of 
patients susceptible to HSV-1 may have 
occurred, because the patient cohort consisted 
predominantly of patients with severe herpetic 
keratitis. Alternatively superinfection with a 
more virulent strain might have occurred. 
Among the clinical data analyzed, only the 
time point of PKP was significantly different 
between the two groups. None of the patients 
of group I underwent PKP between sampling, 
whereas 4 out of 11 patients underwent PKP 
during the inter-recurrence period. The data 
suggest that PKP is a risk factor for corneal 
superinfection with HSV-1 11 • 
121 
In a subsequent study the hypothesis on 
graft-to host transmission of HSV-1 through 
PKP was tested. Three months after PKP for 
congenital glaucoma. a young patient lost his 
only functional eye, as a result of uncontrol-
lable herpetic keratitis and choroidal effusion. 
Genetic characterization of the donor- and 
recipient derived HSV-1 strains was per-
formed. 
The DNA sequences were identical for both 
strains. The patient proved to be HSV-1 na'ive 
before the transplantation. This study is the 
first to provide conclusive evidence for graft-to-
host transmission with subsequent reactiva-
tion of donor-derived HSV-1 in a corneal 
allograft ". 
PREVENTION OF NEWLY ACQUIRED 
OCULAR HSV-1 INFECTION AFTER PKP 
The afore mentioned data demonstrate 
graft-to-host transmission as one of the possi-
ble sources of HSV-1 infection after PKP. 
The retrospective study on newly acquired 
HSV keratitis after PKP, indicates that 0.85 % 
of patients develop corneal epithelial HSV-1 
infection6 • The actual incidence of newly 
acquired HSV-1 related disease after PKP 
might even be higher. This study focused pri-
marily on epithelial defects, whereas HSV-1 
infections in a corneal graft may also present 
as stromal infiltration or endothelial infection 
resembling an allograft rejection". 
Evidence is emerging that allograft rejec-
tion", primary graft failure", and endothelial 
cell loss of cultured eye bank corneas 1", 1' are 
associated with the presence of HSV-1 DNA 
(Table 1). 
Now that we are aware of the fact that newly 
acquired HSV-1 infection after PKP may not 
be as rare as previously suggested, one could 
ask the following question: "Are there ways to 
prevent this potentially blinding infection?". 
This question is reminiscent of the situation 
with other herpesviruses in transplantation"u2 • 
Corneal HSV-1 infection after PKP in 
seronegative recipients may be due to trans-
mission of the virus, either community or graft 
acquired. The annual HSV-1 seroconversion 
rate among university students averages 5-
10%", and ocular infections occur in only 
about 1 % of those infected''. Therefore, the 
chance of a community acquired ocular HSV-1 
infection can be considered less than 0.1% per 
year. HSV-1 transmission with the donor 
cornea to seronegative patients, which was 
conclusively demonstrated in this thesis 12 , 
should be considered a real risk. In HSV-1 
naive recipients no pre-existing immunity 
against the virus is present and immunosup-
pression by topical steroids to prevent graft 
rejection aggravates this situation. The high 
prevalence (10-20%) of HSV-1 DNA in normal 
and eye bank corneas underlines the serious-
ness of this risk". 
The presence ofHSV-1 antibodies depends 
on age, socio-economic status and geographi-
cal location (Fig. 1)"'". The prevalence of 
HSV-1 DNA in the cornea, and the risk to be 
an HSV-1 seronegative transplant recipient 
will vary accordingly. As the overall seropreva-
lence of HSV-1 is declining" ,., the risk of 
transmission through PKP is increasing. The 
actual rate of transmission ofHSV-1 after PKP 
in immunocompromised humans, however, is 
unknown. In the rabbit model, in which 
HSV-1 nalve animals are immunosuppressed 
for only one week after PKP with an HSV-1 
DNA containing donor cornea, a transmission 
rate for HSV-1 of about 18% was found'". As 
humans are the natural reservoir for this high-
ly infectious virus and are immunosuppressed 
for much longer periods of time after PKP, the 
transmission rate can be expected to be higher 
than in the animal model. 
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TABLE 1: COM PLICATION$ IN CORNEAL ALLOGRAFT I NG ASSOCIATED WITH HSV-1 
Complication data for general PI<P 
population 
n % 
Newly acquired HSV-1 
after PI<P 18/2112' o.85 
Corneal allograft rejection 291/3048' 9.5 
Primary graft fa "!lure 215/10363'' 2.1 
Extreme endothelial cell 
loss in cell culture 7 /1205' o.58 
Determination of the overall infection risk for 
infection with HSV-1 after PKP. 
The following variables should be included 
in the risk calculations: HSV-1 seroprevalence 
(Fig.1), geographic location of the population 
studied, age-distribution of the donor- and 
recipient-population (Fig.2). probability that 
the cornea of an HSV-1 seropositive patient 
contains virus and the transmission rate of 
HSV-1 after PKP (Table 2, Fig. 3 a and b): 
The study of Wutzler " is considered repre-
sentative for the seroprevalence of HSV-1 
on the Western European continent. The 
appropriateness of this assumption is illus-
trated by a pilot study on seroprevalence for 
HSV-1 in 290 recipients of conducted in 
Rotterdam between November 1998 and 
September 2001: 14 % of transplant recipi-
ents is HSV-1 naive (unpublished data). The 
study of Nahmias 2 r, is considered represen-
tative for the seroprevalence ofHSV-1 in the 
USA white (non-hispanic) population and 
the USA black population (Figure 1). 
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HSV-1 associated 
graft failure Method 
n % 
14/25'' 56 viral culture 
8/17u 47 PCR 
··-- ------------·- ------------·--· --------------·- ---------
3 /17" 18 GWc 
2/3" 66 PCR 
9/199" 4-5 PCR 
-----·· --------------·· -------------
.... 
-------------···· -----.----
7 199'' I 3.5 viral culture 
Data about the age composition of corneal 
donor- and recipient populations 1n 
Western Europe are presented in figure 2. 
For the USA, the same age distribution of 
donors and recipients as Western Europe is 
assumed. Given the above-mentioned age 
distribution, the overall seroprevalence of 
HSV-1 in the donor- and recipient-popula-
tion was calculated. 
Presence of HSV-1 DNA in non HSK dis-
eased corneas varies from 10 to 21% 2'·' 1• 
For the transmission rate of HSV-1 after 
PKP a sliding scale was assumed from 20-
100% (fig 3b) 
A postulated negligible risk of superinfec-
tion with HSV-1 after PKP in seropositive 
patients. 
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Seroprevalence of HSV by age 
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Age composition 
Age 
The age composition of corneal donor- and recipients in the Netherlands provided by the National Register for Corneal 
Transplantation under the auspices of the Corneal Study group" Kok~van Alphen" of the Dutch Ophthalmologic Society. 
Bio Implant Services (part of the Netherlands Transplantation Foundation, Leiden) provides all corneal donor tissue for the 
Netherlands in conjunction with related cornea banks on the European continent. 
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Based on these data the overall infection risk 
with HSV-1 after PKP may be estimated to be: 
Overall infection risk~ S0 '' (1-SR) ''eye;, Tr 
S0 = overall seroprevalence in% of HSV-1 
corrected for age distribution of donor 
population 
SR overall seroprevalence in% of H SV-1 
corrected for age distribution of 
recipient population 
eye = proportion of donor corneas containing 
HSV-1 DNA 
Tr ~ transmission rate ofHSV-1 though 
corneal transplantation 
Seronegative patients: 
To prevent HSV-1 transmission by PKP to 
seronegative patients, systemic acyclovir treat-
ment for a period that exceeds that of the 
immunosuppressive treatment is an option-1·'. 
This implies that all recipients should be test-
ed serologically for the presence ofHSV-1 anti-
bodies, before PKP is carried out If in 
addition, also donors would be screened in the 
same way, matching of seronegative recipients 
with seronegative donors, whenever logistical-
ly possible, would be an even more attractive 
option. This could obviate prophylactic antivi-
ral treatment in the matched seronegative 
recipients. 
Seropositive patients: superinfection 
Corneal H S V -1 infection after P KP in 
seropositive patients may be due to reactiva-
tion of latent virus in the TG, or transmission 
of the virus, either community acquired or 
through the corneal graft, resulting in superin-
fection. Although the data in this thesis 
demonstrate that corneal reinfection with a 
different strain is possible and suggest that 
PKP is a risk factor for corneal HSV-1 superin-
fection11, the clinical relevance of this finding 
is unknown. At the time point of sampling, the 
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TABLE 2: 
SEROPREVALENCE IN DONOR-AND RECIPIENT POPULATION WITH 
RESULTING INFECTION RISI( FOR TRANSMISSION RATE OF 100% 
FROM HSV-1 DNA+ CORNEA 
Infection risk in% 
when 10%-20% 
corneas 
Population S0 in% S, in% HSV-1 DNA+ 
West European 
USA white 
USA black 
0-9·1.8 
1.8-3.6 
1-5-3-0 
clinical manifestations of HSV keratitis were 
comparable in the group with genetically dif-
ferent sequential samples. As the chance of 
community acquired HSV-1 ocular infection 
in seronegative patients should be considered 
less than 0.1% per year, the chance for seropos-
itive patients to acquire a superinfection of 
HSV-1 through this route should be consid-
ered much less. 
Seropositive patients: reactivation 
Reactivation of latent virus in the trigemi-
nal ganglion is the most important cause of 
active herpetic keratitis '2 , 11 • In seropositive 
patients probably reactivating stimuli related 
to corneal transplantation play a role in newly 
acquired ocular HSV-1 disease. Surgical trau-
ma, suture removal, steroids and immune 
reactions can be reactivating stimuli". 
Prevention of reactivation of HSV-1 infection 
after PKP in seropositive patients by prophy-
lactic treatment with acyclovir is an option. 
This would mean, however, that all seroposi-
tive corneal transplant recipients should be 
treated during the period of immunosuppres-
sion, with all consequences of unnecessary 
treatment, adverse drug effects, toxicity and 
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Overall Risk for HSV Transmission by Penetrating Keratoplasty 
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Figure 3a: 
Overall infection risk for HSV-1 infection through PI<P as function ofseroprevalence in the donor-and recipient population. 
Transmission rate 10%. The white arrows indicate the calculated overall infection r'1sl< (table 2) for HSV after PKP in differ-
ent geographical locations. 
viral resistance. A more practical approach is, 
to alert ophthalmologists, about the possibility, 
that ocular HSV disease can develop after PKP, 
irrespective of the original diagnosis for trans-
plantation. Awareness of the possible manifes-
tations of ocular HSV disease after PKP, the 
use of appropriate diagnostics in these patients 
and the correct,high dose antiviral treatment, 
may prevent HSV-1 related graft failure and 
the possibly associated corneal blindness. 
Active HSV-1 replication in comeal donor 
tissue: 
Transplantation of donor corneas with 
active HSV-1 replication can be avoided by crit-
ical assessment of the graft prior to surgery 17 • 
The other cornea of the same donor should be 
critically examined as well, and not used for 
transplantation, as the explantation might 
have been performed with the same instru-
ments 1'. 
In this way the incidence of primary graft 
failure associated with HSV-1 might be 
reduced. To date, screening of donor cornea 
fluids for HSV-1 DNA has no additional 
value[). 
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Figure 3b: 
Overall risk for infection through PI<P as a function of seroprevalence of donor-and recipient population and rate of HSV-1 
transmission. 
Collectively our data would lead to the fol-
lowing recommendations: 
Stimulation of awareness amongst ophthal-
mologists about the possible development 
of ocular HSV disease after PKP irrespective 
of the original diagnosis for transplantation. 
Serologic screening of corneal transplant 
recipients, and whenever possible and logis-
tically feasible, matching of recipients and 
donors for HSV-1 sera-status. 
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Prophylactic or early therapeutic treatment 
with systemic acyclovir should be consid-
ered in HSV-1 naive corneal transplant 
recipients, when sera-matching for HSV-1 
of corneal donor and recipients is impossi-
ble. 
Assessment of the role ofHSV-1 infection in 
graft rejection, in a large prospective study. 
127 
IMMUNOPATHOGENESIS OF 
HUMAN HSK 
The immune response following an HSV 
corneal infection resembles that observed fol-
lowing HSV infection at non-ocular sites. 
While the immune response elicited by the 
infecting virus is essential for limiting viral 
spread, it can have detrimental effects on the 
function of the cornea. 
Current knowledge on the pathogenesis of 
HSK is primarily based on studies performed 
in the experimental HSK mouse model. Virus-
specific cellular immune responses are central 
to the pathogenesis of HSK. In the mouse 
CD4~ T helper 1 cells have been demonstrated 
to play a key role''". In the first part of chapter 
4 we demonstrate for the first time an HSV-
specific T cell response in corneas of 2 patients 
with active NSK. Whereas the cornea-derived T 
cells consist of both CD4- T cells and CDS' T 
cells, only CD4' HSV-specific T cells could be 
identified. These observations are in agree-
ment with studies on murine HSK. In con-
trast, the human intra-corneal HSV-specific T 
cells exhibited a Tho phenotype, rather than 
the Th 1 phenotype shown in the mouse. This 
may be due to the culture conditions used to 
isolate and culture human intra-corneal T 
cells. In addition to Langerhans' cells and 
macrophages, HSV-infected corneal kerato-
cytes were able to activate intra-corneal HSV-
specific T cells. 
The enigma in the experimental H S K 
mouse model remains the nature of the anti-
gens recognized by the cornea-infiltrating T 
cells. During the clinical phase of HSK, the 
murine cornea is devoid of replicating virus, 
viral mRNA and viral proteins-"'-' 71 ', suggesting 
that the immune response may not be prima-
rily directed against the infectious virus. 
Alternative sources of antigen have been sug-
gested. HSV replication might unmask and 
alter corneal tissue antigens, normally not pre-
sented to the host immune system. Recent 
studies have provided evidence that HSK in 
the mouse represents an auto-immune 
response to corneal tissue-"'·'111 '" 1 • HSK could be 
induced by CD4'T cells directed to an epitope 
derived from the HSV capsid protein UL6, that 
cross reacts with an epitope of an antigen 
uniquely expressed in the murine cornea;·>.o~u."', 
so-called molecular mimicry. Another explana-
tion for the presence of CD4' T cells is that the 
T cell response results from exposure to 
cytokines in the infected cornea, referred to as 
bystander activation"""'. 
The search for auto-antigens in HSK 
becomes somewhat far-fetched in the human 
situation. In human HSK, replicating virus 
and viral antigens"-' -' 1·"' have been demonstrat-
ed in the cornea during the active as well as the 
inactive phase of stromal keratitis. 
In the second part of chapter 4 we demon-
strate an HSV-specific immune response of 
CD4' T cells in nine of twelve patients. HSV-
speciflc T cells could be detected in corneas of 
patients with either active or quiescent H S K, 
in patients treated with steroids and also in 
HSV DNA-negative corneas. These studies 
demonstrated that virus-specific T cells can 
reside in the cornea for prolonged periods of 
time"·~".-"). 
The role of auto-immunity in human HSK 
was analyzed. In none of the T cell lines gen-
erated from corneas of HSK patients, reactivi-
ty to HSV-UL6 or a soluble protein extract of 
human corneas could be demonstrated. These 
data suggested that the T cell response in HSK 
patients would rather be directed to the initiat-
ing virus than to a human corneal autoantigen 
or HSV UL-6''. We hypothesize that HSV-spe-
cific T cells play an important role in the local 
imrnunopathogenesis of HSK in humans. We 
expect HSV-infected corneal cells or viral pep-
tides retained in the corneal stroma or in 
Langerhans cells may initiate and perpetuate 
this local keratogenic cellular immune 
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response involving the interaction betvveen 
infiltrating inflammatory cells and corneal res-
ident cells by means of soluble factors like Tbl 
cytokines and chemokines. 
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CONCLUDING REMARKS 
The new insights described in the present 
thesis relate to three main areas : 
The dendritic pattern, that develops in HSV 
epithelial keratitis, coincides with the pat-
tern of innervation of the subbasal nerve 
plexus of the cornea, again illustrating the 
neurotropic nature of the virus. 
PKP should be considered a risk factor for 
subsequent HSV infection, resulting from 
either direct viral transmission or reactiva-
tion. 
In herpetic stromal keratitis, HSV specific T 
lymphocytes infiltrate the cornea, suggest· 
ing a causative role in the pathogenesis of 
this inflammatory process. 
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Verschillende ]eden van de familie van 
humane herpesvirus sen kunnen ernstige oog-
ontstekingen veroorzaken. Het humane her-
pesvirus type 1 (HHV-1, HSV-1), hetprototype 
virus van deze familie, is de meest frequente 
oorzaak van primaire en recidiverende oogont-
stekingen. Ondanks de beschikbaarheid van 
effectieve antivirale middelen, is recidiverende 
HSV-1 infectie de hoofdoorzaak van unilatera-
le corneale blindheid in de ge!ndustrialiseerde 
wereld. Dit proefschrift beschrijft nieuwe 
inzichten in de rol van het virus en van de 
intracorneale T-cel respons in de pathogenese 
van HSV keratitis bij de mens. 
I<LINISCHE PRESENTATIE VAN 
EPITH ELIALE HSV KERATITIS 
"ROCI<I NG AROUND THE ClOCK". 
HSV infectie van het cornea-epitheel pre-
senteert zich over het algemeen als een klas-
sieke vertakte laesie, die de naarn "keratitis 
dendritica" draagt HSV infecties van de huid 
daarentegen vertonen deze vertakkingen niet 
(Fig 8, Introduction). Men heeft tot nu toe 
geen verklaring waarom de laesies in de cor-
nea zulke specifieke vertakkingen vertonen. 
Vanwege de neurotrope eigenschappen van 
HSV heeft men al eerder gezocht naar een 
relatie met de anatomie van de innervatie van 
het eindorgaan. Tot nu toe kon deze relatie 
echter niet worden bevestigd. 
Tot voor kart was de innervatie van het cor-
nea-epitheel niet bekend. Pas in 1997 beschrij-
ven Muller et al' de subbasale zenuw plexus 
van het cornea-epitheel als een dicht regelma-
tig netvverk met vertakk:ingen van de zenuwve-
zels die vrijwelloodrecht op elkaar staan. Deze 
blijken georienteerd te zijn in de 9-3 uur of de 
12-6 uur richting'. In hoofdstuk 2 wordt de 
opvallende overeenkomst in vorm aangetoond 
tussen het "dendritica" patroon van epitheliale 
HSV keratitis en de subbasale zenuwplexus 
van het cornea-epitheeL Opvallend is, dat het 
vertak:kingspatroon van "keratitis dendritica" 
na corneatransplantatie hetzelfde blijft, maar 
dat de oorspronkelijke orientatie, in de 9-3 uur 
of de 12-6 uur richting, verloren gaat. De 
bevinding, dat herpestakken in meer of min-
dere mate gedraaid zijn na corneatransplanta-
tie, suggereert dat dezelfde rasterachtige 
anatomie van de subbasale zenuw plexus van 
het cornea-epitheel aanwezig is na transplanta-
tie. Dit kan verklaard worden door te postule-
ren dat de oorspronkelijke tvveedimensiona1e 
orientatie van de donorcornea verloren gaat tij-
dens transplantatie, omdat de cornea donor 
qua orientatie at random gelmplanteerd wordt. 
Reinnervatie van het cornea-epitheel zou, na 
corneatransplantatie, overgebleven structuren 
van de subbasale zenuw plexus kunnen volgen. 
Het uiteindelijke bewijs dat de subbasale 
zenuw plexus verantvvoordelijk is voor het ver-
takkingspatroon van epitheliale herpes kerati-
tis moet gegeven worden door in vivo confocale 
microscopie. 
HSV-1 INFECTIES NA 
CORN EATRANS PlANTATI E 
PENETRERENDE I<ERATOPLASTIEI< 
(PKP) EN HSV KERATITIS. 
Vijf tot 10% van alle PKPs worden verricht 
voor corneatroebelingen als gevolg van HSV-1 
infecties van de cornea2• Corneatransplantatie 
voor de diagnose HSVkeratitis heeft een hoog 
risico op postoperatieve complicaties. Een van 
de oorzaken van postoperatieve problemen 
zijn recidiverende HSV infecties in het trans-
plantaat. Bovendien treden er meer afstotings-
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reaches op als HSV-keratitis de diagnose is, 
waarvoor getransplanteerd wordt, dan wan-
neer de diagnose niet gerelateerd is aan HSV'. 
Het aantal recidieven van HSV keratitis en het 
aantal irreversibele afstotingsreacties neemt af 
als er antivirale profylaxe aan de behandeling 
wordt toegevoegd gedurende de periode dat er 
1mmuunsuppress1e gebruikt wordt·'. Het 
gebruik van antivirale middelen als profYlaxe 
is vooral gebaseerd op gegevens van patienten 
met recidiverende HSV keratitis waarbij geen 
PKP verricht is 1• 
DE NOVO HSV-1 INFECTIE IN DE 
CORNEA NA PKP 
Na corneatransplantatie kunnen HSV-1 
infecties optreden in de cornea, dit ondanks 
het feit dat bij de patient nooit oogheelkundige 
afwijkingen als gevolg van HSV-1 werden 
gediagnostiseerd. Deze bevinding roept vragen 
op over de freguentie en het belang van deze 
infectie, over de wijze van overdracht en over 
de omvang van de groep, die het risico loopt 
deze ontstekingsverschijnselen te krijgen na 
transplantatie. 
In dit proefschrift (hoofdstuk 3) wordt een 
retrospectieve studie beschreven over de resul-
taten van 2398 PKPs'', Van de 2112 patienten, 
die getransplanteerd werden voor diagnosen, 
die niet gerelateerd zijn aan HSV-1 infectie, 
presenteerden 18 patienten zich met een epi-
theliale keratitis in hun transplantaat. De inci-
dentie in deze groep van de novo HSV-1 na 
PKP was 1,2 per 1000 persoon-jaren, hetgeen 
14 keer zo hoog is als in de normale populatie', 
Een recent onderzoek naar de conseguenties 
van deze aandoening bij 25 patienten geeft aan 
dat de meerderheid (n~14) ernstige oogheel-
kundige complicaties ontwikkelde, die uit-
mondden in een visus lager dan 1 J 60'''' binnen 
drie jaar na transplantatie (niet gepubliceerde 
gegevens), In de meeste gevallen treedt de novo 
HSV-1 infectie na PKP op binnen de eerste 
twee jaar na operatie, hetgeen duidt op een 
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oorzakelijke relatie tussen de corneatransplan-
tatie en de HSV-1 infectie. In onze retrospec-
tieve studie bleef de oorsprong van het virus 
onopgehelderd_ Er bestaan meerdere mogelijk-
heden, waaronder reactivatie van latent virus 
in het trigeminus ganglion en transmissie van 
het virus door de donorcornea. Van bacterien, 
schimmels, Creutzfeldt-fakob agens, Hepatitis 
B -en C virussen en rabies virus bestaat bewijs, 
dat deze kunnen worden overgedragen door 
corneatransplantatie". 
Ter bevestiging van de hypothese, dat 
transmissie van HSV-1 door corneatransplan-
tatie mogelijk is, werd een nieuwe, op PCR 
gebaseerde, methode ontwikkeld, die gebaseerd 
is op verschillen van reltererende volgorden 
tussen virusstammen, welke stabiel zijn 
binnen het HSV-1 genoom", 
Deze methode maakte het mogelijk bijna 
92% van niet aan elkaar verwante HSV-1 stam-
men te onderscheiden. Een voordeel van deze 
benadering is dat viruskweek niet noodzakelijk 
is. De methode bleek gevoelig genoeg om de 
lage hoeveelheden virus DNA, die aanwezig 
zijn in corneaweefsel, dat beschikbaar komt na 
transplantatie, te kunnen amplificeren en 
karakteriseren. 
In de literatuur wordt aangenomen, dat 
recidiverende herpes laesies veroorzaakt wor-
den door reactivatie van de stam, die ook de 
primaire infectie heeft veroorzaakt. Super-
infectie met HSV-1 wordt gesuggereerd als 
mogelijkheid, maar men gaat er vanuit dat het 
een zeldzaam verschijnsel is'". In het derde 
dee] van hoofdstuk 3 wordt echter aangetoond, 
dat de frequentie van corneale superinfectie 
met HSV-1 boger is dan verwacht mag worden 
op basis van literatuur gegevens, Met behulp 
van de nieuw ontwikkelde PCR methode werd 
viraal DNA van patienten met recidiverende 
herpes keratitis geamplificeerd en geanaly-
seerd. Aangetoond kon worden dat in 63% 
reactivatie optrad van dezelfde stam (groep1), 
daaruit voortvloeiend had 3 7% van de patien-
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ten een verschillend genotype bij het recidief 
(groep 2). Dit duidt aan dat er een superinfec-
tie plaatsgevonden kan hebben in de periode 
tussen de recidieven. De opvallende hoge fre-
quentie, die gevonden werd, kan veroorzaakt 
zijn doordat er selectie heeft plaatsgevonden 
voor patienten die gevoelig zijn voor herpes 
infecties. Het cohort bestond namelijk vooral 
uit patienten, met ernstige vormen van herpe-
tische keratitis. Een andere mogelijkheid is dat 
er superinfectie is opgetreden met een meer 
virulente stam. Van de klinische gegevens die 
geanalyseerd zijn, was aileen het moment 
waarop PKP verricht werd significant verschil-
lend tussen de twee groepen. Geen van de pa-
tienten van groep 1 onderging een PKP tussen 
de recidieven, terv.rijl 4 van de elf pati€nten van 
groep 2 een P KP ondergingen tussen de 
gekweekte recidieven in. Deze data suggereren 
dat corneatransplantatie een risicofactor is 
voor corneale superinfectie met HSV-1 11 • 
In een vervolgstudie werd de hypothese 
getest, dat transmissie van HSV-1 door corne-
atransplantatie mogelijk is. Een jonge patient 
verloor zijn enige functionele oog, drie maan-
den na PKP voor congenitaal glaucoom, als 
gevolg van een onbehandelbare H SV keratitis 
gecombineerd met een choroidea-effusie syn-
droom. Analyse toonde a an, dat de DNA 
sequenties van de HSV-1 stammen van donor-
en recipient identiek waren. De patient was 
seronegatief voor HSV-1 v66r de operatie. Dit 
onderzoek verschaft voor het eerst onomstote-
lijk bewijs van "graft-to-host" transmissie van 
HSV-1, met daarop volgend reactivatie in de 
getransplanteerde cornea 12 • 
PREVENTIE VAN DE NOVO CORNEALE 
HSV-1 IN FECTI E NA PKP 
De bovengenoemde data wijzen op "graft-
to-host" transmissie als een mogelijke oor-
sprong van HSV-1 infectie na PKP. Het 
retrospectieve onderzoek naar de novo HSV 
keratitis na PKP duidt aan dat 0,85% van de 
getransplanteerde patienten een epitheliale 
HSV-1 keratitis ontwikkelt, terwijl de diagnose 
voor transplantatie niet gerelateerd is aan 
HSV-1 infectie'. 
De werkelijke incidentie van de novo HSV 
keratitis na PKP kan nog hager zijn. Het huidi-
ge onderzoek was gericht op het scoren van 
epitheliale herpetische keratitis, terwijl een 
HSV-1 infectie na corneatransplantatie zich 
'ook kan presenteren als een stromaal infiltraat 
of als een endotheel infectie, die sterke over-
eenkomst vertoont met een afstotingsreactie1l. 
Uit de recente literatuur blijkt dat compli-
caties als afstotingsreactieS14, "primary graft fai-
lure"" en massaal endotheelcelverlies van 
cornea's in weefselkweek"w frequent geassoci-
eerd zijn met de aanwezigheid van HSV-1 
DNA (Tabel1). 
Nu dat we ons bewust zijn van het feit, dat 
de novo HSV-1 infecties na PKP niet z6 zeld-
zaam zijn als voorheen gesuggereerd werd, 
kunnen we ons afvragen of er mogelijkheden 
zijn om deze infectie, die tot corneale blind-
heid kan leiden, te voorkomen. Deze vraag 
doet denken aan de situatie bij andere humane 
herpesvirus sen en transplantatien.n. 
HSV-1 keratitis na PKP in seronegatieve 
ontvangers kan het gevolg zijn van transmissie 
van virus afkomstig uit de gewone populatie of 
van de donor cornea. Het seroconversie per-
centage voor HSV-1 in de normale populatie 
bedraagt 5-10% per jaar". Slechts 1% van deze 
mensen ontvvikkelt ooginfecties"·'. De kans dat 
een HSV-1 seronegatieve patient na PKP het 
virus oploopt vanuit de gewone populatie is 
dus kleiner dan 0,1% per jaar. 
Transmissie van HSV-1 via de donor cornea 
naar een seronegatieve patient, hetgeen nu 
onomstotelijk bewezen is 1", moet dus als een 
reeel risico beschouwd worden. HSV-1 serone-
gatieve ontvangers hebben geen preexistente 
immuniteit tegen het virus en immuunsuppres-
sie door middel van lokaal toegediende stero1-
den verergert deze situatie. De hoge prevalentie 
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TABEL 1: (OMPLICATIES BIJ PKP, GEASSOCIEERD MET HSV-1 
Complicaties data voor de algemene verlies van Tx 
PI<P populatie geassocieerd met HSV-1 Methode 
n % n % 
de novo HSV-1 keratitis 
na PI<P 18/2112" o.85 14/25' 56 virus kweek 
8/17'' 47 PCR 
Afstoti ngsreactie 291/3048' 9-5 -------- ------------- ------------- -------------- ----------------
van de cornea 3 /17" 18 GWc 
"Primary graft failure" 215/10363' 0 2.1 2/3'0 66 PCR 
Massaal endotheelcel- 9/199'' 4-5 PCR 
verlies in weefselkweek 7 /1205' 0.58 ------------ ---------- --- -------------- -------------- --------------
7/199" 3-5 virus kweek 
Seropreva!ence ofHSV by age 
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Figuur 1: 
Seroprevalentie als functie van leeftijd voor de West Europese ', alsmede voor de blanke en de zwarte populatie van de 
Verenigde Staten van Amerika''. 
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De leeftijdssamenstelling van corneadonoren en ontvangers in Nederland beschikbaar gesteld door de corneawerkgroep 
"Kok-van Alphen" onder de ausp·;cien van het Nederlands Oogheelkundig Gezelschap. Bio Implant Serv';ces (Onderdeel 
van de Nederlandse Transplantatie Stichting, Leiden) verzorgt al het corneadonorweefsel voor Nederland in samenwerking 
met cornea ban ken op het Europese continent 
(10"20%) van HSV" 1 DNA in normale en donor 
cornea's onderstreept de ernst van het risico2 '. 
De aanwezigheid van antilichamen tegen 
HSV"1 is afhankelijk van leeftijd, socio-eco-
nomische status en geografische locatie 
(Fig.1)'""- De prevalentie van HSV-1 DNA in 
de cornea, en het risico om een seronegatieve 
recipient te zijn, zal navenant varieren. 
Aangezien de seroprevalentie van HSV-1 
daalt"8 2", neemt het risico voor transmissie 
door PKP toe. 
Het werkelijke transrnissiepercentage van 
HSV-1 door PKP in immuungecompromiteer-
de patienten is onbekend. In het diermodel, 
waar HSV-1 naleve dieren getransplanteerd 
worden met een donorcornea, die HSV-1 DNA 
positief is, worden de dieren slechts een week 
na transplantatie met immuunsuppressiva 
behandeld. In dit onderzoek wordt een trans· 
missie percentage van HSV-1 van ongeveer 
18% gevonden. Aangezien de mens de natuur-
lijke gastheer is van dit zeer besmettelijke 
virus en patienten na transplantatie veellanger 
dan een week immuunsuppressiva gebruiken, 
lijkt een hager transmissiepercentage dan in 
het diermodel niet onwaarschijnlijk. 
Bepaling van het overall infectie risico voor 
infectie met HSV-1 na PKP 
De volgende variabelen moeten betrokken 
worden in de risicoberekening: Seropreva-
lentie van HSV-1 (Fig.1), geografische locatie 
van de onderzochte populatie, leeftijdssamen-
stelling van de donor- en recipient populatie 
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(Fig.2), de kans dat een cornea van een patient, 
die seropositiefis voor HSV-1, inderdaad virus 
bevat en de mate van transmissie van HSV-1 
na PKP. (Tabel 2, Fig. 3 a and b): 
Het onderzoek van Wiitzler27 wordt repre-
sentatiefbeschouwd voor de seroprevalentie 
van HSV-1 op het West-Europese continent. 
Dat deze aanname toegestaan is, wordt 
bevestigd door een pilotstudy naar de serop-
revalentie van HSV-1 in Rotterdam. Van 
november 1998 tot september 2001 werd bij 
290 patienten, die een corneatransplantatie 
ondergingen, de HSV-1 infectie status 
bepaald: 14% van de patienten is seronega-
tief voor HSV-1 (niet gepubliceerde data). 
Het onderzoek van Nahmias"'' wordt repre-
sentatiefbeschouwd voor de seroprevalentie 
van HSV-1 voor de blanke (non-hispanic) 
bevolking en voor de zwarte bevolking van 
de Verenigde Staten. (Fig.!) 
Gegevens over leeftijdssamenstelling van 
corneadonoren en ontvangers in West 
Europa worden weergegeven in figuur 2. 
Aangenomen wordt, dat in de Verenigde 
Staten van Amerika, een vergelijkbare leef-
tijdssamenstelling bestaat als in West 
Europa. 
Op basis van de bovengenoemde leeftijds-
samenstelling werd de overall seroprevalen-
tie in de donor- en recipientpopulatie 
berekend. (tabel 2) 
10 tot 20% van de cornea's, waarbij geen 
oculaire HSV-1 infectie in de voorgeschie-
denis heeft gespeeld, bevat HSV-1 DNA""'. 
Voor de mate van transmissie van HSV-1 na 
PKP wordt een glijdende schaal aangeno-
men van 20-100% (fig 3b). 
Het risico van superinfectie met HSV-1 in 
seropositieve patienten wordt in deze bere-
kening als verwaarloosbaar beschouwd. 
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Gebaseerd op deze variabelen kan het over-
all infectie risico van HSV-1 na PKP geschat 
worden op: 
Overall infectie risico= S0 .,., (1-SR) .,,, oog ·k Tr 
S0 = overall seroprevalentie in% of HSV-1 
gecorrigeerd voor leeftijdssamenstel-
ling van de donor populatie 
SR overall seroprevalentie in% van HSV-1 
gecorrigeerd voor leeftijdssamenstel-
ling van de recipient populatie 
oog = het deel van de donor cornea's dat 
HSV-1 DNA bevat 
Tr = mate van transmissie van HSV-1 door 
corneatransplantatie 
lABEL 2: 
OVERALL SEROPREVALENTIE !N DE DONOR- EN RECIPIENT POPULATIE 
MET HET DAARUIT RESULTERENDE HSV-1 INFECTIE RISICO, UITGAANDE 
VAN 100% TRANSMISSIE UIT HSV-1 DNA+ CORNEA'S 
I nfectie r"1sico ·,n % 
als 10%-20% 
cornea's 
Populatie 50 in% SR in% HSV-1 DNA+ 
West Europa 92 90 0.9-1.8 
VS blank 81 78 1.8-3.6 
VS zwart 83 82 1.5·3.0 
Seronegatieve patienten: 
Ter voorkoming van transmissie van HSV-1 
door PKP naar seronegatieve patienten, bestaat 
de mogelijkheid, preventief systemische thera-
pie met acyclovir te gebruiken gedurende de 
periode dat immuunsuppressieve therapie toe-
gepast word!''. Dit houdt in dat alle ontvangers 
serologisch getest zouden moeten worden op 
de aanwezigheid van HSV-1 antilichamen, 
voordat een corneatransplantatie verricht wordt. 
135 
Overall Risk for HSV Transmission by Penetrating Keratoplasty 
6 
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-----e---1o%of ........-2o%of sera prevalence in percent 
corneas with comeas with 
HSV DNA HSV DNA 
Figure 3a: 
OiJera/1 infectie risico voor HSV-1 infectie na PI<P als functie van seroprevalentie in de donor- en recipient populatie. 
Uitgaande van 100% transmissie. Dewitte pijlen geven het berekende overall infectie risico (tabel 2} aan voor HSV-1 infec-
tie na PKP voor de verschillende geografische locaties. 
Als naast het routinematig testen van de 
ontvanger oak de donor op dezelfde wijze 
getest wordt, ontstaat er een nog gunstiger 
situatie, omdat het dan wellicht mogelijk is 
seronegatieve patH~nten met seronegatieve 
donoren te matchen. Dit zou, als matching 
logistiek haalbaar is, profylactische behande-
ling met acyclovir bij seronegatieve patienten 
overbodig maken. 
Seropositieve patienten: superinfectie 
Bij seropositieve patienten kan een HSV-1 
infectie van de cornea na PKP het gevolg zijn 
van reactivatie van latent virus in het ganglion 
trigeminale of van transmissie van het virus. 
In het laatste geval spreekt men van superin-
fectie. Transmissie kan zowel vanuit de bevel-
king, als vanuit de getransplanteerde cornea 
plaatsvinden. Alhoewel de resultaten in dit 
proefschrift aangeven dat superinfectie van de 
cornea mogelijk is en dat PKP een risicofactor 
is voor HSV-1 superinfectie van de cornea 11 , is 
het klinisch belang van deze bevinding nag 
onbekend. Op het moment van afname van 
kvveken, waren de klinische verschijnselen van 
de H SV keratitis vergelijkbaar in de groep met 
genetisch verschillende sequentiele kweken. 
Aangezien de kans op het verkrijgen van een 
HSV-1 infectie vanuit de bevolking bij serone-
gatieve patienten kleiner dan 0.1% kan worden 
beschouwd, moet de kans voor seropositieve 
patienten op superinfectie met HSV-1 nag 
lager worden ingeschat. 
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011erol/ risico voor infectie met HSV-1 door PI<P als functie van seroprevalentie van donor- en recipient populatie en als 
functie van de mate van HSV-1 transmissie vanuit HSV-1 DNA positieve cornea's. 
Seropositieve patienten: reactivatie 
De voornaamste oorzaak van actieve herpes 
keratitis is waarschijnlijk reactivatie van latent 
virus vanuit het ganglion trigerninale' 1 ' Bij 
seropositieve patienten spelen waarschijnlijk 
reactivatie stimuli gerelateerd aan corneatrans-
plantatie een rol in de novo oculaire H SV -1 
infectie na PKP. Dit zouden kunnen zijn: het 
chirurgische trauma van de operatie of van 
hechtingen verwijderen, het gebruik van stero-
lden en afstotingsreacties(·. Het voorkornen 
van reactivatie door profylactisch gebruik van 
acyclovir is een mogelijkheid. Dit zou betekent 
dat dan alle seropositieve ontvangers van een 
corneatransplantaat behandeld rnoeten wor-
den gedurende de periode van immuunsup-
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pressie, met alle consequenties van onnodige 
behandeling, bijwerkingen, toxiciteit en 
resistentie van het virus. Een andere, meer 
praktische, benadering is om oogartsen te 
waarschuwen, dat oculaire HSV infecties kun-
nen optreden na PKP, onafhankelijk van de 
oorspronkelijke diagnose waarvoor getrans-
planteerd werd. 
Het vertrouwd zijn met de mogelijke pre-
sentaties van oogheelkundige HSV infecties 
na PKP, het gebruik van de juiste diagnosti-
sche middelen in deze patientengroep en de 
juiste, hoge dosis antivirale behandeling kan 
het verlies van het transplantaat en de daarmee 
eventueel geassocieerde corneale blindheid 
voorkomen. 
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Actieve HSV-1 replicatie in comeadononveefsel: 
Transplantatie van donor cornea's met 
actieve HSV-1 replicatie kan voorkomen wor-
den door strenge criteria toe te passen bij de 
preoperatieve beoordeling van het transplan-
taat17. Als een actieve infectie van een cornea is 
aangetoond moet ook de andere cornea van 
dezelfde donor niet voor transplantatie 
gebruikt worden omdat waarschijnlijk dezelf-
de instrumenten gebruikt zijn bij de explanta-
tie17. Op deze wijze zou de incidentie van 
"primary graft failure", geassocieerd met 
HSV-1, gereduceerd kunnen worden. Tot op 
heden heeft de screening op HSV-1 van de 
media, die gebruikt worden bij de weefsel-
kweek geen aanvullende waarde17 • 
Samenvattend leiden deze resultaten tot de 
volgende aanbevelingen: 
Het bewust maken van oogartsen dat H SV 
infecties zich na transplantatie kunnen ont-
wikkelen in het oog, onafhankelijk van de 
diagnose waarvoor de patient getransplan-
teerd is. 
Serologisch screenen van de ontvangers van 
een corneatransplantaat, en zo mogelijk en 
indien logistiek haalbaar, matching van ont-
vanger en donor voor HSV-1 sera-status. 
Als sera-matching van donor en ontvanger 
voor HSV-1 niet mogelijk is, moet overwo-
gen worden profylactische of vroege thera-
peutische behandeling met systemisch 
acyclovir in te stellen bij seronegatieve ont-
vangers van een corneatransplantaat. 
De rol van HSV-1 infecties in afstotingsre-
acties moet nader worden onderzocht m 
een groat prospectief onderzoek. 
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IMMUNOPATHOGENESE VAN 
HUMANE HSK 
De immuunrespons in de cornea, die volgt 
op een HSV infectie, komt overeen met de res-
pons die men waarneemt bij HSV infecties op 
andere locaties in het lichaam. Hoewel deze 
immuunrespons essentieel is om de uitbrei-
ding van het virus te beperken, kan zij de func-
tie van de cornea nadelig belnvloeden. 
De huidige kennis over de pathogenese van 
HSK is vooral gebaseerd op experimenteel 
onderzoek in het HSK model in de muis. De 
virusspecifieke ce11ulaire immuunrespons 
staat centraal in de pathogenese van HSK. In 
het muismodel is aangetoond, dat CD4• T hel-
per 1 cellen een hoofdrol spelen n.l4. In het eer-
ste dee! van hoofdstuk 4 wordt voor de eerste 
keer in de literatuur een HSV-specifieke T eel 
res pons aangetoond in de cornea's van twee 
patienten met een actieve HSK. Hoewel uit de 
cornea's van deze patienten zowel CD4'' T eel-
len als CD8' T cellen konden worden opge-
kweekt, konden aileen CD4' HSV-specifieke T 
cellen worden aangetoond. 
Deze bevindingen stemmen overeen met 
onderzoek in het diermodel. Niet in overeen-
stemming met het diermodel is het ex vivo 
cytokine profiel van de intracorneale T cellen 
in de mens. De humane HSV-specifieke intra-
corneale T cellen vertonen een Tho fenotype, 
terwijl deze cellen in de muis een Thl fenoty-
pe vertonen. Dit zou het gevolg kunnen zijn van 
de kweekomstandigheden gedurende kweek 
van humane intracorneale T cellen. Naast 
Langerhans' cellen en macrofagen bleken HSV-
gelnfecteerde keratocyten in staat intracorneale 
HSV-specifieke T cellen te activeren. 
De grote vraag in het dierexperimentele 
model van HSK blijft, welke antigenen her-
kend worden door de T cellen in de cornea. 
Gedurende de fase waarin HSK in de muis kli-
nisch herkend wordt, kunnen er in de cornea 
noch replicerend virus, noch viraal mRNA, 
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noch virale eiwitten worden aangetoond \),_;(,,) 7 • 
Dit suggereert, dat de immuunrespons niet 
direct gericht zou zijn tegen het virus. 
Alternatieve bronnen van antigenen worden 
geopperd. Zo zou HSV replicatie corneaweef-
selantigenen, die normaliter niet worden 
gepresenteerd aan het immuunsysteem van de 
gastheer, kunnen "ontmaskeren" en zelfs ver-
anderen. 
Recent onderzoek heeft bewi js geleverd, 
dat HSK bij de muis een auto-immuun res-
pons is, die gericht is tegen corneaweefsel"·-'''··w_ 
HSK kan veroorzaakt worden door CD4• T eel-
len die gericht zijn tegen een epitoop van het 
HSV-capside eiwit ULG, dat kruisreageert met 
een epitoop van een antigeen dat specifiek tot 
expressie komt in de cornea van de muis_\9-" 0 ·-", 
de zo gehete "molecular mimicry". Een andere 
verklaring voor de aanwezigheid van CD4 + T 
cellen is, dat de T eel respons het resultaat is 
van blootstelling aan cytokinen in de gelnfec-
teerde cornea, waar naar verwezen wordt als 
"bystander activation"-''--'". 
De zoektocht naar auto-antigenen lijkt 
minder noodzakelijk als men de humane HSK 
pathogenese in ogenschouw neemt. Gedu-
rende zowel de actieve als de inactieve fase 
HSK kunnen bij de mens replicerend virus en 
virale antigenen in de cornea worden aange-
toond·n. 4""''. 
In het tweede dee! van Hoofdstuk 4 wordt 
aangetoond, dat er een HSV-specifieke 
immuunrespons van CD4- T cel1en aanwezig 
is, bij negen van de twaalf patienten met een 
HSK. HSV-specifieke T cellen konden worden 
waargenomen zowel in de cornea van patien-
ten met een actief ontstekingsproces, als in de 
cornea gedurende een rustige fase van HSK. 
Bovendien konden HSV-specifieke T cellen 
worden aangetoond gedurende het gebruik 
van sterolden en in cornea's waar geen HSV 
DNA kon worden gedetecteerd. Meerdere 
onderzoeken van onszelf en anderen tonen 
aan, dat virus specifieke T cellen gedurende 
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lange periodes aanwezig kunnen zijn in de 
cornea46 ·• 7 -~~. De rol van auto-immuniteit in 
HSK bij de mens werd desalniettemin onder-
zocht. In geen van de T cellijnen die verkregen 
werden uit de cornea's van HSK patienten kon 
een reactie op HSV-UL6 of op het oplosbare 
deel van het eiwit extract van humane cornea's 
worden aangetoond. 
Deze voorlopige resultaten suggereren, dat 
de T celrespons in HSK patienten gericht is op 
het verwekkende virus en niet op een cornea-
autoantigen of op HSV-UL6"'. Wij denken dat 
HSV-specifieke T cellen een belangrijke rol 
spelen in de locale immunopathogenese van 
HSK bij de mens. Wij verwachten dat HSV-
geinfecteerde cellen of virale peptiden, die 
achterblijven in het cornea stroma of in 
Langerhans' cellen, deze gelokaliseerde cellu-
laire immuunrespons initieren en het proces 
onderhouden. De immuunrespons bestaat uit 
de interactie tussen ontstekingscellen, die de 
cornea infiltreren, en cellen die al aanwezig 
zijn in de cornea, en maakt gebruik van che-
mokines en Th cytokines. Het bewijs dat 
genoemde T cellen inderdaad bij de pathoge-
nese betrokken zijn, is formeel echter niet 
geleverd. 
140 
(ONCLUDERENDE OPMERKINGEN: 
De nieuwe inzichten, die in dit proefschrift 
beschreven worden, betreffen drie onderwerpen: 
Het "dendritica" patroon, dat zo kenmer-
kend is voor epitheliale HSV keratitis, komt 
overeen met het patroon van de subbasale 
zenuw plexus van het cornea-epitheel, het-
geen opnieuw het neurotrope karakter van 
de het herpes simplex virus onderstreept. 
PKP moet als een risicofactor beschouwd 
worden voor een daaropvolgende HSV 
infectie, die ofVvel het resultaat is van direc-
te virale transmissie ofwel van reactivatie 
van het virus. 
Bij een HSK infiltreren HSV-specifieke T 
lymfocyten de cornea, hetgeen suggereert 
dat zij een oorzakelijke rol spelen in de 
pathogenese van dit ontstekingsproces. 
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ABBREVIATIONS 
ACAID anterior chamber associated PGF primary graft failure 
immune deviation PHA-L phytohemagglutinin-L 
AIDS acquired immunodeficiency PKP penetrating keratoplasty 
syndrome PMN polymorphonuclear cells 
APC antigen presenting cell r IFN recombinant interferon 
BLCL B lymphocyte cell lines Re reiteration 
CNS Central Nervous System RFLP restriction fragment length 
cpm counts per minute polymorphism 
DNA desoxy ribonucleic acid rHK recrudescent herpetic keratitis 
EBV Epstein-Barr virus r!L recombinant interleukin 
EM electron micrograph RNA ribonucleic acid 
gC glycoprotein C RT-PCR reverse transcription polymerase 
GI gastro-intestinal chain reaction 
GWc Goldman-Witmer coefficient rVV recombinant vaccinia virus 
HCMV human cytomegalovirus SEI subepithelial infiltrates 
HEK herpetic epithelial keratitis SPK superficial punctate keratitis 
HHV human herpes virus TCC T cell clones 
HSK herpetic stromal keratitis TCL T cell lines 
HSV herpes simplex virus TCR T cell receptor 
HuSoCo human soluble cornea protein TG trigeminal ganglion 
HZO herpes zoster ophthalmicus TGF transforming growth factor 
ICP infected cell protein Th T helper 
IEK infectious epithelial keratitis TNF tumour necrosis factor 
lFN interferon TR terminal reiterated sequence 
Ig immunoglobuline Tx transplantation 
IL interleukin transplantatie 
IR internal reiterated sequence UL unique long sequence 
ISK immune stromal keratitis Us unique short sequence 
kb kilo base pairs vzv varicella-zoster virus 
KP keratic precipitates 
LAT latency associated transcript 
LCs Langerhans cells 
MAbs mouse anti-human monoclonal 
antibodies 
MHC major histocompatibility complex 
MOl multiplicity of infection 
NK natural killer cell 
NSK necrotizing stromal keratitis 
PBMC peripheral blood mononuclear cell 
PCR polymerase chain reaction 
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DANI<WOORD 
Wetenschappelijk onderzoek kan een grote 
impuls krijgen door het uitwisselen van kennis 
tussen "specialisten" uit verschillende vakge-
bieden. Het, met meerdere mensen, vanuit ver-
schillende invalshoeken aan een ondervverp 
werken, is niet aileen nuttig, maar ook enorm 
inspirerend. Ik ben dankbaar dat ik dee! heb 
mogen uitmaken van een prachtig wetenschap-
pelijk spinnenweb. Het feit dat uiteindelijk 
mijn naam op dit proefschrift mag staan is dan 
ook te danken aan een groat aanta1 mensen. 
Ten eerste aan alle patienten, die belange-
loos hebben deelgenomen aan het onderzoek. 
Zonder uw medewerking had dit onderzoek 
nooit plaats kunnen vinden. 
Mijn promotor, Ab Osterhaus, jouw dyna-
miek en stuwende kracht hebben een enorme 
bijdrage geleverd aan dit proefschrift. Door 
jouw directe steun aan het onderzoek bleef 
alles op hoog tempo door rollen. fe gave om 
scherp te formuleren, zal een blijvend voor-
beeld voor mij zijn bij toekomstig werk. 
Mijn copromoter, Georges Verjans, zonder 
jouw komst naar Rotterdam was dit proefschrift 
er nooit geweest. Op het moment van je komst, 
stand mijn onderzoek naar de pathogenese van 
herpes keratitis nog maar net in de steigers. Door 
jouw inbreng werd een nieuwe dimensie toege-
voegd. In alle fasen van het daaropvolgende 
onderzoek en schrijfWerk heb je deelgenomen, 
gestuurd en gediscussieerd. De leiding van het 
werk voor ons onderzoek op de afdeling virologie 
was bij jou absoluut in goede handen. 
Houdijn Beekhuis, je hebt aan de wieg 
gestaan van het onderzoek, dat geleid heeft tot 
dit proefschrift en bij alle stappen heb je me 
ondersteund met opbouwende kritiek. fe geeft 
aan het woord 'collega' een hele bijzondere invul-
ling. Ik beschouw het als een groot voorrecht 
door jou te zijn opgeleid tot comeaspecialist. 
Mijn andere collega's van de comeagroep, 
Annette Geerards en Jeroen van Rooij, jullie heb-
ben mij altijd geholpen met het verzamelen van 
patientenmateriaal en hebben mij de ruimte 
gegeven om, naast het khnisch werk, dat we 
samen volbrengen, mijn proefschrift te voltooien. 
Alle medeauteurs van de artikelen wil ik 
bedanken voor hun bijdrage aan het onder-
zoek. In het bijzonder feroen van Maertzdorf, 
AnnaMarie Lohman en Peter Doornenbal, 
voor hun enthousiasme en inzet. 
Seerp Baarsma, mede door jou hulp is de 
samenwerking met de afdeling virologie zeer 
vruchtbaar geworden. Het is heerlijk om met orga-
nisatorische vragen op jou terug te lmnnen vall en. 
De staf en assistenten van het Oogzieken-
huis, voor de goede sfeer en gezelligheid in ons 
ziekenhuiS. 
Al1e medewerkers van het Oogziekenhuis 
die geholpen hebben met het afnemen van 
bloedmonsters en met de verzending van alle 
material en. 
Ans Hoogendam, voor je niet aflatende 
zorg om mijn werk in het Oogziekenhuis in 
goede barren te leiden. 
Amanda Ottevanger en Nelleke Wigboldus, 
voor de zorg voor onze kinderen als ik weer 
eens een uurtje !anger weg was dan gepland. 
Mijn familie, die altijd enorm meeleeft met 
mijn doen en Iaten, jullie hebben je niet onbe-
tuigd gelaten met lieve adviezen. Marijke, wat 
is het fijn, dat je, net als altijd, naast me wil 
staan. Dit keer bij de verdediging van mijn 
proefschrift. 
Pons, Lot en Bas, jullie hebben me de vrij-
heid gegeven om dit proefschrift te schrijven 
naast mijn "gewone werk" en rnijn "plichten" 
als moedertje. fullie geduld is behoorlijk op de 
proef gesteld doordat ik herhaaldelijk van 
boven geroepen heb: "het is bijna af". 
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